"AHC","PY","nTotDoc","meanAUPerArt","meanAU_IN_PerArt","meanArtWith_AU_IN_FIRST","meanArtWith_AU_IN_LAST","meanArtWith_AU_IN_CORR","mean_articles_per_internal_author","mean_articles_per_internal_first_author","mean_articles_per_internal_last_author","mean_articles_per_internal_corresponding_author","ArtOA","singleAuArt","Q1_nSJR","Q2_nSJR","Q3_nSJR","Q4_nSJR","Q1_percSJR","Q2_percSJR","Q3_percSJR","Q4_percSJR","meanTCperArt","mean_NTC","meanCitationTrend","InternCoauthorship","AffCoauthorship","GC_AUIN_wFractional","GC_AUIN_FIRSTname","GC_AUIN_LASTname","GC_AUIN_CORRESP","top_AU","top_AU_freq","top_AU_wFract","top_AU_freq_wFract","top_AUIN","top_AUIN_freq","top_AUIN_wFract","top_AUIN_freq_wFract","topAUbyCit","topAUbyCit_TC","topAUINbyCit","topAUINbyCit_TC","topAUINbyCit_norm_byYear","topAUINbyCit_TC_norm_byYear","topConcept_L0","topFreq_L0","topConcept_L1","topFreq_L1","topConcept_L2","topFreq_L2","topConcept_L3","topFreq_L3","topConcept_L4","topFreq_L4","topMESH","topMESH_n","topprimary_topic.display_name","topprimary_topic.display_name_n","topDE","topDE_n","topTI_TM","topTI_TM_n","topAB_TM","topAB_TM_n","nDoc_wALTM","percDoc_wALTM","altmetric_score_thirdQu","cited_by_accounts_count_thirdQu","cited_by_fbwalls_count_thirdQu","cited_by_feeds_count_thirdQu","cited_by_gplus_count_thirdQu","cited_by_msm_count_thirdQu","cited_by_patents_count_thirdQu","cited_by_peer_review_sites_count_thirdQu","cited_by_policies_count_thirdQu","cited_by_posts_count_thirdQu","cited_by_rdts_count_thirdQu","cited_by_rh_count_thirdQu","cited_by_tweeters_count_thirdQu","cited_by_videos_count_thirdQu","cited_by_wikipedia_count_thirdQu","cohorts.com_thirdQu","cohorts.doc_thirdQu","cohorts.pub_thirdQu","cohorts.sci_thirdQu","readers.citeulike_thirdQu","readers.connotea_thirdQu","readers.mendeley_thirdQu","readers_count_thirdQu","n_patentsDistinct","nPatentStatus_Abandoned","nPatentStatus_Granted","nPatentStatus_N/A","nPatentStatus_Pending","nPatentStatus_Active","nPatentStatus_Not-in-force","nPatentStatus_Expired - Fee Related","nPatentStatus_Withdrawn","nPatentStatus_Ceased","nPatentStatus_Revoked","nPatentStatus_Expired - Lifetime","nPatentPubType_Application","nPatentPubType_Grant","nPatentPubType_N/A","avg_citations_Patent","avg_Inventors_Patent","inventor_per_AUIN_100","avg_InstitutesInvolved_Patent","nPatent_singleInventor","n_Patents_CoAff","n_Jurisdiction_distinct","nJurisd_AU","nJurisd_CA","nJurisd_EP","nJurisd_IN","nJurisd_CN","nJurisd_US","nJurisd_DE","nJurisd_ES","nJurisd_IT","nJurisd_AT","nJurisd_BR","nJurisd_WO","nJurisd_JP","nJurisd_DK","nJurisd_IL","nJurisd_PT","nJurisd_PL","nJurisd_FR","nJurisd_SA","nJurisd_MY","nJurisd_KR","nJurisd_NL","nJurisd_CO","nJurisd_SM","nJurisd_SI","nJurisd_HR","nJurisd_RU","nJurisd_EA","nJurisd_MX","nJurisd_HK","nPatentKC_A1","nPatentKC_A","nPatentKC_A2","nPatentKC_B1","nPatentKC_D1","nPatentKC_T3","nPatentKC_B2","nPatentKC_T1","nPatentKC_A3","nPatentKC_C","nPatentKC_B","nPatentKC_C2","nPatentKC_C0","nPatentKC_A8","nPatentKC_E","nPatentKC_T4","nPatentKC_D0","nPatentKC_T2","nPatentKC_A0","nPatentKC_B8","nPatentKC_A4","nPatentKC_T8","nPatentKC_C1","nPatentKC_U1","nPatentKC_T5","nPatentKC_B3","nPatentKC_T7","nPatentKC_A9","top_Inventor names_Patent","top_Inventor names_Patent_n","top_Original assignee names_Patent","top_Original assignee names_Patent_n","top_Fields of Research (ANZSRC 2020)_Patent","top_Fields of Research (ANZSRC 2020)_Patent_n","top_RCDC Categories_Patent","top_RCDC Categories_Patent_n","top_HRCS RAC Categories_Patent","top_HRCS RAC Categories_Patent_n","top_IPCR_Patent","top_IPCR_Patent_n","top_CPC_Patent","top_CPC_Patent_n","n_clTrial","avg_durationYear_clTrial","avg_participants_clTrial","clTrial_perAUIN_100","nClTrial_w_AltmScore","cl_AltmS_rel","avg_sponsor_clTrial","nclTrialPhase_Phase 1","nclTrialPhase_Phase 1/2","nclTrialPhase_Phase 2","nclTrialPhase_Phase 2/3","nclTrialPhase_Phase 3","nclTrialPhase_Phase 3/4","nclTrialPhase_Phase 4","nclTrialPhase_N/A","nclTrialPhase_Post Authorisation Studies","nclTrial_StudyType_Interventional","nclTrial_StudyType_Observational","nclTrial_StudyType_Other","nclTrial_StudyType_Expanded access","nclTrial_StudyType_Active surveillance","nclTrial_StudyType_Non-interventional","nclTrial_StudyType_RCT","nclTrial_StudyType_CCT","nclTrial_Gender_All","nclTrial_Gender_Female","nclTrial_Gender_Male","nclTrial_Registry_ClinicalTrials.gov","nclTrial_Registry_EU-CTR","nclTrial_Registry_ENCePP","nclTrial_Registry_ISRCTN","nclTrial_Registry_ANZCTR","nclTrial_Registry_GCTR","nclTrial_Registry_PACTR","nclTrial_Registry_CTRI","nclTrial_Registry_ReBEC","nclTrial_Registry_UMIN-CTR","top_funder_country","top_funder_country_n","top_Fields of Research (ANZSRC 2020)_clTrial","top_Fields of Research (ANZSRC 2020)_clTrial_n","top_RCDC Categories_clTrial","top_RCDC Categories_clTrial_n","top_HRCS HC Categories_clTrial","top_HRCS HC Categories_clTrial_n","top_HRCS RAC Categories_clTrial","top_HRCS RAC Categories_clTrial_n","top_Cancer Types_clTrial","top_Cancer Types_clTrial_n","top_CSO Categories_clTrial","top_CSO Categories_clTrial_n","n_grants","avg_funding_EUR","avg_funding_EUR_perOrganization","avg_durationYear_grant","avg_Organization_per_grant","avg_countries_per_grant","perc_grant_internationalColl","avg_ResultingPublications_per_grant","totFundingOrgbyActivedGrant","avgPubByActivedFundingGrant_1000","top_Research Organization - standardized_Grants","top_Research Organization - standardized_n_Grants","top_Funder_Grants","top_Funder_n_Grants","top_Funder Group_Grants","top_Funder Group_n_Grants","top_Program_Grants","top_Program_n_Grants","top_Fields of Research (ANZSRC 2020)_Grants","top_Fields of Research (ANZSRC 2020)_n_Grants","top_RCDC Categories_Grants","top_RCDC Categories_n_Grants","top_HRCS HC Categories_Grants","top_HRCS HC Categories_n_Grants","top_HRCS RAC Categories_Grants","top_HRCS RAC Categories_n_Grants","top_Cancer Types_Grants","top_Cancer Types_n_Grants","top_CSO Categories_Grants","top_CSO Categories_n_Grants","top_Units of Assessment_Grants","top_Units of Assessment_n_Grants","top_Sustainable Development Goals_Grants","top_Sustainable Development Goals_n_Grants","n_dataset","top_Repository_Dataset","top_Repository_Dataset_n","top_Fields of Research (ANZSRC 2020)_Dataset","top_Fields of Research (ANZSRC 2020)_Dataset_n","top_RCDC Categories_Dataset","top_RCDC Categories_Dataset_n","top_HRCS HC Categories_Dataset","top_HRCS HC Categories_Dataset_n","top_HRCS RAC Categories_Dataset","top_HRCS RAC Categories_Dataset_n","top_Health Research Areas_Dataset","top_Health Research Areas_Dataset_n","top_Broad Research Areas_Dataset","top_Broad Research Areas_Dataset_n","top_Cancer Types_Dataset","top_Cancer Types_Dataset_n","top_Sustainable Development Goals_Dataset","top_Sustainable Development Goals_Dataset_n"
"AOUSSN_GIACCONE",2000,5,5.8,1,1,0,1,1,1,0,1,0,0,0,0,2,3,0,0,0.4,0.6,32.2,0.71033102946526,NA,0,0.4,0.239,0,0,0,"G BIZZINI;VITALE MICELI;L MARASÀ;A. MINORE;ROBERTO LAGALLA;STEFANIA D’AGOSTINO;GIOVANNI SAVETTIERI;A CARCIONE;M FINAZZO;ROCCO URSO;GABRIELLA SCHIERA;MARIA PIA AMATO;LUANA LICATA;VINCENZO TURCO LIVERI;CATERINA CATANIA;GIULIA GIANDALIA;ALESSANDRO CESTELLI;LIBERO ITALO GIANNOLA;MASSIMO MIDIRI;ITALIA DI LIEGRO","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","A. MINORE;MARIA PIA AMATO;VINCENZO TURCO LIVERI;V. MARCIANÒ;SCARPITTA AM;D SINAGRA;G BIZZINI;VITALE MICELI;L MARASÀ;ROBERTO LAGALLA;A CARCIONE;M FINAZZO;ROCCO URSO;MASSIMO MIDIRI;R LAGALLA;ANGELO IOVANE;GIUSEPPE CARUSO;MAURIZIO DE MARIA;STEFANIA D’AGOSTINO;GIOVANNI SAVETTIERI","0.33;0.33;0.33;0.33;0.33;0.33;0.17;0.17;0.17;0.17;0.17;0.17;0.17;0.17;0.17;0.17;0.17;0.17;0.09;0.09","ROBERTO LAGALLA;GIOVANNI SAVETTIERI;V. MARCIANÒ;ANGELO IOVANE;D SINAGRA","1;1;1;1;1","V. MARCIANÒ;D SINAGRA;ROBERTO LAGALLA;ANGELO IOVANE;GIOVANNI SAVETTIERI","0.33;0.33;0.17;0.17;0.09","ALESSANDRO CESTELLI;CATERINA CATANIA;GABRIELLA SCHIERA;GIOVANNA LAURA PITARRESI;GIOVANNI SAVETTIERI;GIULIA GIANDALIA;ITALIA DI LIEGRO;LIBERO ITALO GIANNOLA;LUANA LICATA;STEFANIA D’AGOSTINO;VIVIANA DE;A. MINORE;V. MARCIANÒ;VINCENZO TURCO LIVERI;G BIZZINI;GIUSEPPE CARUSO;L MARASÀ;ROBERTO LAGALLA;ROCCO URSO;VITALE MICELI","122;122;122;122;122;122;122;122;122;122;122;27;27;27;5;5;5;5;5;5","GIOVANNI SAVETTIERI;V. MARCIANÒ;ROBERTO LAGALLA;D SINAGRA;ANGELO IOVANE","122;27;5;4;3","ANGELO IOVANE;D SINAGRA;GIOVANNI SAVETTIERI;ROBERTO LAGALLA;V. MARCIANÒ","1;1;1;1;1","MEDICINE;CHEMISTRY;ENGINEERING;BIOLOGY;COMPUTER SCIENCE;PHYSICS","3;2;2;1;1;1","BIOCHEMISTRY;INTERNAL MEDICINE;RADIOLOGY;ANATOMY;ARTIFICIAL INTELLIGENCE;CELL BIOLOGY;CHEMICAL ENGINEERING;CHROMATOGRAPHY;CIVIL ENGINEERING;ENDOCRINOLOGY;GASTROENTEROLOGY;INORGANIC CHEMISTRY;NEUROSCIENCE;NUCLEAR MEDICINE;ORGANIC CHEMISTRY;PATHOLOGY;SURGERY;THERMODYNAMICS;UROLOGY","2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","AQUEOUS SOLUTION;ASYMPTOMATIC;BEDTIME;BIOPSY;CANCER;CARCINOMA;CENTRAL NERVOUS SYSTEM;CONTRAST (VISION);CORONAL PLANE;DIABETES MELLITUS;EVAPORATION;EXTRACELLULAR;EXTRACELLULAR MATRIX;GENE;GRADING (ENGINEERING);GROUP B;HEPTANE;IN VITRO;INSULIN;LESION;MAGNETIC RESONANCE IMAGING;MATRIX (CHEMICAL ANALYSIS);NANOPARTICLE;PULMONARY SURFACTANT;RADIOGRAPHY;REGIMEN;SAGITTAL PLANE;SALT (CHEMISTRY);SOFT TISSUE;SOLVENT;SUPINE POSITION;TENDON;TIGHT JUNCTION;ULTRASONOGRAPHY;URIC ACID","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ACHILLES TENDON;BLOOD–BRAIN BARRIER;COLOR DOPPLER;ENDOTHELIAL STEM CELL;GLYCEMIC;HYPOGLYCEMIA;LAMININ;MESSENGER RNA;MICELLE;MICROEMULSION;OCCLUDIN;PROSTATE;PROSTATE CANCER;TENDINOPATHY;TYPE 2 DIABETES","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","","","CARCINOMA;ENDOTHELIUM, VASCULAR;PROSTATE;PROSTATIC NEOPLASMS;BLOOD-BRAIN BARRIER;BONE DISEASES;BRAIN;DIABETES MELLITUS, TYPE 2;EXTRACELLULAR MATRIX;HUMANS;MALE;MEMBRANE PROTEINS;NEOVASCULARIZATION, PATHOLOGIC;NEURONS;TIGHT JUNCTIONS;ULTRASONOGRAPHY, DOPPLER, COLOR;CEREBROVASCULAR CIRCULATION;COLLAGEN;FEMALE;GLIAL FIBRILLARY ACIDIC PROTEIN","4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2","ANKLE INJURIES AND DISORDERS IN SPORTS MEDICINE;BLOOD-BRAIN BARRIER AND NEUROVASCULAR INTERACTIONS;MANAGEMENT OF DIABETES MELLITUS AND HYPOGLYCEMIA;ROLE OF CCN PROTEINS IN SIGNALING PATHWAYS;SURFACTANT AGGREGATION AND SELF-ASSEMBLY PHENOMENA","1;1;1;1;1","BEDTIME;COLOR DOPPLER;DIABETES;ENDOTHELIAL CELLS;GRADING (ENGINEERING);GROUP B;HEPTANE;INSULIN THERAPY;LIGAMENT RECONSTRUCTION;MATRIX (CHEMICAL ANALYSIS);MICROEMULSION;MICROEMULSIONS;OCCLUDIN;PROSTATE CANCER;REGIMEN;SUPINE POSITION;TYPE 1 DIABETES;TYPE 2 DIABETES","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","AGENTS COMBINED;BRAIN ENDOTHELIAL;COLOR DOPPLER;COMBINED THERAPY;CONTRAST MEDIUM;ECM REGULATE;ENDOTHELIAL CELLS;HYPOGLYCEMIC AGENTS;INSULIN-ORAL HYPOGLYCEMIC;MAGNETIC RESONANCE;OCCLUDIN LOCALIZATION;OS TRIGONUM;PREPARE SOLID;PROSTATIC CARCINOMAS;REGULATE OCCLUDIN;SIMPLE METHOD;SOLID NANOPARTICLES;SYNDROME ROLE;TARSI SYNDROME;TRIGONUM TARSI;TYPE DIABETES;WATER-IN-OIL MICROEMULSIONS;WATER-SOLUBLE SALTS","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","","",2,0.4,6,2.75,0,0,0,0,2.75,0,0,2.75,0,0,0,0,0,0,0,0,0,0,0,50.25,50.25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,15,142.5,40,0,0,12.5,0,1,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,0,"Italy","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS","2;1;1","CLINICAL RESEARCH;AUTOIMMUNE DISEASE;CANCER;CHRONIC PAIN;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;DIGESTIVE DISEASES;LUNG;LUNG CANCER;MENTAL HEALTH;NEURODEGENERATIVE;NEUROSCIENCES;ORPHAN DRUG;PAIN RESEARCH;RARE DISEASES","2;1;1;1;1;1;1;1;1;1;1;1;1;1","CANCER;INFLAMMATORY AND IMMUNE SYSTEM;NEUROLOGICAL;ORAL AND GASTROINTESTINAL","1;1;1;1","6.1 PHARMACEUTICALS","1","LUNG CANCER","1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_GIACCONE",2001,6,9,3.33333333333333,0.5,0.333333333333333,0.5,1.11111111111111,0.75,0.666666666666667,0.75,0.5,0,3,1,1,1,0.5,0.17,0.17,0.17,21,0.459594739203977,NA,0,0.666666666666667,0.205,0.167,0.167,0.167,"STEFANIA GRIMAUDO;MANLIO TOLOMEO;ANTONIO RUSSO;DANIELE SIMONI;EUGENIA BAJARDI;GIOVANNA PITARRESI;MARINELLA ROBERTI;MARIA ROSARIA VALERIO;MARCELLO CAMPIONE;VITTORIO GEBBIA;L. MANFRÈ;ROBERTO LAGALLA;STEFANIA D’AGOSTINO;M.G. ARMATA;GIOVANNI PANTUSO;ENRÌCO CILLARI;GIOVANNI SAVETTIERI;G. AGOSTA;GLORIA DI BELLA;RICCARDO RONDANIN","2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ANTONIO RUSSO;STEFANIA GRIMAUDO;MANLIO TOLOMEO;DANIELE SIMONI;MARCELLO CAMPIONE;L. MANFRÈ;ROBERTO LAGALLA;GIUSEPPE SALVAGGIO;FABIO CARRARA;GIUSEPPE CARUSO;VITTORIO GEBBIA;VIVIANA BAZAN;GABRIELLA DARDANONI;GAETANO LETO;F M TUMMINELLO;ROSA MARIA TOMASINO;MARINELLA ROBERTI;RICCARDO RONDANIN;RICCARDO BARUCHELLO;FRANCESCO PAOLO INVIDIATA","0.23;0.21;0.21;0.21;0.17;0.17;0.17;0.17;0.17;0.17;0.14;0.14;0.14;0.14;0.14;0.14;0.11;0.11;0.11;0.11","STEFANIA GRIMAUDO;MANLIO TOLOMEO;ANTONIO RUSSO;EUGENIA BAJARDI;MARIA ROSARIA VALERIO;M.G. ARMATA;GIOVANNI PANTUSO;GIOVANNI SAVETTIERI;G. AGOSTA;GIUSEPPE CICERO;GASPARE GULOTTA;M LATTERI;GIUSEPPE MODICA;GIUSEPPE CARUSO;NICOLA GEBBIA;NELLO GRASSI;ROSA MARIA TOMASINO;PIETRO D'AGOSTINO","2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ANTONIO RUSSO;STEFANIA GRIMAUDO;MANLIO TOLOMEO;GIUSEPPE CARUSO;ROSA MARIA TOMASINO;GIOVANNI SAVETTIERI;PIETRO D'AGOSTINO;EUGENIA BAJARDI;MARIA ROSARIA VALERIO;M.G. ARMATA;GIOVANNI PANTUSO;G. AGOSTA;GIUSEPPE CICERO;GASPARE GULOTTA;M LATTERI;GIUSEPPE MODICA;NICOLA GEBBIA;NELLO GRASSI","0.23;0.21;0.21;0.17;0.14;0.1;0.1;0.08;0.08;0.08;0.08;0.08;0.08;0.08;0.08;0.08;0.08;0.08","ALESSANDRO CESTELLI;CATERINA CATANIA;GABRIELLA SCHIERA;GIOVANNA PITARRESI;GIOVANNI SAVETTIERI;GIULIA GIANDALIA;ITALIA DI LIEGRO;LUANA LICATA;STEFANIA D’AGOSTINO;VIVIANA DE;DANIELE SIMONI;MANLIO TOLOMEO;STEFANIA GRIMAUDO;CATERINA BARBERA;ENRÌCO CILLARI;GLORIA DI BELLA;MARZIA LA ROSA;PIETRO D'AGOSTINO;SALVATORE MILANO;VIVIANA FERLAZZO","63;63;63;63;63;63;63;63;63;63;41;41;41;30;30;30;30;30;30;30","GIOVANNI SAVETTIERI;MANLIO TOLOMEO;STEFANIA GRIMAUDO;PIETRO D'AGOSTINO;ANTONIO RUSSO;EUGENIA BAJARDI;G. AGOSTA;GASPARE GULOTTA;GIOVANNI PANTUSO;GIUSEPPE CICERO;GIUSEPPE MODICA;M LATTERI;M.G. ARMATA;MARIA ROSARIA VALERIO;NELLO GRASSI;NICOLA GEBBIA;ROSA MARIA TOMASINO;GIUSEPPE CARUSO","63;41;41;30;17;17;17;17;17;17;17;17;17;17;17;17;5;0","MANLIO TOLOMEO;STEFANIA GRIMAUDO;ANTONIO RUSSO;EUGENIA BAJARDI;G. AGOSTA;GASPARE GULOTTA;GIOVANNI PANTUSO;GIOVANNI SAVETTIERI;GIUSEPPE CICERO;GIUSEPPE MODICA;M LATTERI;M.G. ARMATA;MARIA ROSARIA VALERIO;NELLO GRASSI;NICOLA GEBBIA;PIETRO D'AGOSTINO;ROSA MARIA TOMASINO;GIUSEPPE CARUSO","2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;0","BIOLOGY;MEDICINE;CHEMISTRY","4;4;3","BIOCHEMISTRY;CANCER RESEARCH;BIOTECHNOLOGY;INTERNAL MEDICINE;BIOPHYSICS;CELL BIOLOGY;ENDOCRINOLOGY;GASTROENTEROLOGY;GENETICS;IMMUNOLOGY;NEUROSCIENCE;PATHOLOGY;PHARMACOLOGY;PSYCHIATRY;RADIOLOGY;STEREOCHEMISTRY;SURGERY","4;3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1","APOPTOSIS;IN VITRO;IN VIVO;ANTIBIOTICS;CARCINOMA;CELL CULTURE;CENTRAL NERVOUS SYSTEM;CHEMOTHERAPY;CIRCLE OF WILLIS;CLINICAL TRIAL;CONTRAST MEDIUM;DOPAMINE;ENZYME;GENE;INTERNAL CAROTID ARTERY;ISOXAZOLE;LEUKEMIA;LUNG CANCER;MEMBRANE;MOIETY;NEUROLOGY;PERFUSION;PLASMINOGEN ACTIVATOR;REGIMEN;STENOSIS;TIGHT JUNCTION;TOXICITY;ULTRASOUND;UROKINASE","2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CYTOTOXIC T CELL;BIOLOGICAL ACTIVITY;BLOOD–BRAIN BARRIER;CATHEPSIN D;CYTOTOXICITY;DOCETAXEL;DOXYCYCLINE;EPIDERMOID CARCINOMA;INTERIM ANALYSIS;MICROBUBBLES;MULTIPLE DRUG RESISTANCE;NEURORADIOLOGY;NEUTROPENIA;OCCLUDIN;PERFORMANCE STATUS;PERMEABILITY (ELECTROMAGNETISM);PERMEATION;PROGRAMMED CELL DEATH;RETINOIC ACID;STRUCTURE–ACTIVITY RELATIONSHIP","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CASPASE;FEBRILE NEUTROPENIA;MECHANICAL INDEX","1;1;1","HUMANS;PACLITAXEL;AGED;ANTINEOPLASTIC AGENTS, PHYTOGENIC;CARCINOMA, SQUAMOUS CELL;LARYNGEAL NEOPLASMS;MIDDLE AGED;TETRACYCLINES;ADULT;ANTI-BACTERIAL AGENTS;APOPTOSIS;BIOMARKERS, TUMOR;BRAIN ISCHEMIA;CARCINOMA, NON-SMALL-CELL LUNG;CAROTID ARTERY DISEASES;CAROTID ARTERY, INTERNAL;CAROTID STENOSIS;CASPASES;CATHEPSIN D;CELL SURVIVAL","4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2","BLOOD-BRAIN BARRIER AND NEUROVASCULAR INTERACTIONS;DIAGNOSIS AND TREATMENT OF LUNG CANCER;DNA TOPOISOMERASES: STRUCTURE, FUNCTION, AND INHIBITION;FOCUSED ULTRASOUND TECHNOLOGY AND APPLICATIONS;ROLE OF MATRIX METALLOPROTEINASES IN CANCER AND PHYSIOLOGY;ROLE OF RETINOIC ACID IN BIOLOGICAL PROCESSES","1;1;1;1;1;1","ATP-DEPENDENT TRANSPORTERS;BLOOD-BRAIN BARRIER;CIRCLE OF WILLIS;CNS DRUG DELIVERY;EPIDERMOID CARCINOMA;FOCUSED ULTRASOUND;INTERIM ANALYSIS;ISOXAZOLE;MECHANICAL INDEX;MOIETY;NEURORADIOLOGY;NON-SMALL CELL LUNG CANCER;OCCLUDIN;PERFORMANCE STATUS;REGIMEN;RETINOIC ACID;SQUAMOUS-CELL CARCINOMA;STRUCTURE–ACTIVITY RELATIONSHIP","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ADVANCED LARYNGEAL;APOPTOSIS RESISTANT;ATHEROSCLEROTIC DISEASE;BARRIER STUDIES;BLOOD BRAIN;BRAIN BARRIER;BRAIN PERFUSION;CARCINOMA CLINICAL;CELL CARCINOMA;CELL LINES;CELL LUNG;CHEMICALLY MODIFIED;CHEMOTHERAPEUTIC AGENTS;CLINICAL IMPLICATIONS;DIFFERENTIAL EXPRESSION;EXPRESSION LEVELS;FUNCTIONAL FEATURE;II LINE;II STUDY;INTERIM ANALYSIS;LARYNGEAL SQUAMOUS;LEUKAEMIA CELL;LINE THERAPY;LOCALLY ADVANCED;LUNG CANCER;MODIFIED TETRACYCLINES;MULTIDRUG RESISTANT;NON-SMALL CELL;PERFUSION ULTRASOUND;PHASE II","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CMT- CMT-;MULTIDRUG RESISTANT;APOPTOTIC ACTIVITY;BIOLOGICAL ACTIVITY;CD LEVELS;CELL LINES;CHEMICALLY MODIFIED;EXPRESSION LEVELS;FAS-LIGAND RESISTANT;LOCALLY ADVANCED;MODIFIED TETRACYCLINES;PATIENT OUTCOME;PROLIFERATION RATE;RESISTANT CELLS;STAGE IIIIV;STAGE IV;TUMOR TISSUES;ACITIVITY STRUCTUREACTIVITY;ACTIVATOR UPA;ACTIVITIES SUGGEST;ACTIVITY POTENT;ACTIVITY SIMILAR;ADJACENT NORMAL;ADVANCED ANDOR;ADVANCED FORMS;ADVANCED LARYNGEAL;ADVANCED LSCC;AGENTS ACTIVE;AGGRESSIVE FORMS;ALKENYL PORTION","6;4;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1",2,0.33,3,61,0,0,0,0,61,0,0,61,0,0,0,0,0,0,0,0,0,0,0,15,15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,20,154.5,11.11,0,0,3.5,0,0,0,0,0,0,0,2,0,1,1,0,0,0,0,0,0,1,1,0,2,0,0,0,0,0,0,0,0,0,"Italy","2","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES","2;2","CLINICAL RESEARCH;DIGESTIVE DISEASES;NUTRITION;AUTOIMMUNE DISEASE;CHRONIC PAIN;CROHN'S DISEASE;HEMATOLOGY;INFLAMMATORY BOWEL DISEASE;PAIN RESEARCH;PREVENTION","2;2;2;1;1;1;1;1;1;1","ORAL AND GASTROINTESTINAL;MUSCULOSKELETAL","2;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;6.1 PHARMACEUTICALS","1;1",NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_GIACCONE",2002,5,8.2,1.6,0.8,0.2,0.8,1,0.8,0.5,0.8,0,0,2,0,1,2,0.4,0,0.2,0.4,55.8,1.01144288995615,NA,0.2,0.6,0.242,0,0,0,"LUCIANO MASINI;CORRADO GIRMENIA;C NICOTRA;SETTIMO CARUSO;CECILIA CARAMATTI;ANTONELLA CUSIMANO;LAURA CORVATTA;LUCA MELE;LUISA DUSONCHET;ENRICO HOFFMANN;M FINAZZO;TOMMASO VINCENZO BARTOLOTTA;PIER PAOLO PICCALUGA;GENNARO TAIBI;GIANFRANCO CIARAMITARO;LIVIO PAGANO;M FARINELLA;ANTONINO ROTOLO;MARIA A. CAPPUCCI;LUANA FIANCHI","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","C NICOTRA;GENNARO TAIBI;SETTIMO CARUSO;M FINAZZO;TOMMASO VINCENZO BARTOLOTTA;MASSIMO MIDIRI;ANTONELLA CUSIMANO;LUISA DUSONCHET;ENRICO HOFFMANN;GIANFRANCO CIARAMITARO;M FARINELLA;ANTONINO ROTOLO;MONICA NOTARBARTOLO;MELCHIORRE CERVELLO;MASSIMO BENEDETTO;NATALE D’ALESSANDRO;LUCIANO MASINI;CORRADO GIRMENIA;CECILIA CARAMATTI;LAURA CORVATTA","0.5;0.5;0.25;0.25;0.25;0.25;0.2;0.2;0.2;0.2;0.2;0.2;0.2;0.2;0.2;0.2;0.04;0.04;0.04;0.04","ANTONELLA CUSIMANO;LUISA DUSONCHET;M FINAZZO;GENNARO TAIBI;GIANFRANCO CIARAMITARO;MONICA NOTARBARTOLO;MARIA ENZA MITRA;NATALE D’ALESSANDRO","1;1;1;1;1;1;1;1","GENNARO TAIBI;M FINAZZO;ANTONELLA CUSIMANO;LUISA DUSONCHET;GIANFRANCO CIARAMITARO;MONICA NOTARBARTOLO;NATALE D’ALESSANDRO;MARIA ENZA MITRA","0.5;0.25;0.2;0.2;0.2;0.2;0.2;0.04","A. DEL FAVERO;AGOSTINO CORTELEZZI;ANNAMARIA NOSARI;BERNARDINO ALLIONE;BRUNO MARTINO;CECILIA CARAMATTI;CORRADO GIRMENIA;DOMENICO RUSSO;FRANCESCO FABBIANO;GIUSEPPE MILONE;GIUSEPPE TODESCHINI;LAURA CORVATTA;LIVIO PAGANO;LUANA FIANCHI;LUCA MELE;LUCIANO MASINI;M BUELLI;MARCO PICARDI;MARIA A. CAPPUCCI;MARIA ENZA MITRA","135;135;135;135;135;135;135;135;135;135;135;135;135;135;135;135;135;135;135;135","MARIA ENZA MITRA;ANTONELLA CUSIMANO;LUISA DUSONCHET;MONICA NOTARBARTOLO;NATALE D’ALESSANDRO;GENNARO TAIBI;GIANFRANCO CIARAMITARO;M FINAZZO","135;89;89;89;89;54;1;0","ANTONELLA CUSIMANO;GENNARO TAIBI;GIANFRANCO CIARAMITARO;LUISA DUSONCHET;MARIA ENZA MITRA;MONICA NOTARBARTOLO;NATALE D’ALESSANDRO;M FINAZZO","1;1;1;1;1;1;1;0","MEDICINE;BIOLOGY;CHEMISTRY;COMPUTER SCIENCE","3;1;1;1","BIOCHEMISTRY;INTERNAL MEDICINE;ANATOMY;ARTIFICIAL INTELLIGENCE;CANCER RESEARCH;CARDIOLOGY;CELL BIOLOGY;CHROMATOGRAPHY;GASTROENTEROLOGY;GENETICS;INTENSIVE CARE MEDICINE;MICROBIOLOGY;MOLECULAR BIOLOGY;PSYCHIATRY;RADIOLOGY;SURGERY","2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ABLATION;ANALYTE;ANTIOXIDANT;APOPTOSIS;BLOOD PLASMA;BLOOD PROTEINS;BONE MARROW;CARDIAC IMAGING;CHEMOTHERAPY;CHLOROFORM;CLINICAL TRIAL;DETECTION LIMIT;DRUG RESISTANCE;EXTRACTION (CHEMISTRY);FIBROMA;HEMATOLOGY;HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY;HUMAN PLASMA;INTERVENTIONAL RADIOLOGY;LUNG;MAGNETIC RESONANCE IMAGING;NEUROLOGY;PERSPECTIVE (GRAPHICAL);PNEUMONIA;QUANTITATIVE ANALYSIS (CHEMISTRY);SAMPLE PREPARATION;SYNCOPE (PHONOLOGY);TACHYCARDIA;VITAMIN","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","BRONCHOALVEOLAR LAVAGE;CATHETER ABLATION;CISPLATIN;ELECTROPHYSIOLOGIC STUDY;ETHANOL PRECIPITATION;HL60;MULTIPLE DRUG RESISTANCE;MYELOFIBROSIS;NEURORADIOLOGY;PNEUMOCYSTIS JIROVECII;PROGRAMMED CELL DEATH;PROTEIN PRECIPITATION;RETINOL;SURVIVIN;VITAMIN E","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CASPASE;FAS LIGAND;INHIBITOR OF APOPTOSIS;P-GLYCOPROTEIN;PNEUMOCYSTIS CARINII;TOCOPHEROL","1;1;1;1;1;1","HUMANS;HEMATOLOGIC NEOPLASMS;LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL;LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE;LEUKEMIA, MYELOID;LYMPHOMA, NON-HODGKIN;MULTIPLE MYELOMA;MYELODYSPLASTIC SYNDROMES;PNEUMONIA, PNEUMOCYSTIS;PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;PRIMARY MYELOFIBROSIS;THALASSEMIA;ARRHYTHMIAS, CARDIAC;ADULT;ANTI-INFECTIVE AGENTS;ANTINEOPLASTIC AGENTS;ATP BINDING CASSETTE TRANSPORTER, SUBFAMILY B, MEMBER 1;BRONCHOALVEOLAR LAVAGE FLUID;CASPASES;CHROMATOGRAPHY, HIGH PRESSURE LIQUID","5;4;4;4;4;4;4;4;4;4;4;4;3;2;2;2;2;2;2;2","DIAGNOSIS AND MANAGEMENT OF CARDIAC TUMORS;DIAGNOSIS AND MANAGEMENT OF SYNCOPE;EPIDEMIOLOGY AND PATHOGENESIS OF PNEUMOCYSTIS PNEUMONIA;MECHANISMS AND APPLICATIONS OF RNA INTERFERENCE;ROLE OF OXIDATIVE STRESS IN HEALTH AND DISEASE","1;1;1;1;1","BLOOD PLASMA;CARDIAC IMAGING;CARDIAC MYXOMAS;CARDIAC TUMORS;CHILDHOOD PNEUMONIA;DIAGNOSIS GUIDELINES;DILATED CARDIOMYOPATHY;DOCOSAHEXAENOIC ACID (DHA);ELECTROPHYSIOLOGIC STUDY;ETHANOL PRECIPITATION;FAS LIGAND;FIBROMA;HEMATOLOGY;HL60;INHIBITOR OF APOPTOSIS;INTERVENTIONAL RADIOLOGY;MULTIDRUG RESISTANCE;NEURORADIOLOGY;P-GLYCOPROTEIN;PNEUMOCYSTIS","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ANTI-APOPTOSIS FACTORS;APOPTOSIS PROTEINS;APOPTOTIC TRIGGERS;BULKY FIBROMA;CARINIII PNEUMONIA;CHROMATOGRAPHIC ASSAY;DIVERSE APOPTOTIC;ELECTROPHYSIOLOGIC STUDY;FACTORS IAP;GIMEMA CENTRES;HAEMATOLOGICAL DISEASES;HL CELLS;HUMAN SERUM;IAP INHIBITORY;IMAGING FINDINGS;IPNEUMOCYSTIS CARINIII;LIQUIDLIQUID EXTRACTION;MALIGNANT HAEMATOLOGICAL;MULTIDRUG RESISTANT;P-GLYCOPROTEIN FAS;RESISTANT HL;SENSITIVE CHROMATOGRAPHIC","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","","",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,7,400,12.5,0,0,48,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,"Italy","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS","1;1",NA,NA,"CANCER","1",NA,NA,"PANCREATIC CANCER","1","5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT","1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_GIACCONE",2003,11,6.18181818181818,1.27272727272727,0.636363636363636,0.272727272727273,0.636363636363636,1.16666666666667,1,0.75,1,0.181818181818182,1,2,2,1,5,0.18,0.18,0.09,0.45,18.27,0.345238082016209,NA,0,0.636363636363636,0.457,0.167,0.167,0.167,"G MILIO;MANLIO TOLOMEO;MASSIMO GALIA;GIUSEPPINA GRISOLIA;DANILO MIRIZZI;ALESSIA LO VERDE;DOMENICO MERANTE;GIANVINCENZO SPARACIA;GIANLUCA IACOBELLIS;C. FALCELLI;MARINELLA ROBERTI;ANTONIO LO CASTO;VITO LO GRECO;CESARE SELLI;F PISELLO;GIOVANNI SAVETTIERI;VALENTINA COSPITE;RICCARDO RONDANIN;C COSCELLI;EUGENIO FIORENTINO","2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MANLIO TOLOMEO;G MILIO;ALESSIA LO VERDE;MAURIZIO AVERNA;D SINAGRA;A. M. SCARPITTA;VALENTINA COSPITE;M COSPITE;C COSPITE;CARLO GENOVA;V COSPITE;CESARE SELLI;GIORGIO POMARA;MARIA GIUSEPPA CUTTANO;CLAUDIO TRIPODO;FRANCESCO CARLINO;F PISELLO;GIROLAMO GERACI;C SCIUMÈ;MARTA CAJOZZO","1.08;0.58;0.5;0.5;0.5;0.5;0.33;0.33;0.25;0.25;0.25;0.2;0.2;0.2;0.2;0.2;0.17;0.17;0.17;0.17","G MILIO;MANLIO TOLOMEO;ALESSIA LO VERDE;GIOVANNI SAVETTIERI;FILIPPO BARBIERA;C SCIUMÈ;STEFANIA GRIMAUDO;MAURIZIO AVERNA;ALDO GALLUZZO;CLAUDIO TRIPODO;V. PIRRONE;A. M. SCARPITTA","2;2;1;1;1;1;1;1;1;1;1;1","MANLIO TOLOMEO;G MILIO;ALESSIA LO VERDE;MAURIZIO AVERNA;A. M. SCARPITTA;CLAUDIO TRIPODO;C SCIUMÈ;GIOVANNI SAVETTIERI;FILIPPO BARBIERA;STEFANIA GRIMAUDO;ALDO GALLUZZO;V. PIRRONE","1.08;0.58;0.5;0.5;0.5;0.2;0.17;0.14;0.11;0.08;0.06;0.06","ALESSIA GALLO;EPIFANIA BONO;GABRIELLA SCHIERA;GIOVANNA LAURA PITARRESI;GIOVANNI SAVETTIERI;ITALIA DI LIEGRO;MARÍA PÍA RAFFA;MANLIO TOLOMEO;DANIELE SIMONI;DANILO MIRIZZI;FRANCESCO PAOLO INVIDIATA;GIUSEPPE GIANNINI;GIUSEPPINA GRISOLIA;MARCELLO ROSSI;MARINELLA ROBERTI;PIER GIOVANNI BARALDI;RICCARDO BARUCHELLO;RICCARDO RONDANIN;ROMEO ROMAGNOLI;STEFANIA GRIMAUDO","88;88;88;88;88;88;88;51;35;35;35;35;35;35;35;35;35;35;35;35","GIOVANNI SAVETTIERI;MANLIO TOLOMEO;STEFANIA GRIMAUDO;ALDO GALLUZZO;V. PIRRONE;CLAUDIO TRIPODO;G MILIO;ALESSIA LO VERDE;C SCIUMÈ;MAURIZIO AVERNA;FILIPPO BARBIERA;A. M. SCARPITTA","88;51;35;25;25;13;11;5;5;5;3;0","G MILIO;MANLIO TOLOMEO;ALDO GALLUZZO;ALESSIA LO VERDE;C SCIUMÈ;CLAUDIO TRIPODO;FILIPPO BARBIERA;GIOVANNI SAVETTIERI;MAURIZIO AVERNA;STEFANIA GRIMAUDO;V. PIRRONE;A. M. SCARPITTA","2;2;1;1;1;1;1;1;1;1;1;0","MEDICINE;BIOLOGY;CHEMISTRY;ECONOMICS;ENGINEERING;PHYSICS","8;2;2;1;1;1","INTERNAL MEDICINE;ENDOCRINOLOGY;BIOCHEMISTRY;SURGERY;CARDIOLOGY;INTENSIVE CARE MEDICINE;ASTRONOMY;CELL BIOLOGY;COMBINATORIAL CHEMISTRY;ECONOMIC GROWTH;EMERGENCY MEDICINE;GENETICS;MECHANICAL ENGINEERING;MEDICAL EMERGENCY;MOLECULAR BIOLOGY;NEUROSCIENCE;NUCLEAR MEDICINE;NURSING;ORGANIC CHEMISTRY;PHARMACOLOGY;RADIOLOGY;STEREOCHEMISTRY;UROLOGY;VIROLOGY","6;5;3;3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","DIABETES MELLITUS;IN VITRO;ALKYL;AMBULATORY;ANGIOLOGY;APOPTOSIS;CANCER;CARBOHYDRATE METABOLISM;CELL;CELL CULTURE;CENTRAL NERVOUS SYSTEM;CHOLESTEROL;CINERADIOGRAPHY;CORONARY HEART DISEASE;COUPLING (PIPING);DISEASE;DNA;ENDOSCOPY;EVENING;EXTRACORPOREAL;HEALTH CARE;HEMODYNAMICS;INSULIN;LACTIC ACIDOSIS;LARYNX;LITHOTRIPSY;MEAL;MEMBRANE;MICROCIRCULATION;MITOCHONDRION;MORNING;NEURON;PERIPHERAL;PHARYNX;PLETHYSMOGRAPH;PUBLIC HEALTH;REGIMEN;RISK FACTOR;SWALLOWING;TIGHT JUNCTION;VASCULAR DISEASE;VASCULAR PERMEABILITY;VIRUS","3;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","AMBULATORY CARE;ARTERIAL DISEASE;ARYL;ASTROCYTE;BIOLOGICAL ACTIVITY;BLOOD–BRAIN BARRIER;CELL TYPE;COLORECTAL CANCER;DAPI;ENDOTHELIAL STEM CELL;ETHIDIUM BROMIDE;GLYCEMIC;HEALTH ADMINISTRATION;HEALTH SERVICES RESEARCH;LARYNGECTOMY;LIPOPROTEIN;METABOLIC SYNDROME;MITOCHONDRIAL TOXICITY;OCCLUDIN;PERMEABILITY (ELECTROMAGNETISM);TRIGLYCERIDE;TYPE 2 DIABETES;VASCULAR RESISTANCE;VIRAL LOAD","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ANTIRETROVIRAL THERAPY;COLONOSCOPY;HYPERTRIGLYCERIDEMIA;OCCLUSIVE ARTERIAL DISEASE;PARACELLULAR TRANSPORT;SUZUKI REACTION;VERY LOW-DENSITY LIPOPROTEIN","1;1;1;1;1;1;1","DIABETES MELLITUS, TYPE 2;HUMANS;INSULIN;HYPOGLYCEMIC AGENTS;MALE;AGED;DIABETES MELLITUS;FEMALE;FOREIGN BODIES;METFORMIN;ADULT;ARTERIAL OCCLUSIVE DISEASES;ASTROCYTES;BLOOD GLUCOSE;CHOLEDOCHOLITHIASIS;DEGLUTITION DISORDERS;DIABETES MELLITUS, TYPE 1;ENDOTHELIUM, VASCULAR;ESOPHAGUS;LYMPHOMA, B-CELL","8;8;8;7;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3","BLOOD-BRAIN BARRIER AND NEUROVASCULAR INTERACTIONS;CHOLESTEROL-LOWERING TREATMENT;COMPLICATIONS OF GALLSTONE DISEASE;EFFECTS OF KETOGENIC DIET ON HEALTH;EPIDEMIOLOGY AND TREATMENT OF HEAD AND NECK CANCER;HEALTHCARE POLICY REFORMS AND INEQUALITIES IN FRANCE;IMPACT OF HIV INFECTION ON CARDIOVASCULAR HEALTH;MALE CIRCUMCISION FOR HIV PREVENTION AND PENILE HEALTH;MANAGEMENT AND TREATMENT OF PERIPHERAL ARTERIAL DISEASE;MANAGEMENT OF DIABETES MELLITUS AND CARDIOVASCULAR RISK;TRANSITION METAL-CATALYZED CROSS-COUPLING REACTIONS","1;1;1;1;1;1;1;1;1;1;1","DIABETES;INSULIN SIGNALING;ANGIOLOGY;ANTIRETROVIRAL THERAPY;BARIUM ENEMA;CARBOHYDRATE METABOLISM;CELL TYPE;CINERADIOGRAPHY;CONTINUOUS GLUCOSE MONITORING;CROSS-COUPLING REACTIONS;CT SCREENING;DAPI;DIDANOSINE;ENDOSCOPIC THERAPY;ENDOTHELIAL CELLS;ETHIDIUM BROMIDE;EXTRACORPOREAL;GLUCOSE TRANSPORTER DEFICIENCY;GLYCOGEN METABOLISM;HEALTH ADMINISTRATION","2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ACTIVE ANTIRETROVIRAL;ACTIVE STILBENES;AMBULATORY CARE;ANGIOLOGY SERVICES;ANTIRETROVIRAL THERAPY;ARTERIAL OCCLUSIVE;BASKET IMPACTED;BCELL LYMPHOMA;BILIARY TRACT;BIOLOGICALLY ACTIVE;BRAIN CAPILLARY;CAPILLARY ENDOTHELIAL;CARE CENTER;CHOLEDOCHOLITHIASIS REPORT;CONVENIENT SYNTHESIS;CROSS-COUPLING PROTOCOL;CURRENT METHODS;DIABETES MELLITUS;DIABETIC PATIENTS;DIETARY HABITS;DIFFICULT RESIDUAL;DIGITAL CINERADIOGRAPHY;DORMIA BASKET;DOUBLE SUZUKI;ENDOSCOPIC REMOVAL;ENDOTHELIAL CELLS;GLUCOSE METABOLISM;GLYCEMIC CONTROL;HIGHLY ACTIVE;HIV INFECTED","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","BRAIN CAPILLARY;CAPILLARY ENDOTHELIAL;ENDOTHELIAL CELLS;HIV INFECTED;MORPHOLOGICAL ALTERATIONS;APOPTOTIC CELLS;INFECTED PATIENT;LACTIC ACID;LYMPHOCYTE APOPTOSIS;TIGHT JUNCTIONS;TREATMENT WITHDRAWAL;ABSTRACT BRAIN;ACID CONCENTRATIONS;ACID VALUES;ACRIDINE ORANGE;ACTIVE ANTIRETROVIRAL;ALTERATIONS PERSISTED;ALTERED MITOCHONDRIA;ANTIRETROVIRAL THERAPY;APOPTOTIC LYMPHOCYTES;APOPTOTIC PATHWAY;BAIMSB HIGHLY;BRAIN BASED;CELL PERIPHERY;CELLS BRAIN;CELLS COCULTURED;CELLS CULTURED;CELLS FORM;COLLAGEN IV;COMBINED EFFECTS","3;3;3;3;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",2,0.18,5.25,3,0,0,0,0,3,0,0,3,0,0,0,0,0,0,0,0,0,0,0.75,55.75,56,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3,9.33,575,25,0,0,44.33,0,0,0,1,2,0,0,0,0,3,0,0,0,0,0,0,0,2,1,0,3,0,0,0,0,0,0,0,0,0,"United Kingdom;United States","1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS","3;2;2","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;ORPHAN DRUG;RARE DISEASES;BREAST CANCER;COMPARATIVE EFFECTIVENESS RESEARCH;DIABETES;LUNG;LUNG CANCER;OVARIAN CANCER","3;3;2;2;2;1;1;1;1;1;1","CANCER;METABOLIC AND ENDOCRINE","2;1","6.1 PHARMACEUTICALS","2","LUNG CANCER;OVARIAN CANCER","1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","2",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_GIACCONE",2004,17,8.47058823529412,1.47058823529412,0.823529411764706,0.117647058823529,0.823529411764706,1.19047619047619,1.27272727272727,0.666666666666667,1.27272727272727,0.235294117647059,1,4,3,1,8,0.24,0.18,0.06,0.47,28.65,0.608817409853072,NA,0.117647058823529,0.470588235294118,0.35,0.243,0,0.243,"EUGENIO FIORENTINO;FILIPPO BARBIERA;F LATTERI;GIUSEPPE BUSCEMI;SALVATORE VIENI;F PISELLO;G MODICA;ACHILLE MASTROSIMONE;GIROLAMO GERACI;C SCIUMÈ;GIUSEPPA GRACEFFA;ANTONIO VALENTI;TIZIANA FACELLA;FRANCESCA SCORDATO;GIOVANNI D’ARENA;ENRICO BALLEARI;CARMELO SARANITI;ROBERTO LATAGLIATA;SANTINA COTTONE;SALVATORE ARTALE","4;4;3;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1","SANTINA COTTONE;EUGENIO FIORENTINO;FILIPPO BARBIERA;F LATTERI;ANTONINO GIARRATANO;MARK GJOMARKAJ;SANTI MAURIZIO RAINERI;F PISELLO;G MODICA;GIROLAMO GERACI;C SCIUMÈ;TIZIANA FACELLA;SALVATORE VIENI;GIUSEPPA GRACEFFA;FRANCESCA SCORDATO;GABRIELLA CARLINO;G INDOVINA;GIUSEPPE COPPOLA;SALVATORE NOVO;ACHILLE MASTROSIMONE","1;0.51;0.51;0.41;0.33;0.33;0.33;0.29;0.29;0.29;0.29;0.29;0.29;0.29;0.29;0.25;0.25;0.25;0.25;0.22","EUGENIO FIORENTINO;C SCIUMÈ;CARMELO SARANITI;SANTINA COTTONE;GAETANO ROMANO;ROBERTO LAGALLA;GABRIELLA CARLINO;FRANCESCO DISPENZA;GIUSEPPE SALVAGGIO;C CARAMANNA;ANTONINO GIARRATANO;MARIA MELI;FRANCESCO ANTONIO SALZANO;IGNAZIO CARRECA;GIUSEPPE BRANCATELLI;MARY ELLEN PAVONE;SERGIO SALERNO;MARIA ENZA MITRA;SANTI MAURIZIO RAINERI;GIUSEPPE CARUSO","4;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","SANTINA COTTONE;EUGENIO FIORENTINO;ANTONINO GIARRATANO;SANTI MAURIZIO RAINERI;C SCIUMÈ;GABRIELLA CARLINO;CARMELO SARANITI;ROBERTO LAGALLA;FRANCESCO DISPENZA;GIUSEPPE SALVAGGIO;C CARAMANNA;FRANCESCO ANTONIO SALZANO;GIUSEPPE BRANCATELLI;SERGIO SALERNO;GIUSEPPE CARUSO;CARLO DISPENZA;MARIA MELI;GAETANO ROMANO;MARY ELLEN PAVONE;IGNAZIO CARRECA","1;0.51;0.33;0.33;0.29;0.25;0.2;0.2;0.2;0.2;0.2;0.2;0.2;0.2;0.2;0.2;0.11;0.09;0.08;0.06","A. SIDI;ANTOINE G. VAN DER HEIJDEN;FLORIAN HASNER;J. ALFRED WITJES;JACK BANIEL;LAMBERTUS A. KIEMENEY;MARY ELLEN PAVONE;OFER N. GOFRIT;OFER NATIV;RENZO COLOMBO;RICHARD NASPRO;Z. LEIB;A. LAMBIASE;ANDREA BONETTI;ANTONIO CASSATA;ANTONIO IANNELLI;DIEGO CORTINOVIS;E. FERRARIO;ELENA BERETTA;EMILIO BAJETTA","158;158;158;158;158;158;158;158;158;158;158;158;135;135;135;135;135;135;135;135","MARY ELLEN PAVONE;IGNAZIO CARRECA;MARIA ENZA MITRA;C CARAMANNA;CARLO DISPENZA;CARMELO SARANITI;FRANCESCO ANTONIO SALZANO;FRANCESCO DISPENZA;GAETANO ROMANO;EUGENIO FIORENTINO;MARIA MELI;GIUSEPPE BRANCATELLI;GIUSEPPE CARUSO;GIUSEPPE SALVAGGIO;ROBERTO LAGALLA;SERGIO SALERNO;C SCIUMÈ;GABRIELLA CARLINO;ANTONINO GIARRATANO;SANTI MAURIZIO RAINERI","158;135;108;54;54;54;54;54;9;6;6;5;5;5;5;4;1;1;0;0","EUGENIO FIORENTINO;C SCIUMÈ;C CARAMANNA;CARLO DISPENZA;CARMELO SARANITI;FRANCESCO ANTONIO SALZANO;FRANCESCO DISPENZA;GABRIELLA CARLINO;GAETANO ROMANO;GIUSEPPE BRANCATELLI;GIUSEPPE CARUSO;GIUSEPPE SALVAGGIO;IGNAZIO CARRECA;MARIA ENZA MITRA;MARIA MELI;MARY ELLEN PAVONE;ROBERTO LAGALLA;SERGIO SALERNO;ANTONINO GIARRATANO;SANTI MAURIZIO RAINERI","4;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;0;0","MEDICINE;BIOLOGY;COMPUTER SCIENCE;ART;CHEMISTRY;MATERIALS SCIENCE;PHYSICS","16;2;2;1;1;1;1","INTERNAL MEDICINE;SURGERY;RADIOLOGY;ENDOCRINOLOGY;GASTROENTEROLOGY;GENERAL SURGERY;ONCOLOGY;PSYCHIATRY;ANATOMY;BIOCHEMISTRY;CANCER RESEARCH;CARDIOLOGY;CLASSICS;COMPUTER SECURITY;GENETICS;HUMANITIES;INTENSIVE CARE MEDICINE;LIBRARY SCIENCE;METALLURGY;MICROBIOLOGY;MOLECULAR BIOLOGY;NUCLEAR MEDICINE;NURSING;OPTICS;QUANTUM MECHANICS;UROLOGY","13;10;3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","DISEASE;CANCER;ENDOSCOPY;DIABETES MELLITUS;DYSPHAGIA;ESOPHAGUS;HELICOBACTER PYLORI;HERNIA;LESION;NEUROLOGY;STOMACH;ABDOMEN;ABSCESS;ANEMIA;ANGIOGRAPHY;ANTIBIOTICS;APOPTOSIS;BLOOD TRANSFUSION;BONE MARROW;CARCINOMA;CARTILAGE;CELL CULTURE;CHEMOTHERAPY;CLINICAL HISTORY;COMPLICATION;DNA;DOSING;ECTASIA;ELECTROCOAGULATION;FIBRIN GLUE;FUNCTIONAL DISORDER;GENE;HEMATOMA;HEMOGLOBIN;HORMONE;HYPERTHERMIA;INTENSITY (PHYSICS);INTERVENTIONAL RADIOLOGY;KIDNEY;LAPAROSCOPY;LASER;LYMPHOMA;MEDICAL HISTORY;MEDICAL THERAPY;MELENA;METAPLASIA;NOSE;PATHOLOGICAL;PERFUSION;PHARYNX;PHYSICAL EXAMINATION;PREOPERATIVE CARE;PROTON-PUMP INHIBITOR;PUNCHING;QUALITY OF LIFE (HEALTHCARE);RANDOMIZED CONTROLLED TRIAL;REGIMEN;RISK ASSESSMENT;SURGICAL PATHOLOGY;SWALLOWING;THYROID;ULTRASOUND","5;3;3;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","REFLUX;NEURORADIOLOGY;ACHALASIA;ADIPOSE CAPSULE OF KIDNEY;AMOXICILLIN;ANGIOMYOLIPOMA;ARGON PLASMA COAGULATION;BLADDER CANCER;COLORECTAL CANCER;DNA DAMAGE;ENDOCRINE SYSTEM;ENDOSCOPIC TREATMENT;EPOETIN ALFA;GASTRIC MUCOSA;GEMCITABINE;INTESTINAL METAPLASIA;LANSOPRAZOLE;MALT LYMPHOMA;METRONIDAZOLE;MICROALBUMINURIA;MOTOR DISORDER;MYELODYSPLASTIC SYNDROMES;NASAL SEPTUM;OROPHARYNGEAL DYSPHAGIA;PERFORATION;PERFUSION SCANNING;PROGRAMMED CELL DEATH;PROTEIN SUBUNIT;SECOND-HARMONIC GENERATION;THYROID NODULES;THYROIDECTOMY","3;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HIATAL HERNIA;CAPECITABINE;DEOXYCYTIDINE;ESOPHAGITIS;FAS LIGAND;GASTRIC ANTRAL VASCULAR ECTASIA;GASTRO-;GERD;IRINOTECAN;MUCOSA-ASSOCIATED LYMPHOID TISSUE;MYOTOMY;NISSEN FUNDOPLICATION;RIBONUCLEOTIDE REDUCTASE;SECOND-HARMONIC IMAGING MICROSCOPY;TOTAL THYROIDECTOMY;TRANSITIONAL CELL CARCINOMA","3;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;GASTROESOPHAGEAL REFLUX;MALE;AGED;MIDDLE AGED;DEOXYCYTIDINE;HERNIA, HIATAL;ADULT;DEGLUTITION DISORDERS;ESOPHAGUS;CAMPTOTHECIN;ESOPHAGITIS;FLUOROSCOPY;LYMPHOMA, T-CELL;MYELODYSPLASTIC SYNDROMES;PHARYNGEAL MUSCLES;POSTOPERATIVE COMPLICATIONS;WATER;ABSCESS","15;13;12;12;10;9;8;8;7;7;5;4;4;4;4;4;4;4;4;3","DIAGNOSIS AND MANAGEMENT OF GASTROESOPHAGEAL REFLUX DISEASE;ADVANCEMENTS IN COLORECTAL CANCER RESEARCH;DIAGNOSIS AND MANAGEMENT OF FUNGAL INFECTIONS;DIAGNOSIS AND MANAGEMENT OF GASTROINTESTINAL BLEEDING;DIAGNOSIS AND TREATMENT OF BLADDER CANCER;DYSPHAGIA AND SWALLOWING DISORDERS;GASTRIC CANCER RESEARCH AND TREATMENT;MAGNETIC RESONANCE IMAGING APPLICATIONS IN MEDICINE;MANAGEMENT AND DIAGNOSIS OF THYROID CANCER;MANAGEMENT OF HYPERTENSION AND CARDIOVASCULAR RISK FACTORS;MOLECULAR MECHANISMS OF DNA DAMAGE RESPONSE;NASAL SURGERY TECHNIQUES AND OUTCOMES;PERIOPERATIVE CARDIAC RISK ASSESSMENT AND MANAGEMENT;ROLE OF ERYTHROPOIETIN IN DISEASE TREATMENT AND MANAGEMENT;TUBEROUS SCLEROSIS COMPLEX AND RELATED DISORDERS","3;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HIATAL HERNIA;ESOPHAGEAL PERFORATION;NEURORADIOLOGY;ANASTOMOTIC LEAKS;ANGIOMYOLIPOMA;ANTIFUNGAL RESISTANCE;APOPTOSIS;BLADDER CANCER;CARDIAC RISK;CARDIOVASCULAR EVALUATION;CLINICAL HISTORY;CRICOPHARYNGEAL MYOTOMY;DEOXYCYTIDINE KINASE;DIAGNOSTIC ACCURACY;DIAGNOSTIC CRITERIA;DIFFUSION-WEIGHTED IMAGING;ECTASIA;ELECTROCOAGULATION;END ORGAN DAMAGE;ENDOSCOPIC TREATMENT","3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","SURGICAL TREATMENT;ANGIOMYOLIPOMAS CT;ANTI-REFLUX LAPAROSCOPIC;ANTRAL VASCULAR;BLEEDING RENAL;CASE-CONTROL STUDY;CELL CARCINOMA;CELL LINE;CEREBRAL PERFUSION;CHEMOTHERAPY TREATMENT;COLORECTAL CARCINOMA;CT FINDINGS;DIABETIC PATIENTS;DIAGNOSTIC APPROACH;DIGITAL CINERADIOLOGY;DIGITAL VIDEOFLUOROGRAPHY;DOSING REGIMEN;EASY APPROACH;ENDOTHELIAL ACTIVATION;EPOETIN ALFA;ESOPHAGEAL DIGITAL;EUROPEAN RESULTS;EXPERIENCE ANALYSIS;FAS-MEDIATED APOPTOSIS;FIRSTLINE TREATMENT;GASTRIC ANTRAL;GASTRIC MUCOSA-ASSOCIATED;GASTRO-OESOPHAGEAL REFLUX;GASTROESOPHAGEAL REFLUX;HARMONIC IMAGING","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ANTIHYPERTENSIVE THERAPY;DIABETIC HYPERTYENSIVES;ENDOTHELIAL ACTIVATION;LOWER DOSES;ORGAN DAMAGE;PATIENTS TREATED;PERCUTANEOUS TRACHEOSTOMY;PORTEX DISPOSABLE;RHINO DILATOR;SAFETY PROFILE;SEPTAL ABSCESS;SEPTAL CARTILAGE;SIZE PORTEX;ABDOMINAL PAIN;ACCEPTABLE SAFETY;ACTIVATION POSITIVELY;ACTIVE FIRSTLINE;ACUTE PHASE;ADVERSE EVENT;AIRWAY CONTROL;ALLGRADE HANDFOOT;AMERICAN CANCER;ANALYSISORAL GLUCOSE;BANK CARTILAGE;BLOOD PRESSURE;BLUE RHINO;BOUGIE DAMAGE;BOUGIE PPERCUTANEOUS;BOUGIE REMAINS;CANCER AMERICAN","2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",1,0.06,7,3,0,0,0,0,0,0,2,3,0,0,1,0,0,0,0,1,0,0,0,54,54,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,2,900,4.76,1,1,101,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,NA,NA,"32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES","1;1","CHRONIC LIVER DISEASE AND CIRRHOSIS;CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;COMPARATIVE EFFECTIVENESS RESEARCH;DIGESTIVE DISEASES;EMERGING INFECTIOUS DISEASES;HEPATITIS;HEPATITIS - C;INFECTIOUS DISEASES;LIVER DISEASE","1;1;1;1;1;1;1;1;1;1",NA,NA,"6.1 PHARMACEUTICALS","1",NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_GIACCONE",2005,19,6.31578947368421,2.36842105263158,0.789473684210526,0.31578947368421,0.894736842105263,1.28571428571429,1.36363636363636,1,1.30769230769231,0.105263157894737,1,3,1,1,13,0.16,0.05,0.05,0.68,11.63,0.21969701128333,NA,0,0.421052631578947,0.517,0.507,0.25,0.497,"GIROLAMO GERACI;C SCIUMÈ;TIZIANA FACELLA;F PISELLO;GIUSEPPE MODICA;LI VOLSI F;VITTORIO GEBBIA;SALVATORE NOVO;FABIO FULFARO;C ARCARA;RAFFAELA ANASTASIO;GIULIA ROMANO;GIUSEPPE BUSCEMI;ROSALIA PATTI;SALVATORE VIENI;EGLE CORRADO;DANIELA CABIBI;MARIA ROSARIA VALERIO;EC VOLSI;ENRÌCO CILLARI","10;10;10;9;8;4;3;2;2;2;1;1;1;1;1;1;1;1;1;1","GIROLAMO GERACI;C SCIUMÈ;TIZIANA FACELLA;F PISELLO;GIUSEPPE MODICA;ANTONIO CRAXÌ;LI VOLSI F;VITTORIO GEBBIA;ANTONINO GIARRATANO;D CANZIO;MANLIO TOLOMEO;SANTI MAURIZIO RAINERI;DANIELE SIMONI;SALVATORE NOVO;FABIO FULFARO;C ARCARA;GIULIA ROMANO;GIUSEPPE BUSCEMI;EC VOLSI;GIUSEPPE SGARITO","1.53;1.53;1.53;1.37;1.33;1;0.6;0.54;0.33;0.33;0.33;0.33;0.33;0.31;0.2;0.2;0.17;0.17;0.17;0.17","C SCIUMÈ;TIZIANA FACELLA;F PISELLO;VITTORIO GEBBIA;SALVATORE NOVO;FABIO FULFARO;C ARCARA;RAFFAELA ANASTASIO;GIULIA ROMANO;ROSALIA PATTI;SALVATORE VIENI;MARIA ROSARIA VALERIO;EC VOLSI;SALVATORE FRICANO;CALOGERO CIPOLLA;ANTONINO GIARRATANO;GAETANO DI VITA;GIANFRANCO CIARAMITARO;VALENTINA DAVÌ;VINCENZO ABBADESSA","10;10;9;3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1","C SCIUMÈ;TIZIANA FACELLA;F PISELLO;ANTONIO CRAXÌ;VITTORIO GEBBIA;ANTONINO GIARRATANO;D CANZIO;MANLIO TOLOMEO;SANTI MAURIZIO RAINERI;DANIELE SIMONI;SALVATORE NOVO;FABIO FULFARO;C ARCARA;GIULIA ROMANO;EC VOLSI;GIANFRANCO CIARAMITARO;ROBERTO VAGLICA;R TANTILLO;ROSALIA PATTI;SALVATORE VIENI","1.53;1.53;1.37;1;0.54;0.33;0.33;0.33;0.33;0.33;0.31;0.2;0.2;0.17;0.17;0.17;0.17;0.14;0.12;0.12","ALESSANDRA MALATO;C ARCARA;FABIO FULFARO;G BAJARDI;LUCIO LO COCO;MARIA ROSARIA VALERIO;RAFFAELA ANASTASIO;S. SIRAGUSA;STEFANIA GRIMAUDO;VINCENZO ABBADESSA;VITTORIO GEBBIA;C SCIUMÈ;GIROLAMO GERACI;TIZIANA FACELLA;GIUSEPPE MODICA;F PISELLO;SALVATORE NOVO;ADA MARIA FLORENA;ANNA STRANO;CALOGERO CIPOLLA","100;100;100;100;100;100;100;100;100;100;100;62;62;62;58;49;26;25;25;25","ALESSANDRA MALATO;C ARCARA;FABIO FULFARO;G BAJARDI;LUCIO LO COCO;MARIA ROSARIA VALERIO;RAFFAELA ANASTASIO;S. SIRAGUSA;STEFANIA GRIMAUDO;VINCENZO ABBADESSA;VITTORIO GEBBIA;C SCIUMÈ;CALOGERO CIPOLLA;LIBORIO NAPOLI;R TANTILLO;SALVATORE FRICANO;SALVATORE NOVO;SALVATORE VIENI;F PISELLO;GAETANO DI VITA","100;100;100;100;100;100;100;100;100;100;100;41;25;25;25;25;25;25;15;10","C SCIUMÈ;VITTORIO GEBBIA;C ARCARA;F PISELLO;ALESSANDRA MALATO;CALOGERO CIPOLLA;EC VOLSI;FABIO FULFARO;G BAJARDI;GAETANO DI VITA;GIANFRANCO CIARAMITARO;LIBORIO NAPOLI;LUCIO LO COCO;M ARCARA;MARIA ROSARIA VALERIO;R TANTILLO;RAFFAELA ANASTASIO;ROBERTO VAGLICA;ROSALIA PATTI;S. SIRAGUSA","7;3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;CHEMISTRY;ENGINEERING;HISTORY;MATERIALS SCIENCE;PSYCHOLOGY","19;4;1;1;1;1;1","INTERNAL MEDICINE;SURGERY;GENERAL SURGERY;GASTROENTEROLOGY;BIOCHEMISTRY;CARDIOLOGY;RADIOLOGY;ANATOMY;CANCER RESEARCH;CLASSICS;COMPOSITE MATERIAL;ELECTRICAL ENGINEERING;ENDOCRINOLOGY;INTENSIVE CARE MEDICINE;MICROBIOLOGY;PATHOLOGY;PHARMACOLOGY;ZOOLOGY","11;10;6;3;2;2;2;1;1;1;1;1;1;1;1;1;1;1","BILIARY TRACT;ASYMPTOMATIC;CANCER;CHOLECYSTECTOMY;GALLSTONES;ACUTE PANCREATITIS;CARCINOMA;COMMON BILE DUCT;ECHINOCOCCOSIS;GALLBLADDER;JAUNDICE;LAPAROSCOPIC CHOLECYSTECTOMY;PANCREATITIS;STENT;ABDOMINAL PAIN;ADENOID;ALBENDAZOLE;AMPULLA;ANAMNESIS;ANTIBIOTICS;APEX (GEOMETRY);APOPTOSIS;ATRIAL FIBRILLATION;BILE DUCT;BIOPSY;BLOOD PRESSURE;BLOOD TRANSFUSION;CAROTID ARTERIES;CHOLERETIC;CHOLESTASIS;CHRONIC RENAL FAILURE;COAGULATION;COMPLICATION;CONCOMITANT;CONSERVATIVE TREATMENT;CYST;DIABETES MELLITUS;DISSECTION (MEDICAL);ECHINOCOCCUS GRANULOSUS;ENDOSCOPIC ULTRASOUND;ENDOSCOPY;ENDOTHELIAL DYSFUNCTION;FISTULA;GENE;HEART FAILURE;IMMUNOHISTOCHEMISTRY;NERVE INJURY;PANCREAS;PERCUTANEOUS;PERFUSION;PORT (CIRCUIT THEORY);PULMONARY EMBOLISM;RECEPTOR;RESECTION;RISK FACTOR;SCINTIGRAPHY;STOMACH;THROMBOSIS;THYROID;ULTIMATE TENSILE STRENGTH;URSODEOXYCHOLIC ACID;VEGF RECEPTORS;VENTRICULAR FUNCTION","4;3;3;3;3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ACUTE CHOLECYSTITIS;ADENOID CYSTIC CARCINOMA;AMPULLA OF VATER;BILIARY COLIC;BILIARY FISTULA;BILIARY STENT;BRACHIAL ARTERY;CANCER CELL;CHEMOTHERAPEUTIC DRUGS;CHOLECYSTITIS;CHROMOGRANIN A;COLORECTAL CANCER;CYSTIC DUCT;DEEP VEIN;ECHINOCOCCUS;ENDOCRINE SURGERY;ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY;FIBROBLAST GROWTH FACTOR;GALLBLADDER STONE;GASTRIC MUCOSA;HEPATECTOMY;HISTOGENESIS;HYDATID CYST;INTIMA-MEDIA THICKNESS;LEVOFLOXACIN;LOW MOLECULAR WEIGHT HEPARIN;MYOEPITHELIAL CELL;PHENOTYPE;PROGRAMMED CELL DEATH;RECURRENT LARYNGEAL NERVE;SYNAPTOPHYSIN;TENSION (GEOLOGY);THROMBOELASTOGRAPHY;THYROIDECTOMY;TUNICA MEDIA;VENTRICULAR PACING;WARFARIN","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CASPASE;COLONOSCOPY;TOTAL THYROIDECTOMY","1;1;1","HUMANS;ADULT;MALE;FEMALE;MIDDLE AGED;ECHINOCOCCOSIS, HEPATIC;AGED;CHORISTOMA;GALLSTONES;PANCREATITIS;JAUNDICE;TREATMENT OUTCOME;ABDOMINAL PAIN;ADOLESCENT;AGED, 80 AND OVER;ATHEROSCLEROSIS;BIOMARKERS, TUMOR;BREAST NEOPLASMS;CARCINOMA, ADENOID CYSTIC;CARCINOMA, BASAL CELL","16;11;11;10;10;9;8;7;7;6;5;5;4;4;4;4;4;4;4;4","INTUSSUSCEPTION AND MECKEL'S DIVERTICULUM;ARTERIAL STIFFNESS AND CARDIOVASCULAR HEALTH;BIOLOGICAL, EPIDEMIOLOGICAL, AND CLINICAL ASPECTS OF ECHINOCOCCOSIS;CARDIAC RESYNCHRONIZATION THERAPY IN HEART FAILURE;CLINICAL AND PATHOLOGICAL ASPECTS OF URACHAL CARCINOMA;COMPLICATIONS AND TECHNIQUES IN THYROID SURGERY;COMPLICATIONS OF GALLSTONE DISEASE;DIAGNOSIS AND MANAGEMENT OF BILIARY TRACT DISORDERS;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;ESOPHAGEAL INTERVENTION TECHNIQUES;ETIOLOGY AND MANAGEMENT OF ABDOMINAL WALL DEFECTS;FLUID RESUSCITATION IN TRAUMA AND CRITICAL CARE;HETEROCYCLIC COMPOUNDS FOR DRUG DISCOVERY;MANAGEMENT OF SPLEEN TRAUMA IN POLYTRAUMA PATIENTS;MICROSURGICAL RECONSTRUCTION TECHNIQUES;PATHOGENESIS AND MANAGEMENT OF BILIARY ATRESIA;PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM;SALIVARY GLAND TUMORS AND CARCINOMAS","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","TREATMENT;CHOLECYSTITIS;ENDOSCOPIC THERAPY;ADENOID;ADENOID CYSTIC CARCINOMA;ALBENDAZOLE;AMPULLA;AMPULLA OF VATER;ANAMNESIS;ANTICANCER AGENTS;APEX (GEOMETRY);ARTERIAL STIFFNESS;BILIARY COLIC;BILIARY FISTULA;BILIARY STENT;BLADDER CANCER;BRACHIAL ARTERY;CAROTID INTIMA-MEDIA THICKNESS;CENTRAL VENOUS CATHETERIZATION;CHEMOTHERAPEUTIC DRUGS","4;3;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","PERSONAL EXPERIENCE;LIVER HYDATIDOSIS;ABERRANT PANCREAS;ACUTE PANCREATITIS;ADENOID CYSTIC;ANTICANCER DRUGS;APOPTOTIC PATHWAY;ASYMPTOMATIC SUBJECTS;B-FGF PROFILES;BASALOID FEATURES;BILIARY STENTS;CANCER PATIENTS;CARDIOVASCULAR RISK;CELL CARCINOMA;CHOLECYSTECTOMY PERSONAL;CONVENTIONAL HERNIOPLASTY;CYSTIC CARCINOMA;DEEP VEIN;DRUGS TARGETING;DYSFUNCTION INTIMA;ENDOSCOPIC SPHINCTEROTOMY;ENDOTHELIAL DYSFUNCTION;FEATURES MERGING;GASTRIC MUCOSA;HEPATIC HYDATID;HETEROTOPIC GASTRIC;HOME THERAPY;HYDATID DISEASE;HYDATIDOSIS TREATMENT;INJURY PERSONAL","3;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","SAPS II;II SCORE;SEPTIC SHOCK;ADENOID CYSTIC;CYSTIC CARCINOMA;INVASIVE MECHANICAL;NOSOCOMIAL INFECTIONS;PORT SCORE;PREVIOUS HEPATIC;ACUTE RENAL;AGE COMORBIDITIES;AGE SEX;AGENTS MULTIORGAN;AGENTS NOSOCOMIAL;ALCOHOL DEPENDENTSSIXTYEIGHT;ARDS SEPTIC;ASPECTS SUGGESTING;AVERAGE LENGTH;BASALOID ADENOID;BASALOID FEATURES;CARCINOMA MERGING;CARCINOMA SCC;CARDIAC ARREST;CELL CARCINOMA;CHI-SQUARE TEST;CHRONIC DISEASE;CHRONIC LIVER;CLOSE ASSOCIATION;COMMON CONDITION;COMMUNITY-ACQUIRED PNEUMONIA","4;3;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,8,1100,3.03,1,1,107,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,"Italy;United States","1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES","1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;PATIENT SAFETY","1;1;1","CANCER","1","6.1 PHARMACEUTICALS","1","STOMACH CANCER","1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_GIACCONE",2006,24,8.08333333333333,2,0.75,0.0833333333333333,0.708333333333333,1.26315789473684,1.38461538461538,0.666666666666667,1.41666666666667,0.0833333333333333,2,7,2,1,12,0.29,0.08,0.04,0.5,19.12,0.37442582768115,NA,0.208333333333333,0.625,0.532,0.411,0,0.411,"F PISELLO;GIROLAMO GERACI;C SCIUMÈ;TIZIANA FACELLA;GIUSEPPE MODICA;EMILIO IANNITTO;FRANCESCO LI VOLSI;CARLA FLANDINA;SALVATORE NOVO;GIUSEPPE BADALAMENTI;LORENA INCORVAIA;GAETANO LETO;LI VOLSI F;ANDREA GALLAMINI;MASSIMO CAJOZZO;M. PAVONE‐MACALUSO;LUIGI RIGACCI;NICOLA GEBBIA;MARILENA CRESCIMANNO;FRANCESCA MARIA TUMMINELLO","7;7;6;5;5;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2","M. PAVONE‐MACALUSO;F PISELLO;GIROLAMO GERACI;C SCIUMÈ;TIZIANA FACELLA;GIUSEPPE MODICA;SALVATORE NOVO;F RAPPA;M P TERNULLO;FRANCESCO LI VOLSI;LI VOLSI F;GIUSEPPE COPPOLA;G MILIO;CARLA FLANDINA;GIUSEPPE BADALAMENTI;LORENA INCORVAIA;GAETANO LETO;NICOLA GEBBIA;MARILENA CRESCIMANNO;FRANCESCA MARIA TUMMINELLO","2;1.06;1.06;0.95;0.81;0.79;0.57;0.5;0.5;0.48;0.48;0.33;0.33;0.29;0.29;0.29;0.29;0.24;0.24;0.24","F PISELLO;GIROLAMO GERACI;C SCIUMÈ;TIZIANA FACELLA;EMILIO IANNITTO;FRANCESCO LI VOLSI;CARLA FLANDINA;GIUSEPPE BADALAMENTI;LORENA INCORVAIA;GAETANO LETO;M. PAVONE‐MACALUSO;NICOLA GEBBIA;MARILENA CRESCIMANNO;FRANCESCA MARIA TUMMINELLO;DANILO PUCCIO;ANTONINO MULÈ;F RAPPA;G. ROMANO;CONCETTA LO BIUNDO;ANGELO B. CEFALÙ","7;7;6;5;3;3;3;3;3;3;2;2;2;2;1;1;1;1;1;1","M. PAVONE‐MACALUSO;F PISELLO;GIROLAMO GERACI;C SCIUMÈ;TIZIANA FACELLA;F RAPPA;FRANCESCO LI VOLSI;G MILIO;CARLA FLANDINA;GIUSEPPE BADALAMENTI;LORENA INCORVAIA;GAETANO LETO;NICOLA GEBBIA;MARILENA CRESCIMANNO;FRANCESCA MARIA TUMMINELLO;EMILIO IANNITTO;DANILO PUCCIO;CHIARA DI LIBERTO;MASSIMO MIDIRI;GAETANA DIFEDE","2;1.06;1.06;0.95;0.81;0.5;0.48;0.33;0.29;0.29;0.29;0.29;0.24;0.24;0.24;0.2;0.17;0.17;0.14;0.14","CARLA FLANDINA;FRANCESCA MARIA TUMMINELLO;GAETANO LETO;GIUSEPPE BADALAMENTI;LORENA INCORVAIA;MARILENA CRESCIMANNO;NICOLA GEBBIA;GIOVAMBATTISTA RINI;FILIPPO CADEMARTIRI;FRANCESCO SAIA;GABRIËL P. KRESTIN;MASSIMO MIDIRI;NICO R. MOLLET;PEDRO A. LEMOS;PIM J. DE FEYTER;ALESSIA MORO;C. ANNALORO;CLAUDIA VENER;FEDERICA SAVI;FRANCA RADAELLI","127;127;127;127;127;127;127;112;99;99;99;99;99;99;99;62;62;62;62;62","GAETANO LETO;CARLA FLANDINA;FRANCESCA MARIA TUMMINELLO;GIOVAMBATTISTA RINI;GIUSEPPE BADALAMENTI;LORENA INCORVAIA;MARILENA CRESCIMANNO;NICOLA GEBBIA;MASSIMO MIDIRI;VITO FRANCO;GAETANA DIFEDE;GASPARE CUSUMANO;C SCIUMÈ;M. PAVONE‐MACALUSO;ANGELO B. CEFALÙ;ANTONIO CARROCCIO;LIDIA DI PRIMA;G MILIO;G. ROMANO;GIORGIO ROMANO","127;112;112;112;112;112;112;112;99;62;44;44;40;37;17;17;17;11;10;5","C SCIUMÈ;GAETANO LETO;EMILIO IANNITTO;CARLA FLANDINA;GIROLAMO GERACI;M. PAVONE‐MACALUSO;ANGELO B. CEFALÙ;ANTONIO CARROCCIO;CHIARA DI LIBERTO;DANILO PUCCIO;F PISELLO;FRANCESCA MARIA TUMMINELLO;FRANCESCO LI VOLSI;G MILIO;G. ROMANO;GAETANA DIFEDE;GASPARE CUSUMANO;GIORGIO ROMANO;GIOVAMBATTISTA RINI;GIUSEPPE BADALAMENTI","4;3;3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;PHYSICS;CHEMISTRY;COMPUTER SCIENCE;ENGINEERING;PHILOSOPHY","24;4;2;1;1;1;1","INTERNAL MEDICINE;SURGERY;GASTROENTEROLOGY;ENDOCRINOLOGY;CARDIOLOGY;PATHOLOGY;RADIOLOGY;GENERAL SURGERY;INTENSIVE CARE MEDICINE;ENVIRONMENTAL HEALTH;IMMUNOLOGY;PALEONTOLOGY;ANATOMY;ANESTHESIA;BIOCHEMISTRY;DERMATOLOGY;FAMILY MEDICINE;GENETICS;GYNECOLOGY;LINGUISTICS;MECHANICAL ENGINEERING;NUCLEAR MEDICINE;NURSING;ONCOLOGY;OPTICS;PHARMACOLOGY;PSYCHIATRY;THERMODYNAMICS;UROLOGY;WORLD WIDE WEB","18;12;7;5;4;4;4;3;3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CANCER;DISEASE;CHEMOTHERAPY;COMPLICATION;MYOCARDIAL INFARCTION;PANCREATITIS;STENOSIS;BONE MARROW;CORONARY ARTERY DISEASE;ENDOSCOPY;ETIOLOGY;FIBRINOGEN;HYPOPARATHYROIDISM;PELVIC PAIN;PERIPHERAL;POPULATION;RADIATION THERAPY;STENT;THYROID;TRANSPLANTATION;VASCULAR DISEASE","6;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2","ALEMTUZUMAB;CYCLOPHOSPHAMIDE;METASTASIS;PERCUTANEOUS CORONARY INTERVENTION;PROSTATE;PROSTATE CANCER;THYROIDECTOMY;ADENOMATOID TUMOR;ANTITHROMBIN;ARTERIAL DISEASE;B SYMPTOMS;BALLOON DILATION;BISPHOSPHONATE;BREAST CANCER;CATHEPSIN;CATHEPSIN B;CATHEPSIN D;CD34;CHOP;CIDOFOVIR;CORONARY ANGIOGRAPHY;CORONARY ATHEROSCLEROSIS;ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY;ENDOSCOPIC STENTING;ESSENTIAL THROMBOCYTHEMIA;GIST;GOITER;HEART RATE;HUMAN CYTOMEGALOVIRUS;INFLAMMATORY BOWEL DISEASE;INSULIN RESISTANCE;INTERSTITIAL CYSTITIS;LASER DOPPLER VELOCIMETRY;MASSAGE;METABOLIC SYNDROME;MUCOSITIS;MYELOFIBROSIS;MYELOLIPOMA;OSTEOCLAST;PANCREATIC CANCER;PARATHYROID HORMONE;PLACEBO;PROCALCITONIN;RECURRENT LARYNGEAL NERVE;STROMAL TUMOR;TARGETED THERAPY;THERAPEUTIC ENDOSCOPY;THROMBIN;VIRAL DISEASE;WARFARIN","2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","BONE METASTASIS;PROSTATITIS;ABDOMINAL OBESITY;BAROREFLEX;BIVALIRUDIN;CALPROTECTIN;CD117;CD52;CLAUDICATION;DABIGATRAN;DISCOVERY AND DEVELOPMENT OF DIRECT THROMBIN INHIBITORS;GANCICLOVIR;HERPESVIRIDAE;HIRUDIN;INFERIOR THYROID ARTERY;INTERMITTENT CLAUDICATION;PARATHYROID GLAND;PARATHYROIDECTOMY;VINCRISTINE","2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MIDDLE AGED;MALE;AGED;ADULT;BONE NEOPLASMS;;BREAST NEOPLASMS;PROSTATIC NEOPLASMS;AGED, 80 AND OVER;RETROSPECTIVE STUDIES;TREATMENT OUTCOME;ADENOMATOID TUMOR;GASTROINTESTINAL STROMAL TUMORS;HYPOPARATHYROIDISM;PANCREATIC NEOPLASMS;UTERINE NEOPLASMS;ADRENAL GLAND NEOPLASMS;ALPROSTADIL","18;14;14;13;11;9;7;6;6;6;5;5;5;4;4;4;4;4;3;3","BISPHOSPHONATES IN CANCER TREATMENT AND BONE HEALTH;COMPLICATIONS OF GALLSTONE DISEASE;STANDARDISATION OF LOWER URINARY TRACT FUNCTION;;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;ANALYSIS AND APPLICATIONS OF HEART RATE VARIABILITY;COMPLICATIONS AND TECHNIQUES IN THYROID SURGERY;DIAGNOSIS AND MANAGEMENT OF PANCREATITIS;DIAGNOSIS AND TREATMENT OF GASTROINTESTINAL STROMAL TUMORS;DYSPHAGIA AND SWALLOWING DISORDERS;EPIDEMIOLOGY AND MANAGEMENT OF CYTOMEGALOVIRUS INFECTION;GENOMIC ABERRATIONS AND TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA;GENOMIC STUDIES AND TREATMENT OF OVARIAN CARCINOMA;LYMPHOID NEOPLASMS;MANAGEMENT AND DIAGNOSIS OF THYROID CANCER;MANAGEMENT AND TREATMENT OF PERIPHERAL ARTERIAL DISEASE;MOLECULAR PATHOGENESIS OF MYELOPROLIFERATIVE DISORDERS;PANCREATIC CANCER RESEARCH AND TREATMENT;PHEOCHROMOCYTOMA AND PARAGANGLIOMA;PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM","2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","BONE METASTASIS;CHRONIC BACTERIAL PROSTATITIS;ETIOLOGY;HYPOPARATHYROIDISM;PROSTATE INFLAMMATION;THYROID SURGERY;;ABDOMINAL OBESITY;ABVD;ACUTE PANCREATITIS;ADENOMATOID TUMOR;ADRENAL VEIN SAMPLING;ANTICOAGULATION THERAPY;B SYMPTOMS;BALLOON DILATION;BAROREFLEX SENSITIVITY;BETAHERPESVIRINAE;BILE DUCT INJURY;BILIARY DRAINAGE;BIVALIRUDIN","2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","PERSONAL EXPERIENCE;CHRONIC PROSTATITIS;POORLY UNDERSTOOD;PROSTATITIS SYNDROME;TREATMENT OUTCOME;UNDERSTOOD CONDITION;ACUTE PANCREATITIS;ADENOMATOID TUMOR;ADRENAL MYELOLIPOMA;ADVANCED STAGE;ANASTOMOSIS BLEEDING;ANTICOAGULANT DRUGS;ATTENUATION IMPROVES;AUTOLOGOUS BONE;BAROREFLEX GAIN;BENIGN BILE;BILE DUCT;BILIARY STENT;BLEEDING PERSONAL;BONE MARROW;BONE METASTASES;BONE METASTASIS;CALPROTECTIN LEVELS;CAMPATH-H CHOP-C;CANCER PERSONAL;CD EXPRESSION;CHOP CHEMOTHERAPY;CHRONIC IDIOPATHIC;CIRCULATING LEVELS;CLL PATIENTS","4;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","PLASMA CAL;CAL VALUES;AP PATIENTS;CAL CONCENTRATION;CAL PLASMA;CONTROLS PLASMA;DIFFERENTIAL DIAGNOSIS;INFECTED NECROSIS;PLASMA LEVELS;ABDOMINAL FLUID;ABNORMALITIES DISAPPEARED;ACUTE INFLAMMATORY;ACUTE PANCREATITIS;ADMISSION INCLUDED;AGE SEX;ALKALINE PHOSPHATASE;ANTIBIOTIC CHEMOTHERAPY;ANTIBIOTIC THERAPYWE;AP FORTY-SIX;AP PLASMA;APPEARANCEBECAUSE DIFFERENTIAL;APRIL CONFIRMED;ATLANTA CRITERIA;AVOID UNNECESSARY;BENEFITA PERCUTANOUS;BENIGN DISEASE;BENIGN TUMOR;BIOPSY SIMPLE;BLOOD HYPERTENSION;CAL ASSAY","6;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",2,0.08,3,48,0,0,0,0,63,0,0,48,0,0,0,0,3,0,0,0,0,0,0,52.75,52.75,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3,3.67,709,8.82,0,0,86.33,0,0,1,0,2,0,0,0,0,3,0,0,0,0,0,0,0,2,1,0,3,0,0,0,0,0,0,0,0,0,"Canada;Italy;Switzerland;United States","2;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS","3;2;2","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;DIGESTIVE DISEASES;EMERGING INFECTIOUS DISEASES;HEPATITIS;LIVER DISEASE;LUNG;LUNG CANCER;ORPHAN DRUG;OVARIAN CANCER;RARE DISEASES","3;3;2;1;1;1;1;1;1;1;1;1","CANCER","2","6.1 PHARMACEUTICALS","2","LUNG CANCER;OVARIAN CANCER","1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT","2;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_GIACCONE",2007,23,7.30434782608696,2.82608695652174,0.869565217391304,0.260869565217391,0.91304347826087,1.22641509433962,1.25,1,1.23529411764706,0.0869565217391304,0,5,3,5,10,0.22,0.13,0.22,0.43,8.57,0.16229382411873,NA,0.0434782608695652,0.521739130434783,0.424,0.342,0.311,0.341,"GIROLAMO GERACI;C SCIUMÈ;F PISELLO;DARVINIO MELLONI;TIZIANA FACELLA;GIUSEPPE MODICA;R.F. LIOTTA;FRANCESCO LI VOLSI;SALVATORE NOVO;MASSIMO MIDIRI;EGLE CORRADO;CARLO PAVONE;ENRICO HOFFMANN;SALVATORE EVOLA;GIUSEPPE RUNZA;CIRO IMBIMBO;VALERIO ALAIMO;GIUSEPPINA PALAZZOLO;FRANCESCO MANGIAPIA;GAETANO LETO","5;5;4;4;4;4;4;3;3;3;2;2;2;2;2;2;2;2;2;2","DARVINIO MELLONI;R.F. LIOTTA;GIROLAMO GERACI;C SCIUMÈ;MARÍA TARANTINO;SALVATORE NOVO;EGLE CORRADO;F PISELLO;GIUSEPPE MODICA;TIZIANA FACELLA;MICHELA CONTI;D SINAGRA;FRANCESCO LI VOLSI;GAETANO LETO;CARLO PAVONE;CIRO IMBIMBO;FRANCESCO MANGIAPIA;ALESSANDRO PALMIERI;VINCENZO MIRONE;MASSIMO MIDIRI","0.95;0.95;0.7;0.7;0.67;0.65;0.58;0.57;0.57;0.55;0.5;0.5;0.43;0.36;0.29;0.29;0.29;0.29;0.29;0.28","GIROLAMO GERACI;C SCIUMÈ;F PISELLO;DARVINIO MELLONI;TIZIANA FACELLA;R.F. LIOTTA;MASSIMO MIDIRI;EGLE CORRADO;CARLO PAVONE;GIUSEPPE RUNZA;FRANCESCO MANGIAPIA;GAETANO LETO;MARÍA TARANTINO;GIUSEPPINA NOVO;GIOVANNI FRANCO;SPERANZA RUBATTU;GIULIANO TOCCI;EMILIO IANNITTO;CALOGERO CARUSO;DANIELE DI CARLO","5;5;4;4;4;4;3;2;2;2;2;2;2;2;1;1;1;1;1;1","DARVINIO MELLONI;R.F. LIOTTA;GIROLAMO GERACI;C SCIUMÈ;MARÍA TARANTINO;EGLE CORRADO;F PISELLO;TIZIANA FACELLA;D SINAGRA;GAETANO LETO;CARLO PAVONE;FRANCESCO MANGIAPIA;MASSIMO MIDIRI;CARLA FLANDINA;MARILENA CRESCIMANNO;FRANCESCA MARIA TUMMINELLO;CALOGERO CARUSO;DANIELE DI CARLO;ANNA MARIA CAMPAGNA;IRENE CUPPARI","0.95;0.95;0.7;0.7;0.67;0.58;0.57;0.55;0.5;0.36;0.29;0.29;0.28;0.25;0.25;0.25;0.17;0.17;0.17;0.17","GAETANO LETO;NICOLA GEBBIA;C. SFERRAZZA;CARLO ARCARA;D. DI TRAPANI;GIOVAMBATTISTA RINI;GIUSEPPE BADALAMENTI;LORENA INCORVAIA;SALVATORE FRICANO;CARLA FLANDINA;FRANCESCA MARIA TUMMINELLO;MARILENA CRESCIMANNO;ANTONIO BASILE;ANTONIO GRANATA;DIMITRIOS TSETIS;FRANCESCO COPPOLINO;GIACOMO CALCARA;MARIA TERESA PATTI;MASSIMO MIDIRI;MICHELE FIGUERA","108;85;76;76;76;76;76;76;76;32;32;32;20;20;20;20;20;20;20;20","LORENA INCORVAIA;CARLA FLANDINA;FRANCESCA MARIA TUMMINELLO;GAETANO LETO;MARILENA CRESCIMANNO;FRANCESCO COPPOLINO;MASSIMO MIDIRI;ANNA MARIA CAMPAGNA;CALOGERO CARUSO;CLAUDIA MINEO;DANIELE DI CARLO;IRENE CUPPARI;EMILIANO MARESI;ANTONIETTA DI CRISTINA;EMILIO IANNITTO;GIOVANNI FRANCO;GIROLAMO GERACI;MANLIO TOLOMEO;ROSARIA MARIA PIPITONE;STEFANIA GRIMAUDO","76;32;32;32;32;20;20;18;18;18;18;18;13;9;9;9;9;9;9;9","DARVINIO MELLONI;GIROLAMO GERACI;R.F. LIOTTA;CARLO PAVONE;FRANCESCO MANGIAPIA;ANNA MARIA CAMPAGNA;ANTONIETTA DI CRISTINA;CALOGERO CARUSO;CARLA FLANDINA;CLAUDIA MINEO;D SINAGRA;DANIELE DI CARLO;EGLE CORRADO;EMILIANO MARESI;EMILIO IANNITTO;FRANCESCA MARIA TUMMINELLO;FRANCESCO COPPOLINO;GAETANO LETO;GIOVANNI FRANCO;IRENE CUPPARI","4;4;4;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;CHEMISTRY;COMPUTER SCIENCE;ECONOMICS;ENGINEERING;PHILOSOPHY;PHYSICS","21;3;2;1;1;1;1;1","INTERNAL MEDICINE;SURGERY;CARDIOLOGY;RADIOLOGY;GASTROENTEROLOGY;GENERAL SURGERY;UROLOGY;PATHOLOGY;ANESTHESIA;BIOCHEMISTRY;ENDOCRINOLOGY;ARTIFICIAL INTELLIGENCE;ASTRONOMY;CELL BIOLOGY;COMBINATORIAL CHEMISTRY;COMPUTATIONAL BIOLOGY;DENTISTRY;ENVIRONMENTAL HEALTH;FINANCE;GENETICS;GYNECOLOGY;HUMANITIES;IMMUNOLOGY;MECHANICAL ENGINEERING;NUCLEAR MEDICINE;ONCOLOGY;STEREOCHEMISTRY","18;11;6;6;5;4;4;3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CANCER;BLOOD PRESSURE;MYOCARDIAL INFARCTION;ARTERY;BIOPSY;GENE;GOLD STANDARD (TEST);MAGNETIC RESONANCE IMAGING;STENOSIS;ULTRASOUND;URINARY INCONTINENCE;ACUTE PANCREATITIS;ANASTOMOSIS;ANGIOGRAPHY;ANTIBODY;ANTIGEN;AORTA;ASPIRIN;BEZOAR;CELL;CELL GROWTH;CHEMOTHERAPY;CHEST PAIN;COMMON BILE DUCT;COMPUTED TOMOGRAPHY;CONTROL (MANAGEMENT);CORONARY ARTERY DISEASE;DIABETES MELLITUS;DISSECTION (MEDICAL);DIVERTICULITIS;DIVERTICULUM (MOLLUSC);DRUG DISCOVERY;DUODENUM;DYSPHAGIA;ENDOSCOPY;ENZYME;EVENING;FENOFIBRATE;GASTROSTOMY;HEMANGIOPERICYTOMA;IMMUNE SYSTEM;INFERIOR VENA CAVA;INFLAMMATION;KIDNEY;LEIOMYOSARCOMA;LYMPH NODE;LYMPHOMA;MALIGNANCY;MATRIX METALLOPROTEINASE;MENOPAUSE;MESENCHYMAL STEM CELL;MITOSIS;NECROSIS;OBESITY;OCCLUSION;ORAL CAVITY;PANCREATITIS;PARENTERAL NUTRITION;PEG RATIO;PHARMACOPHORE;POPULATION;PREDNISONE;RADIATION THERAPY;RANDOMIZED CONTROLLED TRIAL;RECEIVER OPERATING CHARACTERISTIC;RECEPTOR;RENAL FUNCTION;RESECTION;SEDATION;SPINAL ANESTHESIA;SPLEEN;STENT;STOMACH;STROKE (ENGINE);SUPERIOR MESENTERIC ARTERY;SWALLOWING;THYROID;VEIN;VENTRICLE","10;4;3;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","PROSTATE CANCER;PROSTATE;METASTASIS;ABDOMINAL AORTA;ALLELE;AUTOANTIBODY;AUTOIMMUNITY;BREAST CANCER;BYPASS SURGERY;C-REACTIVE PROTEIN;C4A;CATHEPSIN;CELL CYCLE;CLOPIDOGREL;COLORECTAL CANCER;COMPUTED TOMOGRAPHY ANGIOGRAPHY;CORONARY ANGIOGRAPHY;CORONARY ARTERIES;CORONARY ARTERY BYPASS SURGERY;CYCLOPHOSPHAMIDE;CYSTATIN C;DIASTOLE;ENTERAL ADMINISTRATION;ESSENTIAL HYPERTENSION;GASTRECTOMY;HEAD AND NECK CANCER;HEART RATE;HUMAN LEUKOCYTE ANTIGEN;LEFT RENAL VEIN;LYMPHADENECTOMY;METABOLIC SYNDROME;MITOTIC INDEX;MULTIDETECTOR COMPUTED TOMOGRAPHY;OSTEOCLAST;OVARIAN CANCER;PERCUTANEOUS ENDOSCOPIC GASTROSTOMY;RENAL ARTERY;RENAL VEIN;RETINOBLASTOMA;RITUXIMAB;SPLENECTOMY;THYROIDECTOMY;THYROIDITIS;UNSTABLE ANGINA;WEDGE RESECTION","6;3;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","PROSTATE-SPECIFIC ANTIGEN;PROSTATECTOMY;BONE METASTASIS;CATHEPSIN K;COLONOSCOPY;CYSTATIN;DEBULKING;DIASTOLIC FUNCTION;HAPLOTYPE;NUTCRACKER SYNDROME;RENAL ARTERY STENOSIS;RETINOBLASTOMA PROTEIN;RIGHT RENAL ARTERY;SYSTOLE;THYROID LYMPHOMA;TRANSRECTAL ULTRASONOGRAPHY;VINCRISTINE","2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;FEMALE;;METABOLIC SYNDROME;MIDDLE AGED;ADULT;BONE NEOPLASMS;AGED;BREAST NEOPLASMS;PROSTATIC NEOPLASMS;AGED, 80 AND OVER;IMMUNOGLOBULIN G;CARDIOVASCULAR DISEASES;HEMATURIA;HLA-B8 ANTIGEN;HLA-DR3 ANTIGEN;PROTEINURIA;STOMACH NEOPLASMS;TOMOGRAPHY, X-RAY COMPUTED","15;11;10;8;8;8;7;7;6;6;6;5;5;4;4;4;4;4;4;4","PROSTATE CANCER RESEARCH AND TREATMENT;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;MOLECULAR MECHANISMS OF OSTEOCLAST DIFFERENTIATION AND BONE REMODELING;CHOLESTEROL-LOWERING TREATMENT;CLINICOPATHOLOGY OF FIBROUS TUMORS AND TREATMENT STRATEGIES;COMPLICATIONS OF GALLSTONE DISEASE;DIAGNOSIS AND TREATMENT OF GASTROINTESTINAL STROMAL TUMORS;GLOBAL TRENDS IN COLORECTAL CANCER RESEARCH;LYMPHOID NEOPLASMS;MANAGEMENT AND DIAGNOSIS OF THYROID CANCER;MANAGEMENT OF HYPERTENSION AND CARDIOVASCULAR RISK FACTORS;NUTRITIONAL GENOMICS: PERSONALIZED NUTRITION AND HEALTH;PELVIC FLOOR DISORDERS;PROVISION AND ASSESSMENT OF NUTRITION SUPPORT THERAPY;RECOMMENDATIONS FOR CARDIAC CHAMBER QUANTIFICATION BY ECHOCARDIOGRAPHY;ROLE OF SIRTUINS IN HEALTH AND AGING;THERAPEUTIC ANTIBODIES: DEVELOPMENT, ENGINEERING, AND APPLICATIONS;VENOUS ANOMALIES AND SYNDROMES IN VASCULAR SYSTEM","4;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","BONE METASTASIS;BREAST MRI;CARDIAC IMAGING;CARDIOVASCULAR RISK ASSESSMENT;COMPUTED TOMOGRAPHY ANGIOGRAPHY;DIAGNOSTIC ACCURACY;DYNAMIC CONTRAST-ENHANCED MRI;GOLD STANDARD (TEST);HYPERTENSION;LAPAROSCOPIC RADICAL PROSTATECTOMY;MAGNETIC RESONANCE IMAGING;METABOLIC SYNDROME;MRI IMAGING;PROSTATE CANCER;URINARY CONTINENCE;ABDOMINAL AORTA;AUTOIMMUNITY;BLOOD PRESSURE;BOWEL PREPARATION;BYPASS SURGERY","2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1","PERSONAL EXPERIENCE;PROSTATE CANCER;COMPUTED TOMOGRAPHY;ENDORECTAL MAGNETIC;HYPERTENSIVE PATIENTS;LAPAROSCOPIC TRANSPERITONEAL;MAGNETIC RESONANCE;METABOLIC SYNDROME;MULTIDETECTOR COMPUTED;RESONANCE IMAGING;SPECIFICITY EVALUATION;TRANSPERITONEAL RADICAL;TRANSRECTAL SONOGRAPHY;ACUTE ONSET;ANCESTRAL HAPLOTYPE;ANTIPROLIFERATIVE AGENTS;AORTO-CORONARY BYPASS;ARTERY DISEASE;BILIARY STENT;BLOOD LEVELS;BLOOD PRESSURE;BONE DISEASE;BOWEL PREPARATION;BREAST CANCER;BYPASS PATENCY;C-REACTIVE PROTEIN;CANCER METASTATIC;CANCER RELATED;CARDIOVASCULAR PREVENTION;CELL CYCLE","4;3;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","BLOOD PRESSURE;HYPERTENSIVE SUBJECTS;ACUTE SALINE;DOSE FUROSEMIDE;FAST WALKING;HEART FAILURE;ABPM CONFIRMS;ANP BNP;EUROPEAN SOCIETY;HF CONTROLS;HYPERTENSIVE PATIENTS;IL- E-SELECTIN;IL--BETA TNF-ALFA;LEFT VENTRICULAR;NATRIURETIC PEPTIDES;PHARMACOLOGICAL THERAPY;PHYSICAL EXERCISE;PLASMA LEVELS;RISK FACTORS;SALINE LOAD;TNF-ALFA IL-;ABPM PERFORMED;ABSOLUTE CHANGE;ADHESION MOLECULES;ADMISSIONTHESE SUBJECTS;ALVD CONTROLS;ALVDWE EVALUATED;AMBULATORY BLOOD;ANP IL--BETA;ANTIHYPERTENSIVE DRUGS","6;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1",1,0.04,3,1,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,4,7.25,1345.5,8.33,2,0.5,87.25,0,0,0,0,4,0,0,0,0,4,0,0,0,0,0,0,0,3,1,0,4,0,0,0,0,0,0,0,0,0,"Italy","3","32 BIOMEDICAL AND CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3202 CLINICAL SCIENCES","4;4;2","CANCER;CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;BREAST CANCER;COLO-RECTAL CANCER;DIGESTIVE DISEASES;HEMATOLOGY;LUNG;LUNG CANCER;PATIENT SAFETY;RARE DISEASES","4;4;4;1;1;1;1;1;1;1;1","CANCER","3","6.1 PHARMACEUTICALS","4","BLOOD CANCER;BREAST CANCER;COLON AND RECTAL CANCER;LEUKEMIA / LEUKAEMIA;LUNG CANCER","1;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","4",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_GIACCONE",2008,26,8.07692307692308,2.84615384615385,0.576923076923077,0.538461538461538,0.538461538461538,1.17460317460317,1,1,1,0.230769230769231,0,9,4,7,6,0.35,0.15,0.27,0.23,26.54,0.483644191563647,NA,0.153846153846154,0.769230769230769,0.304,0.269,0.322,0.267,"SALVATORE NOVO;MARÍA TARANTINO;EGLE CORRADO;GIUSEPPE COPPOLA;GIUSEPPINA NOVO;GIULIA ALAGNA;OLGA CRUZ‐LÓPEZ;MARÍA DORA CARRIÓN;CARLO PAVONE;IDA MARIA MURATORI;ROMEO ROMAGNOLI;VINCENZO MIRONE;ROSA LIOTTA;MANFREDI RIZZO;STEFANIA GRIMAUDO;S. DI MEO;PIER GIOVANNI BARALDI;MANLIO TOLOMEO;FRANCESCO MANGIAPIA;FILIPPO GIAMBARTINO","5;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","MARÍA TARANTINO;ROSA LIOTTA;SALVATORE NOVO;EGLE CORRADO;GIUSEPPE COPPOLA;GIULIA ALAGNA;FILIPPO GIAMBARTINO;LAWRENCE CAMARDA;CARLO PAVONE;G. GRECOMORO;IDA MARIA MURATORI;UMBERTO MARTORANA;VINCENZO MIRONE;MANFREDI RIZZO;S. DI MEO;FRANCESCO MANGIAPIA;D. MELLONI;R.F. LIOTTA;GIUSEPPINA NOVO;SALVATORE MANGIONE","1.17;0.83;0.64;0.48;0.48;0.37;0.37;0.33;0.33;0.33;0.33;0.33;0.33;0.33;0.33;0.33;0.33;0.33;0.33;0.2","SALVATORE NOVO;MARÍA TARANTINO;EGLE CORRADO;GIUSEPPE COPPOLA;GIUSEPPINA NOVO;GIULIA ALAGNA;CARLO PAVONE;IDA MARIA MURATORI;MANFREDI RIZZO;STEFANIA GRIMAUDO;MANLIO TOLOMEO;FILIPPO GIAMBARTINO;R.F. LIOTTA;DAVIDE NOTO;SALVATORE MANGIONE;RENATO VENEZIA;SANTINA COTTONE;GIOVANNI GUERCIO;NICOLÒ RENDA;E BORRUSO","5;4;3;3;3;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1","MARÍA TARANTINO;SALVATORE NOVO;EGLE CORRADO;GIUSEPPE COPPOLA;GIULIA ALAGNA;FILIPPO GIAMBARTINO;LAWRENCE CAMARDA;CARLO PAVONE;G. GRECOMORO;IDA MARIA MURATORI;UMBERTO MARTORANA;MANFREDI RIZZO;R.F. LIOTTA;GIUSEPPINA NOVO;SALVATORE MANGIONE;RENATO VENEZIA;GIOVANNI GUERCIO;SALVATORE PIRRI;GASPARE CUCINELLA;LUIGI SANDONATO","1.17;0.64;0.48;0.48;0.37;0.37;0.33;0.33;0.33;0.33;0.33;0.33;0.33;0.33;0.2;0.2;0.2;0.2;0.2;0.2","SALVATORE NOVO;GIUSEPPINA NOVO;ANDREA BRANCALE;ERNEST HAMEL;JAN BALZARINI;M CARA;MANLIO TOLOMEO;MARÍA DORA CARRIÓN;OLGA CRUZ‐LÓPEZ;PIER GIOVANNI BARALDI;ROMEO ROMAGNOLI;STEFANIA GRIMAUDO;TARADAS SARKAR;EGLE CORRADO;GIUSEPPE COPPOLA;IDA MARIA MURATORI;MANFREDI RIZZO;A. DI GIROLAMO;ANNABELLA BRASCHI;G BIONDO","257;178;131;131;131;131;131;131;131;131;131;131;131;121;121;120;120;117;117;117","SALVATORE NOVO;MANLIO TOLOMEO;MANFREDI RIZZO;GIUSEPPINA NOVO;NICOLÒ RENDA;ANTONELLA DI CRISTINA;STEFANIA GRIMAUDO;IDA MARIA MURATORI;FRANCESCO COPPOLINO;A PERINO;GASPARE CUCINELLA;RENATO VENEZIA;ALFREDO CHIARINI;ANNA GIAMMANCO;RITA IMMORDINO;SALVATORE ANTONINO DISTEFANO;T. AMATO;CALOGERO D’AMICO;FABIO FULFARO;FRANCESCA MARIA TUMMINELLO","137;131;120;117;117;108;108;78;60;42;42;42;37;37;37;37;37;35;35;35","MARÍA TARANTINO;SALVATORE NOVO;MANFREDI RIZZO;MANLIO TOLOMEO;A PERINO;ALFREDO CHIARINI;ANGELO B. CEFALÙ;ANNA GIAMMANCO;ANTONELLA DI CRISTINA;BARBARA BUSCEMI;CALOGERO D’AMICO;DAVIDE NOTO;DIANA DI GIOIA;E BORRUSO;EGLE CORRADO;EMILIO IANNITTO;FABIO FULFARO;FRANCESCA MARIA TUMMINELLO;FRANCESCO COPPOLINO;G. GRECOMORO","4;3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;PHYSICS;ART;CHEMISTRY;GEOGRAPHY;PHILOSOPHY;POLITICAL SCIENCE;SOCIOLOGY","23;7;4;3;2;1;1;1;1","INTERNAL MEDICINE;PATHOLOGY;SURGERY;CARDIOLOGY;GENETICS;UROLOGY;ENDOCRINOLOGY;ANESTHESIA;BIOCHEMISTRY;CELL BIOLOGY;GASTROENTEROLOGY;HUMANITIES;OPTICS;ORGANIC CHEMISTRY;STEREOCHEMISTRY;ARCHAEOLOGY;AUDIOLOGY;DEMOGRAPHY;ENVIRONMENTAL HEALTH;FAMILY MEDICINE;GYNECOLOGY;IMMUNOLOGY;LAW;LINGUISTICS;LITERATURE;METEOROLOGY;MICROBIOLOGY;MOLECULAR BIOLOGY;ONCOLOGY;PHYSIOLOGY;PSYCHIATRY;QUANTUM MECHANICS;RADIOLOGY;THERMODYNAMICS","18;6;6;5;5;5;3;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CANCER;ATRIAL FIBRILLATION;BIOPSY;COLCHICINE;CYTOLOGY;DIABETES MELLITUS;DNA;ENDOTHELIAL DYSFUNCTION;EPITHELIUM;ETIOLOGY;HYPERPLASIA;IN VITRO;INCIDENCE (GEOMETRY);INFLAMMATION;MICROTUBULE;MYOCARDIAL INFARCTION;PATHOLOGICAL;URINARY BLADDER;URINARY SYSTEM;ABLATION;AIR TEMPERATURE;ALKYL;ALTERNATIVE MEDICINE;AMINO ACID;ANAEROBIC EXERCISE;ANTIBIOTICS;ANTIFUNGAL;ASYMPTOMATIC;BACTERIA;CALCIUM;CANDIDA ALBICANS;CHALCONE;CHEMOTHERAPY;CHEST PAIN;CHOLESTEROL;CHRONIC RENAL FAILURE;CLINICAL TRIAL;CLONIDINE;CONCOMITANT;CONFIDENCE INTERVAL;CORONARY ARTERY DISEASE;CREATININE;CYST;DISEASE;DISSECTION (MEDICAL);DOUBLE BOND;ELECTROCARDIOGRAPHY;ELECTROENCEPHALOGRAPHY;ENDOMETRIOSIS;ENONE;ESCHAR;EXPOSITION (NARRATIVE);FIBRINOGEN;GENE;GOUT;HEART FAILURE;HYPERKINESIA;HYPERPARATHYROIDISM;INSULIN;INTRATHECAL;ISCHEMIA;ISOBARIC PROCESS;LAPAROSCOPY;MALAISE;MEMBRANE;MOIETY;MULTIPLE MYELOMA;OBESITY;ODDS RATIO;ORTHOPEDIC SURGERY;PERCUTANEOUS;POLYMER;POPULATION;PREGNANCY;PYRIDINE;RADIATION THERAPY;RADON;RASH;REFERRAL;REGIMEN;RELATIVE HUMIDITY;RHEUMATOLOGY;ROPIVACAINE;SICILIAN;STANDARDIZATION;STENOSIS;SUBCLINICAL INFECTION;TENDON;THIOPHENE;URINE;VENTRICLE;VIRUS;VISUAL ANALOGUE SCALE","5;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","BIOLOGICAL ACTIVITY;BLADDER CANCER;CHROMATIN;CYSTOSCOPY;PROSTATE;TUBULIN;ACUTE CORONARY SYNDROME;ANAEROBIC BACTERIA;APPARENT TEMPERATURE;ARYL;BACILLI;BASAL (MEDICINE);BLEOMYCIN;BLOOD CULTURE;BORTEZOMIB;C-REACTIVE PROTEIN;CARDIOMYOPATHY;CHEMICAL SYNTHESIS;CHEMOTHERAPY REGIMEN;CYCLOPHOSPHAMIDE;CYSTATIN C;DACARBAZINE;DYSLIPIDEMIA;ETOPOSIDE;EXON;FUNGEMIA;HYPNOSIS;INSULIN RESISTANCE;INTRON;LAPAROSCOPIC SURGERY;LEFT ATRIUM;LIPOPROTEIN;METABOLIC SYNDROME;METASTASIS;MUTATION;MYOCARDIAL STUNNING;OBLIGATE ANAEROBE;OBSTETRICS AND GYNAECOLOGY;PARATHYROID HORMONE;PATELLAR TENDON;PHOSPHOLIPID;PLASMA CELL;PLASMA CELL LEUKEMIA;POISSON REGRESSION;POLYMERIZATION;PROINFLAMMATORY CYTOKINE;PROSTATE CANCER;QUADRICEPS TENDON;RADIOFREQUENCY ABLATION;RELATIVE RISK;RICKETTSIA;RNA;T WAVE;TROPONIN;TUMOR MARKER;TYPE 2 DIABETES;VINBLASTINE;WAIST","2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","NUCLEAR MATRIX;PROSTATE-SPECIFIC ANTIGEN;PROSTATITIS;TRANSITIONAL CELL CARCINOMA;URINE CYTOLOGY;ADIPONECTIN;ALTERNATIVE SPLICING;ANTIMITOTIC AGENT;BONE METASTASIS;CHOLESTERYLESTER TRANSFER PROTEIN;COMBRETASTATIN;PHOSPHOLIPID TRANSFER PROTEIN;POINT MUTATION;PROBAND;RICKETTSIOSIS;RNA SPLICING;SECONDARY HYPERPARATHYROIDISM;SPOTTED FEVER;TRANSURETHRAL RESECTION OF THE PROSTATE;VINCRISTINE","2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;BONE NEOPLASMS;MIDDLE AGED;;CAROTID ARTERY DISEASES;MALE;AGED;TUBULIN;ITALY;ADULT;BIOMARKERS;HYPERLIPOPROTEINEMIAS;ANTIMITOTIC AGENTS;ANTINEOPLASTIC AGENTS;ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;BREAST NEOPLASMS;CARDIOVASCULAR DISEASES;CHALCONES;CHOLESTEROL ESTER TRANSFER PROTEINS","16;11;9;9;8;8;8;7;7;6;5;5;5;4;4;4;4;4;4;4","ARTERIAL STIFFNESS AND CARDIOVASCULAR HEALTH;HETEROCYCLIC COMPOUNDS FOR DRUG DISCOVERY;PROSTATE CANCER RESEARCH AND TREATMENT;ADAPTATION OF TENDON AND SKELETAL MUSCLE TO MECHANICAL LOADING;BISPHOSPHONATES IN CANCER TREATMENT AND BONE HEALTH;CELLULAR SENESCENCE AND AGING-RELATED DISEASES;CHOLESTEROL-LOWERING TREATMENT;DIAGNOSIS AND MANAGEMENT OF ENDOMETRIOSIS;DIAGNOSIS AND MANAGEMENT OF GASTROESOPHAGEAL REFLUX DISEASE;DIAGNOSIS AND MANAGEMENT OF PERICARDIAL DISEASES;DIAGNOSIS AND TREATMENT OF BLADDER CANCER;DIAGNOSIS AND TREATMENT OF MULTIPLE MYELOMA;EPIDEMIOLOGY AND MANAGEMENT OF NEUROENDOCRINE TUMORS;IMPACT OF CLIMATE CHANGE ON HUMAN HEALTH;INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING IN SURGERY;LYMPHOID NEOPLASMS;MANAGEMENT OF DIABETES MELLITUS AND HYPOGLYCEMIA;MANAGEMENT OF POSTOPERATIVE PAIN AND COMPLICATIONS;MANAGEMENT OF SPINAL METASTATIC TUMORS;MICROBIAL IDENTIFICATION AND DIAGNOSIS","2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","COLCHICINE;ENDOTHELIAL DYSFUNCTION;ETIOLOGY;NUCLEAR MATRIX;URINE CYTOLOGY;ABVD;ANTICANCER AGENTS;ANTICOAGULANT THERAPY;ANTIMICROBIAL SUSCEPTIBILITY TESTING;ANTIMITOTIC AGENT;APPARENT TEMPERATURE;BASAL (MEDICINE);BLADDER CANCER;BLOOD CULTURE;BONE METASTASES;BONE METASTASIS;BOUTONNEUSE FEVER;BRACHIAL ARTERY ASSESSMENT;CANCER METABOLISM;CANCER THERAPY","2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","BIOLOGICAL EVALUATION;CELL CARCINOMA;CHRONIC PROSTATITIS;CLINICAL EVALUATION;MATRIX PROTEIN;NUCLEAR MATRIX;PSA VALUES;STRONG PREDICTORS;TRANSITIONAL CELL;URINARY MARKER;ACHALASIA SURGICAL;ACUTE MYOCARDIAL;AEROBIC ANAEROBIC;AMINO---TRIMETHOXYBENZOYL--SUBSTITUTED--TETRAHYDROTHIENO-CPYRIDINE DERIVATIVES;ANTIMITOTIC AGENTS;ATRIAL FIBRILLATION;AUTOMATED SYSTEM;BACTEC AUTOMATED;BASED MONITOR;BLADDER ENDOMETRIOSIS;BONE DISEASE;BONE METASTASES;CAROTID LESIONS;CELL LEUKEMIA;CETP GENE;CHOLECYSTECTOMY ATTRIBUTED;CHRONIC RUPTURE;CLIMATIC VARIABLES;CLINICAL ATHEROSCLEROSIS;CLINICAL EVENTS","2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ATRIAL FIBRILLATION;STAGE IA;UNFAVORABLE STAGE;AMI HOSPITAL;BLOOD CULTURES;BLOODSTREAM INFECTIONS;CANCER CELL;CHRONIC RENAL;EVE ARM;EVE ARMS;FUNGAL BOTTLES;GRAM-NEGATIVE BACILLI;HL PATIENTS;ICF BOTTLES;IIA HL;INCIDENCE RELATIVE;MYCOSIS ICF;RENAL FAILURE;TUBULIN POLYMERIZATION;UNIVERSITY HOSPITAL;ABVD ARM;ABVD REGIMEN;ACTIVITY INHIBITION;ACUTE FEBRILE;ACUTE MYOCARDIAL;ADDITIONAL ROUTINE;ADMISSIONSMETHODSWE CORRELATED;AEROBIC BOTTLES;AIR FORCE;ALKYL CHAIN","4;4;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1",6,0.23,3,2.5,1,0,0,0,3,0,1,2.5,0,0,1,0,0,0,0,1,0,0,0,73.5,73.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,4,5.25,296.25,6.56,0,0,44.75,0,0,0,0,4,0,0,0,0,4,0,0,0,0,0,0,0,4,0,0,4,0,0,0,0,0,0,0,0,0,"Italy","3","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY","4;2;2;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;RARE DISEASES;CANCER;HEMATOLOGY;CARDIOVASCULAR;DENTAL/ORAL AND CRANIOFACIAL DISEASE;DIGESTIVE DISEASES;HEART DISEASE;HEART DISEASE - CORONARY HEART DISEASE;NEUROSCIENCES;PATIENT SAFETY;TRANSPLANTATION","4;3;3;2;2;1;1;1;1;1;1;1;1","BLOOD;CANCER;CARDIOVASCULAR;SKIN","1;1;1;1","6.1 PHARMACEUTICALS;6.4 SURGERY","4;1","HEAD AND NECK CANCER;LARYNGEAL CANCER;LEUKEMIA / LEUKAEMIA;ORAL CAVITY AND LIP CANCER;PHARYNGEAL CANCER","1;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;5.5 COMBINATIONS OF LOCALIZED AND SYSTEMIC THERAPIES","2;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_GIACCONE",2009,30,9.63333333333333,3.13333333333333,0.433333333333333,0.466666666666667,0.533333333333333,1.34285714285714,1.44444444444444,1.07692307692308,1.23076923076923,0.2,0,11,8,4,5,0.37,0.27,0.13,0.17,23.8,0.514514250027022,NA,0.166666666666667,0.833333333333333,0.411,0.36,0.206,0.333,"CARLO PAVONE;DANIELA ABBADESSA;EMILIO IANNITTO;FRANCESCO DI RAIMONDO;VINCENZO ABBADESSA;SERGIO SIRAGUSA;VINCENZO SERRETTA;ROBERTA GRANESE;A. SCARCELLA;DOMENICA CARAMAZZA;G EVOLA;MAURA BRUGIATELLI;MASSIMO CANDIANI;F. SCUTO;GASPARE CUCINELLA;M. KARYDI;SALVATORE NOVO;DARVINIO MELLONI;ANGELO MAGGIONI;L. DI GREGORIO","6;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2","CARLO PAVONE;DANIELA ABBADESSA;MARIA LAURA DI LORENZO;F. SCUTO;L. DI GREGORIO;MARIA CRISTINA RIGHETTI;FRANCESCO MOSCHELLA;VINCENZO SERRETTA;ROBERTA GRANESE;MASSIMO CANDIANI;GASPARE CUCINELLA;ANGELO MAGGIONI;D. ABED EL RAHMAN;A. SCARCELLA;M. KARYDI;DARVINIO MELLONI;G. CORACI;CARLO MELLONI;SERGIO SIRAGUSA;EMILIO IANNITTO","1.2;0.87;0.5;0.5;0.5;0.5;0.4;0.37;0.37;0.37;0.37;0.37;0.37;0.33;0.33;0.33;0.33;0.33;0.26;0.25","CARLO PAVONE;DANIELA ABBADESSA;EMILIO IANNITTO;VINCENZO ABBADESSA;SERGIO SIRAGUSA;VINCENZO SERRETTA;A. SCARCELLA;DOMENICA CARAMAZZA;F. SCUTO;GASPARE CUCINELLA;M. KARYDI;SALVATORE NOVO;DARVINIO MELLONI;L. DI GREGORIO;G. CORACI;CARLO MELLONI;ALESSANDRA MALATO;CLAUDIO TRIPODO;GIORGIA SACCULLO;V. CILLINO","6;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1","CARLO PAVONE;DANIELA ABBADESSA;MARIA LAURA DI LORENZO;F. SCUTO;L. DI GREGORIO;VINCENZO SERRETTA;GASPARE CUCINELLA;A. SCARCELLA;M. KARYDI;DARVINIO MELLONI;G. CORACI;CARLO MELLONI;SERGIO SIRAGUSA;EMILIO IANNITTO;VINCENZO ABBADESSA;DOMENICA CARAMAZZA;ALESSANDRA MALATO;GIORGIA SACCULLO;EMILIANO MARESI;A PERINO","1.2;0.87;0.5;0.5;0.5;0.37;0.37;0.33;0.33;0.33;0.33;0.33;0.26;0.25;0.24;0.21;0.21;0.21;0.2;0.2","SERGIO SIRAGUSA;CLIVE KEARON;DAN WITT;DAVID GARCÍA;DAVID R. ANDERSON;J S GINSBERG;LUQI WANG;MARC RODGER;MARK BLOSTEIN;MARK CROWTHER;MARY BETH DOWD;MAURO SILINGARDI;MICHAEL J. KOVACS;NATHAN P. CLARK;PHILIP S. WELLS;RITA SELBY;SAM SCHULMAN;SARA K. VESELY;SUSAN R. KAHN;WALTER AGENO","221;148;148;148;148;148;148;148;148;148;148;148;148;148;148;148;148;148;148;148","SERGIO SIRAGUSA;GASPARE CUCINELLA;EMILIO IANNITTO;ALESSANDRA MALATO;DOMENICA CARAMAZZA;GIORGIA SACCULLO;MAURIZIO AVERNA;A PERINO;FEDERICO ROMANO;CALOGERO CARUSO;CLAUDIA RIZZO;LAURA CASTIGLIA;EMILIANO MARESI;GIUSEPPE PIZZO;IGNAZIO ABBENE;LUCIO LO COCO;CLEMENTINA CARACCIOLO;GERLANDO QUINTINI;RITA BARONE;VALERIA CIGNA","221;91;80;73;73;73;71;68;68;67;67;67;66;42;42;42;31;31;31;31","SERGIO SIRAGUSA;ALESSANDRA MALATO;DOMENICA CARAMAZZA;EMILIO IANNITTO;GASPARE CUCINELLA;GIORGIA SACCULLO;VINCENZO ABBADESSA;A PERINO;ANTONINO ROTOLO;C NICOTRA;CALOGERO CARUSO;CARMELO COPPOLINO;CATERINA TRAPANESE;CLAUDIA COLOMBA;CLAUDIA RIZZO;CLAUDIO TRIPODO;CLEMENTINA CARACCIOLO;CRISTINA RAIMONDI;DANIELE TORRES;ELIANA VALENTINA LIARDO","3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;CHEMISTRY;COMPUTER SCIENCE;PHYSICS;ENGINEERING;MATERIALS SCIENCE;HISTORY","29;6;3;3;3;2;2;1","INTERNAL MEDICINE;SURGERY;CARDIOLOGY;GASTROENTEROLOGY;PATHOLOGY;RADIOLOGY;UROLOGY;ANESTHESIA;GENERAL SURGERY;PHARMACOLOGY;BIOCHEMISTRY;CELL BIOLOGY;COMPUTER SECURITY;ENVIRONMENTAL HEALTH;GENETICS;INTENSIVE CARE MEDICINE;NEUROSCIENCE;NUCLEAR MEDICINE;ONCOLOGY;OPHTHALMOLOGY","20;14;5;5;5;5;4;3;3;3;2;2;2;2;2;2;2;2;2;2","CANCER;ADVERSE EFFECT;ALTERNATIVE MEDICINE;ATRIAL FIBRILLATION;CHEMOTHERAPY;ANTICOAGULANT;BIOMETRICS;CLINICAL TRIAL;COMPLICATION;CONFIDENCE INTERVAL;DISEASE;HEART FAILURE;HYPERPLASIA;LYMPHOMA;MIOSIS;POPULATION;PROSTHESIS;PUPIL;RANDOMIZED CONTROLLED TRIAL;RETINAL;VENTRICLE;VISUAL ACUITY","5;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","BLADDER CANCER;COLORECTAL CANCER;EJECTION FRACTION;GEMCITABINE;IRIS (BIOSENSOR);PENILE PROSTHESIS;PHACOEMULSIFICATION;PHOTOPIC VISION;TAMSULOSIN;WARFARIN;ABDOMINAL ULTRASONOGRAPHY;ABSOLUTE RISK REDUCTION;AORTIC ROOT;APOLIPOPROTEIN B;ASCENDING AORTA;BACK PAIN;BREAST CANCER;CELL CYCLE;CLINICAL ENDPOINT;COGNITIVE IMPAIRMENT;CONTRAINDICATION;CYCLOPHOSPHAMIDE;CYTOTOXIC T CELL;DEMENTIA;DEVITRIFICATION;DIASTOLE;DUPUYTREN'S CONTRACTURE;ESSENTIAL THROMBOCYTHEMIA;EZETIMIBE;HAEMATOPOIESIS;HAZARD RATIO;IMATINIB;INTERIM ANALYSIS;LEFT ATRIUM;LOW MOLECULAR WEIGHT HEPARIN;MICROWAVE ABLATION;MULTIDETECTOR COMPUTED TOMOGRAPHY;MYELOFIBROSIS;MYOCARDIAL INFARCTION DIAGNOSIS;NATRIURETIC PEPTIDE;NEUTROPENIA;PERFORATION;PHOSPHODIESTERASE;PLACEBO;RANDOMIZATION;RITUXIMAB;ROSUVASTATIN CALCIUM;TELOMERASE;THROMBOCYTOSIS;TOLERABILITY;TUNEL ASSAY;VAGINAL VAULT;VAGINAL VAULT PROLAPSE;XANTHINE;XANTHINE OXIDASE","2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CYSTECTOMY;MESOPIC VISION;CARDIAC SKELETON;CETUXIMAB;CYCLIN-DEPENDENT KINASE 1;DIASTOLIC FUNCTION;DOPPLER ECHOCARDIOGRAPHY;HORMONAL THERAPY;IMATINIB MESYLATE;MEGAKARYOCYTE;ORAL ANTICOAGULANT;OXALIPLATIN;SYSTEMIC THERAPY;TELOMERASE REVERSE TRANSCRIPTASE;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE;VASCULAR DEMENTIA;VINCRISTINE;ZAPRINAST","2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MIDDLE AGED;AGED;;MALE;ADULT;ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;TREATMENT OUTCOME;AGED, 80 AND OVER;DEOXYCYTIDINE;THROMBOEMBOLISM;ANTICOAGULANTS;ANTINEOPLASTIC AGENTS;THROMBOCYTHEMIA, ESSENTIAL;WARFARIN;ANTIBODIES, MONOCLONAL;ENDOMETRIOSIS;EPITHELIAL CELLS;HEMORRHAGE","19;15;14;12;11;11;8;8;7;6;6;6;5;5;5;5;4;4;4;4","CATARACT SURGERY TECHNIQUES AND COMPLICATIONS;EPIDEMIOLOGY AND MANAGEMENT OF SEXUAL DYSFUNCTION;LYMPHOID NEOPLASMS;MOLECULAR PATHOGENESIS OF MYELOPROLIFERATIVE DISORDERS;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;ADVANCEMENTS IN LUNG CANCER RESEARCH;ATRIAL FIBRILLATION;CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY;CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY IN CANCER TREATMENT;CHOLESTEROL-LOWERING TREATMENT;DIAGNOSIS AND MANAGEMENT OF AORTIC DISEASES;DIAGNOSIS AND MANAGEMENT OF ENDOMETRIOSIS;DIAGNOSIS AND MANAGEMENT OF PERICARDIAL DISEASES;DIAGNOSIS AND TREATMENT OF BLADDER CANCER;DIAGNOSIS AND TREATMENT OF HEART FAILURE;EFFICACY AND RESISTANCE IN CML TREATMENT;GENITOURINARY SOFT TISSUE TUMORS AND ANOMALIES;MICROSURGICAL RECONSTRUCTION TECHNIQUES;PATHOPHYSIOLOGY OF LUMBAR DISC DEGENERATION AND TREATMENT;PELVIC FLOOR DISORDERS","2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CARDIAC IMAGING;ECHOCARDIOGRAPHY;INTRAOCULAR LENS IMPLANTATION;IRIS (BIOSENSOR);MESOPIC VISION;MIOSIS;PENILE PROSTHESIS;TAMSULOSIN;ABDOMINAL ULTRASONOGRAPHY;ABSOLUTE RISK REDUCTION;ABVD;ALLOPURINOL;ANGIOLOGY;AORTIC DISSECTION;BACK PAIN;BLADDER CANCER;CARDIAC SKELETON;CARDIOVASCULAR MRI;CEREBROVASCULAR DYSFUNCTION;CETUXIMAB","3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","BENIGN DISEASES;BENIGN PROSTATIC;CASE-CONTROL STUDY;FLOPPY IRIS;INTRAOPERATIVE COMPLICATION;IRIS SYNDROME;LUNG CANCER;MALLEABLE PENILE;PENILE PROSTHESIS;PROSTATIC HYPERPLASIA;PROSTHESIS SOLVING;PUPIL DIAMETER;SEMINAL-SPARING CYSTECTOMY;SURGICAL RISK;SYNDROME RESULTS;ABDOMINAL SURGERY;ABDOMINIS MUSCLE;ABVD CHEMOTHERAPY;ADULT PS;ADVANCED LUNG;ADVANCED NON-SMALL-CELL;AMORPHOUS FRACTION;ANTICOAGULANT THERAPY;APOPTOTIC PROFILES;ASCENDING AORTA;B-CELL LYMPHOMA;BIOLOGICAL ACTIVITY;BREAST CANCER;CALC-PS RANDOMIZED;CANCER CALC-E","2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","AMORPHOUS FRACTION;RIGID AMORPHOUS;INFARCT MASS;LV MASS;ADVERSE EVENTS;COGNITIVE IMPAIRMENT;RELATIVE INFARCT;CELL LINE;EZESIMVA MG;ICD THERAPY;INDEPENDENT PREDICTORS;LIFE THREATENING;LIPOPROTEIN CHOLESTEROL;RISK STRATIFICATION;ROSUVA MG;SECONDARY CRYSTALLIZATION;THREATENING VENTRICULAR;TOTAL CHOLESTEROL;VENTRICULAR ARRHYTHMIA;WBC LEVEL;ABOVE-MENTIONED COMPOUNDS;ABSTRACT VITRIFICATION;ACCURATE RISK;ACHIEVED LDL-C;ACTIVE COMPOUNDS;ADDITIONAL INFORMATION;AGREED INSTRUMENTS;AMORPHOUS CHAIN;AMORPHOUS REGIONS;ANALYSIS THERAPY","6;6;4;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1",9,0.3,6,2,0,0,0,0,5.25,0,1,2,0,0,4,0,0,0,1,3.5,0,0,0,72,72,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3,3.67,176.33,4.41,0,0,25.67,0,0,1,0,1,0,1,0,0,3,0,0,0,0,0,0,0,3,0,0,3,0,0,0,0,0,0,0,0,0,"Japan","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3213 PAEDIATRICS","3;2;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;DIGESTIVE DISEASES;BRAIN DISORDERS;CANCER;LIVER CANCER;LIVER DISEASE;NEUROSCIENCES;PEDIATRIC;RARE DISEASES","3;2;2;1;1;1;1;1;1;1",NA,NA,"6.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES","3;1","LIVER CANCER","1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_GIACCONE",2010,23,7,3.78260869565217,0.608695652173913,0.565217391304348,0.608695652173913,1.31818181818182,1.16666666666667,1.44444444444444,1.16666666666667,0.521739130434783,0,6,5,3,3,0.26,0.22,0.13,0.13,11.3,0.250148248113194,NA,0.173913043478261,0.739130434782609,0.391,0.225,0.292,0.225,"G DIANA;MIRKO MANGIAPANE;GASPARE PARRINELLO;BIANCA CUDIA;GIUSEPPE LICATA;DANIELE TORRES;EGLE CORRADO;S SERANTONI;MANUEL PERA;CARLO PAVONE;FRANCESCO PAOLO PALUMBO;IDA MARIA MURATORI;I. OXENIUS;CATERINA TRAPANESE;SALVATORE NOVO;R TANTILLO;MAURIZIO AVERNA;MANUELA USALA;CARLO MELLONI;DANIELA ABBADESSA","4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2","GASPARE PARRINELLO;GIUSEPPE LICATA;DANIELE TORRES;G DIANA;MIRKO MANGIAPANE;BIANCA CUDIA;CATERINA TRAPANESE;MAURIZIO AVERNA;CARLO PAVONE;GIROLAMO D’ALLEO;I. OXENIUS;MANUELA USALA;CARLO MELLONI;TERESA CALANDRA;ROSI ALESSI;DANIELA ABBADESSA;A. MULARO;GIANCARLO NAPOLI;A SANSONE;MICHELE LANZETTA","0.73;0.73;0.73;0.56;0.42;0.4;0.39;0.36;0.33;0.33;0.33;0.33;0.33;0.33;0.33;0.33;0.33;0.33;0.33;0.33","G DIANA;MIRKO MANGIAPANE;GASPARE PARRINELLO;BIANCA CUDIA;GIUSEPPE LICATA;DANIELE TORRES;EGLE CORRADO;CARLO PAVONE;FRANCESCO PAOLO PALUMBO;IDA MARIA MURATORI;I. OXENIUS;CATERINA TRAPANESE;SALVATORE NOVO;R TANTILLO;MAURIZIO AVERNA;MANUELA USALA;CARLO MELLONI;DANIELA ABBADESSA;E BONAFEDE;GIANCARLO NAPOLI","4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2","GASPARE PARRINELLO;GIUSEPPE LICATA;DANIELE TORRES;G DIANA;MIRKO MANGIAPANE;BIANCA CUDIA;CATERINA TRAPANESE;MAURIZIO AVERNA;CARLO PAVONE;I. OXENIUS;MANUELA USALA;CARLO MELLONI;ROSI ALESSI;DANIELA ABBADESSA;GIANCARLO NAPOLI;A SANSONE;MICHELE LANZETTA;FRANCESCO PAOLO PALUMBO;E BONAFEDE;PIETRO NAPOLI","0.73;0.73;0.73;0.56;0.42;0.4;0.39;0.36;0.33;0.33;0.33;0.33;0.33;0.33;0.33;0.33;0.33;0.29;0.25;0.25","EGLE CORRADO;GIUSEPPINA NOVO;IDA MARIA MURATORI;R TANTILLO;SALVATORE NOVO;ANDREA IGOREN GUARICCI;CARLO TEDESCHI;DEODATA MONTRONE;ERICA MAFFEI;FILIPPO CADEMARTIRI;JOANNE D. SCHUIJF;LUCA MACARINI;LUIGI DI BIASE;MASSIMO MIDIRI;MATTEO DI BIASE;NATALE DANIELE BRUNETTI;RICCARDO IEVA;ALESSANDRA MALATO;DOMENICA CARAMAZZA;GERLANDO QUINTINI","53;53;53;53;53;50;50;50;50;50;50;50;50;50;50;50;50;32;32;32","EGLE CORRADO;GIUSEPPINA NOVO;IDA MARIA MURATORI;R TANTILLO;SALVATORE NOVO;MASSIMO MIDIRI;ALESSANDRA MALATO;DOMENICA CARAMAZZA;GERLANDO QUINTINI;GIORGIA SACCULLO;GIUSEPPINA MARIA PIZZO;GIUSEPPINA MAZZOLA;IGNAZIO ABBENE;LUCIO LO COCO;RITA BARONE;ROBERTO PALAZZOLO;ROSA DI TRAPANI;SÉRGIO RIZZO;VINCENZO ABBADESSA;PATRIZIA CARITÀ","53;53;53;53;53;50;32;32;32;32;32;32;32;32;32;32;32;32;32;31","G DIANA;DANIELE TORRES;BIANCA CUDIA;CARLO PAVONE;CATERINA TRAPANESE;EGLE CORRADO;FRANCESCO PAOLO PALUMBO;GASPARE PARRINELLO;GIUSEPPE LICATA;GIUSEPPINA NOVO;IDA MARIA MURATORI;MAURIZIO AVERNA;R TANTILLO;SALVATORE NOVO;ALESSANDRA MALATO;CARLA FLANDINA;CARLO MELLONI;CLAUDIA VISCONTI;DANIELA ABBADESSA;DOMENICA CARAMAZZA","4;3;3;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1","MEDICINE;BIOLOGY;COMPUTER SCIENCE;PHYSICS;CHEMISTRY;ENGINEERING;HISTORY;MATERIALS SCIENCE;PHILOSOPHY;PSYCHOLOGY","23;2;2;2;1;1;1;1;1;1","INTERNAL MEDICINE;SURGERY;CARDIOLOGY;ENDOCRINOLOGY;GASTROENTEROLOGY;PATHOLOGY;UROLOGY;PHYSICAL THERAPY;RADIOLOGY;ANESTHESIA;IMMUNOLOGY;NUCLEAR MEDICINE;ANATOMY;ANDROLOGY;ARCHAEOLOGY;BIOCHEMISTRY;CIVIL ENGINEERING;COMPOSITE MATERIAL;DERMATOLOGY;ENVIRONMENTAL HEALTH;GENETICS;LINGUISTICS;MACHINE LEARNING;MEDICAL EDUCATION;METEOROLOGY;NEUROSCIENCE;NURSING;ONCOLOGY;OPTICS;PALEONTOLOGY;PHARMACOLOGY;PROGRAMMING LANGUAGE","17;9;6;6;5;5;5;4;4;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","REHABILITATION;ALTERNATIVE MEDICINE;ASYMPTOMATIC;DIABETES MELLITUS;ABDOMEN;ADVERSE EFFECT;MYOCARDIAL INFARCTION;PROSTACYCLIN;RECEPTOR;SIMVASTATIN;STATIN;ULTRASOUND;ABDOMINAL PAIN;ACUTE PANCREATITIS;ANGIOLOGY;ANTIBODY;ASTHMA;ATORVASTATIN;BAY;BETA (PROGRAMMING LANGUAGE);BLOOD PRESSURE;CALCIUM;CANCER;CAROTID ARTERIES;CHOLECYSTECTOMY;CHOLESTEROL;CHRONIC VENOUS INSUFFICIENCY;CIRRHOSIS;COGNITION;COMBINATION THERAPY;COMPUTED TOMOGRAPHY;CONTEXT (ARCHAEOLOGY);CONTINUING EDUCATION;CORONARY HEART DISEASE;DISEASE;DUCTUS ARTERIOSUS;ELBOW;ENUCLEATION;ENZYME;ERECTILE DYSFUNCTION;FEMORAL ARTERY;FOLLISTATIN;FOOT (PROSODY);GALLBLADDER;GUIDELINE;HEART FAILURE;HEMATOLOGY;HEMODIALYSIS;HYPERPARATHYROIDISM;HYPERPLASIA;INCIDENCE (GEOMETRY);INCIDENTALOMA;INFLAMMATION;INTUBATION;LESION;LUNG;MAGNETIC RESONANCE IMAGING;MATRIX METALLOPROTEINASE;MITRAL REGURGITATION;MULTISLICE;ORTHOPEDIC SURGERY;PANCREATITIS;PAPILLARY MUSCLE;PENIS;PLAN (ARCHAEOLOGY);PLATELET;POLYURETHANE;POPULATION;POST-HOC ANALYSIS;PREGNANCY;PREMEDICATION;PRIMARY HYPERPARATHYROIDISM;PROPOFOL;QUALITY OF LIFE (HEALTHCARE);RANGE OF MOTION;RECEIVER OPERATING CHARACTERISTIC;RISK STRATIFICATION;ROSUVASTATIN;SCHWANNOMA;SHOCK (CIRCULATORY);SHUNT (MEDICAL);SPORTS MEDICINE;SURGICAL ONCOLOGY;TEARS;THALASSEMIA;TRAINING (METEOROLOGY);URINARY SYSTEM;VALUE (MATHEMATICS);VASCULAR DISEASE;VOMITING","4;3;3;3;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","PLACEBO;EZETIMIBE;ILOPROST;PEYRONIE'S DISEASE;TOLERABILITY;ANGINA;ARTERIAL DISEASE;ATENOLOL;AUTOANTIBODY;BETA BLOCKER;BLOCKADE;BRONCHOALVEOLAR LAVAGE;CARDIAC MAGNETIC RESONANCE;CARDIOGENIC SHOCK;CARDIOVASCULAR EVENT;CHEMOTAXIS;CHOLECYSTITIS;CONTINUING MEDICAL EDUCATION;CORONARY ANGIOGRAPHY;DIABETIC FOOT;DYSURIA;EOSINOPHIL;EPIGASTRIC PAIN;FETUS;GUANYLATE CYCLASE;HEART RATE;INTIMA-MEDIA THICKNESS;METALLOPROTEINASE;MULTISLICE COMPUTED TOMOGRAPHY;PARATHYROID HORMONE;PLASMAPHERESIS;PORTAL HYPERTENSION;PROSTATE;PROSTATE CANCER;RITUXIMAB;THROMBOTIC THROMBOCYTOPENIC PURPURA;TYPE 2 DIABETES;TYPE 2 DIABETES MELLITUS;ULNAR NERVE;VON WILLEBRAND FACTOR","3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ADAMTS13;BRADYCARDIA;CRITICAL LIMB ISCHEMIA;DUCTUS VENOSUS;EOTAXIN;IVABRADINE;MICROANGIOPATHIC HEMOLYTIC ANEMIA;PORTOSYSTEMIC SHUNT;SECONDARY HYPERPARATHYROIDISM;SOLUBLE GUANYLYL CYCLASE;THROMBOSPONDIN","1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;MIDDLE AGED;FEMALE;;AGED;CAROTID ARTERY DISEASES;ANTICHOLESTEREMIC AGENTS;AZETIDINES;CARDIOVASCULAR DISEASES;LIVER;SIMVASTATIN;ADULT;HYPERCHOLESTEROLEMIA;HYPERPARATHYROIDISM, SECONDARY;BIOMARKERS;CHOLESTEROL;CHOLESTEROL, LDL;KNEE INJURIES;TREATMENT OUTCOME","16;14;12;8;7;7;7;6;6;6;6;6;5;5;5;4;4;4;4;4","ARTERIAL STIFFNESS AND CARDIOVASCULAR HEALTH;CHOLESTEROL-LOWERING TREATMENT;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;ASTHMA;BISPHOSPHONATES IN CANCER TREATMENT AND BONE HEALTH;EPIDEMIOLOGY AND MANAGEMENT OF SEXUAL DYSFUNCTION;ERRORS AND COMMUNICATION IN RADIOLOGY IMAGING;GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS;HEPATOCELLULAR CARCINOMA;HYPERSENSITIVITY REACTIONS TO DRUGS AND MEDICATIONS;IMPACT OF RESTING HEART RATE ON CARDIOVASCULAR HEALTH;MANAGEMENT AND TREATMENT OF PERIPHERAL ARTERIAL DISEASE;MINERAL METABOLISM IN CHRONIC KIDNEY DISEASE;NEUROFIBROMATOSIS TYPE 1 AND TYPE 2;PATHOGENESIS AND MANAGEMENT OF BILIARY ATRESIA;PERIOPERATIVE CARDIAC RISK ASSESSMENT AND MANAGEMENT;PREVENTION AND MANAGEMENT OF DIABETIC FOOT ULCERS;ROLE OF CCN PROTEINS IN SIGNALING PATHWAYS;ROLE OF COMPLEMENT SYSTEM IN IMMUNE RESPONSE;ROLE OF FIBROBLAST ACTIVATION IN CANCER PROGRESSION","2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CARDIAC IMAGING;CAROTID ARTERY STENOSIS;CAROTID INTIMA-MEDIA THICKNESS;CHOLESTEROL-LOWERING;EZETIMIBE;ILOPROST;TOLERABILITY;TREATMENT;ADAMTS;ADAMTS13;ANGIOLOGY;AORTIC STIFFNESS;ARTERIAL STIFFNESS;ATENOLOL;ATHEROSCLEROTIC PLAQUE;BETA (PROGRAMMING LANGUAGE);BETA BLOCKER;CARDIAC MAGNETIC RESONANCE;CARDIAC RUPTURE;CARDIOVASCULAR EVENT","2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","CARDIOVASCULAR RISK;EZETIMIBESIMVASTATIN MG;LOCAL TREATMENT;PEYRONIES DISEASE;PHASE PILOT;PILOT STUDY;SYMPTOM QUESTIONNAIRE;TRANSIENT HEPATIC;ABDOMINAL PAIN;ACUTE MYOCARDIAL;ASYMPTOMATIC CAROTID;ATHEROSCLEROSIS ENHANCES;ATTENUATION DIFFERENCE;BNP PLASMA;CANCER METASTATIC;CARDIOVASCULAR EVENTS;CAROTID ATHEROSCLEROSIS;CAROTID LESIONS;CHOLECYSTECTOMIZED PATIENT;CHRONIC ULCERS;COMBINED TREATMENT;COMPLICATING ACUTE;COMPUTED TOMOGRAPHY;CONTINUING MEDICAL;CORNER RECONSTRUCTION;CORONARY ANGIOGRAPHY;CORONARY HEART;CUTANEOUS CHRONIC;DEFICIENCY LEG;DETERMINING POSTOPERATIVE","2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MGDL MMOLL;LDL-C TOTAL;TOTAL CHOLESTEROL;COMBINATION RESULTED;CV EVENTS;EZESIMVA COMBINATION;LIPOPROTEIN CHOLESTEROL;SIMVASTATIN MG;VERSUS DOUBLING;ARTERIAL PHASE;ASYMPTOMATIC PATIENTS;EZETIMIBESIMVASTATIN MG;FEMORAL TUNNEL;FIBULAR-BASED TECHNIQUE;MG EZESIMVA;ACHIEVED LDL-C;ACHIEVING LDL-C;ASYMPTOMATIC CAROTID;ATTENUATION DIFFERENCES;BASELINE CHARACTERISTICS;BASELINE LDL-C;BLIND PLACEBO-CONTROLLED;BLOOD SUPPLY;CAROTID ARTERIES;CHD PATIENTS;CHOLESTEROL HDL-C;CHOLESTEROL HIGH-DENSITY;CHOLESTEROL LDL-C;CLINICAL OUTCOME;CLINICAL TRIAL","8;6;6;4;4;4;4;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2",1,0.04,9.6,10,0,0,0,0,0,0,0,10,0,0,9,0,1,0,2,7,0,0,0,37,37,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3,5,253.33,4.92,0,0,53.33,0,0,1,0,0,0,0,2,0,3,0,0,0,0,0,0,0,3,0,0,3,0,0,0,0,0,0,0,0,0,"United States","1","32 BIOMEDICAL AND CLINICAL SCIENCES;30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;38 ECONOMICS;3801 APPLIED ECONOMICS","2;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;CHILDHOOD LEUKEMIA;EMERGING INFECTIOUS DISEASES;HEMATOLOGY;ORPHAN DRUG;PEDIATRIC;PEDIATRIC CANCER;RARE DISEASES","2;2;1;1;1;1;1;1;1;1","CANCER;INFECTION","1;1","6.1 PHARMACEUTICALS","2","LEUKEMIA / LEUKAEMIA;NON-HODGKIN'S LYMPHOMA","1;1","5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT;5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_GIACCONE",2011,35,10.3142857142857,2.31428571428571,0.457142857142857,0.314285714285714,0.485714285714286,1.15714285714286,1,1,1,0.571428571428571,0,16,8,7,1,0.46,0.23,0.2,0.03,14.91,0.350641488874304,NA,0.314285714285714,0.942857142857143,0.257,0.175,0.192,0.247,"ANTONELLA MELONI;ALESSIA PEPE;MASSIMO LOMBARDI;MASSIMO MIDIRI;MARCELLO CAPRA;MARGUS VIIGIMAA;ALBERTO FIRENZE;AMY O. JOHNSON‐LEVONAS;PHILIPPE BRUDI;MARIA CHIARA DELL’AMICO;MICHEL FARNIER;PASQUALE PEPE;LUC MISSAULT;MAURIZIO AVERNA;ARVIND SHAH;H VAVERKOVÁ;GIUSEPPE ROSSI;QIAN DONG;FABIO TRAMUTO;EGLE CORRADO","5;5;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2","SALVATORE ROMEO;D. MELLONI;ALBERTO FIRENZE;ANTONELLA MELONI;ALESSIA PEPE;GIOACCHINO LETO;MARGUS VIIGIMAA;AMY O. JOHNSON‐LEVONAS;PHILIPPE BRUDI;MICHEL FARNIER;LUC MISSAULT;MAURIZIO AVERNA;ARVIND SHAH;H VAVERKOVÁ;QIAN DONG;EMANUELE AMODIO;MASSIMO LOMBARDI;FELICE PECORARO;MASSIMO MIDIRI;VINCENZO SERRETTA","0.4;0.4;0.37;0.36;0.36;0.34;0.31;0.31;0.31;0.31;0.31;0.31;0.31;0.31;0.31;0.29;0.28;0.28;0.26;0.25","MASSIMO MIDIRI;ALBERTO FIRENZE;MAURIZIO AVERNA;EGLE CORRADO;SALVATORE ROMEO;GIOACCHINO LETO;FELICE PECORARO;ELIANA CRACOLICI;D. MELLONI;CRISTINA RASPANTI;CLAUDIA RIZZO;VINCENZO SERRETTA;GIOVANNI FRANCO;GIUSEPPE PIZZO;DANIELA CABIBI;MARIA ROSARIA VALERIO;EMILIO IANNITTO;CALOGERO CARUSO;KHALIL FATTOUCH;SALVATORE D’ARPA","4;3;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1","SALVATORE ROMEO;D. MELLONI;ALBERTO FIRENZE;GIOACCHINO LETO;MAURIZIO AVERNA;FELICE PECORARO;MASSIMO MIDIRI;VINCENZO SERRETTA;MARIA ROSARIA VALERIO;ANNA GIAMMANCO;MARCO VELLA;MARCO VELIA;COSTANZA SALAMONE;G. MASTROCINQUE;DANIELE TORRES;EGLE CORRADO;CLAUDIA RIZZO;CALOGERO CARUSO;SALVATORE D’ARPA;MARIA VALERIA TORREGROSSA","0.4;0.4;0.37;0.34;0.31;0.28;0.26;0.25;0.25;0.2;0.2;0.2;0.2;0.2;0.2;0.18;0.17;0.17;0.17;0.17","FELICE PECORARO;ALBERTO FIRENZE;DIETER MAYER;DIMITRI PAPADIMITRIOU;FRANK J. VEITH;LUKAS HECHELHAMMER;MÁRIO LACHAT;THOMAS FRAUENFELDER;THOMAS PFAMMATTER;ZORAN RANČIĆ;EMANUELE AMODIO;ADRIANA VISONÀ;ANGELO CLAUDIO MOLINARI;ANNA FALANGA;DAVIDE IMBERTI;DOMENICO PRISCO;FABIO FULFARO;MAURO SILINGARDI;MELINA VERSO;MONICA CARPENEDO","90;85;83;83;83;83;83;83;83;83;79;55;55;55;55;55;55;55;55;55","FELICE PECORARO;ALBERTO FIRENZE;FABIO FULFARO;SERGIO SIRAGUSA;LUCIA GIOVANNELLI;R. DI STEFANO;GIUSEPPE CALAMUSA;MARIA VALERIA TORREGROSSA;MARIA ROSARIA VALERIO;VINCENZO SERRETTA;GIUSEPPE GULLO;F NARESE;VALERIA VENTURELLA;ACCURSIO AUGELLO;EMILIO IANNITTO;GIOVANNI FRANCO;SALVATRICE MANCUSO;C SARNO;GIOVANNI MAZZOLA;P. COLLETTI","90;79;55;55;51;51;40;39;35;35;31;25;25;22;22;22;22;21;21;21","MASSIMO MIDIRI;MAURIZIO AVERNA;ALBERTO FIRENZE;D. MELLONI;ELIANA CRACOLICI;FELICE PECORARO;GIOACCHINO LETO;SALVATORE ROMEO;A ALBANESE;ACCURSIO AUGELLO;ANNA GIAMMANCO;C SARNO;CALOGERO CARUSO;CARLO PADERNI;CARLO PAVONE;CLAUDIA RIZZO;COSTANZA SALAMONE;CRISTINA RASPANTI;DANIELA ABBADESSA;DANIELA CABIBI","4;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;COMPUTER SCIENCE;ECONOMICS;ENGINEERING;MATHEMATICS;ART;BUSINESS;PHILOSOPHY;POLITICAL SCIENCE;PSYCHOLOGY;SOCIOLOGY","34;6;3;3;2;2;2;2;1;1;1;1;1;1","INTERNAL MEDICINE;CARDIOLOGY;RADIOLOGY;SURGERY;ENVIRONMENTAL HEALTH;ENDOCRINOLOGY;PHARMACOLOGY;GASTROENTEROLOGY;GENETICS;IMMUNOLOGY;ONCOLOGY;PEDIATRICS;PSYCHIATRY;UROLOGY;BIOCHEMISTRY;ECOLOGY;ECONOMIC GROWTH;EMERGENCY MEDICINE;GYNECOLOGY;NUCLEAR MEDICINE;PATHOLOGY;VIROLOGY","27;7;7;7;5;4;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2","CANCER;HEART FAILURE;POPULATION;DISEASE;THALASSEMIA;CHOLESTEROL;DEFEROXAMINE;MAGNETIC RESONANCE IMAGING;MYOCARDIAL INFARCTION;ROSUVASTATIN;SIMVASTATIN;STATIN;ANGIOLOGY;CONCORDANCE;CORONARY ARTERY DISEASE;DIABETES MELLITUS;ELECTROCARDIOGRAPHY;EMERGENCY DEPARTMENT;GENE;HEALTH CARE;LOGISTIC REGRESSION;MULTISLICE;POST-HOC ANALYSIS;PREGNANCY;PROSPECTIVE COHORT STUDY;VACCINATION;VENTRICLE;VIRUS","6;5;5;4;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","APOLIPOPROTEIN B;EZETIMIBE;INFECTIOUS DISEASE (MEDICAL SPECIALTY);INFLUENZA VACCINE;ACUTE CORONARY SYNDROME;CARDIOMYOPATHY;DEFERASIROX;DEFERIPRONE;2019-20 CORONAVIRUS OUTBREAK;ALCOHOL CONSUMPTION;ALLELE;AORTIC ANEURYSM;ARTIFICIAL URINARY SPHINCTER;BASAL (MEDICINE);BIRTH WEIGHT;BLAND–ALTMAN PLOT;BREAST CANCER;CARDIAC DYSFUNCTION;CARDIAC FUNCTION CURVE;CELL CYCLE;CENTENARIAN;CHIMNEY (LOCOMOTIVE);CHRONIC LYMPHOCYTIC LEUKEMIA;COLORECTAL CANCER;CORONARY ARTERY CALCIUM;CYCLOPHOSPHAMIDE;DIFFUSION MRI;DOCETAXEL;EJECTION FRACTION;ENCEPHALITIS;EPSTEIN–BARR VIRUS;EUROPEAN POPULATION;GESTATIONAL AGE;GREAT ARTERIES;HEART BLOCK;HISTONE;IN VITRO FERTILISATION;INFLUENZA-LIKE ILLNESS;INSEMINATION;LEUKOPLAKIA;LIFE EXPECTANCY;METABOLIC SYNDROME;MONONUCLEOSIS;NEURORADIOLOGY;OOCYTE;PENILE PROSTHESIS;PROPAFENONE;PROSTATE;PROSTATE CANCER;PROSTHESIS IMPLANTATION;PROTEIN SUBUNIT;RELIABILITY (SEMICONDUCTOR);RITUXIMAB;ROSUVASTATIN CALCIUM;SALVAGE THERAPY;ST ELEVATION;STRESS INCONTINENCE;SUPRAVENTRICULAR TACHYCARDIA;T WAVE;UNSTABLE ANGINA;VENOUS THROMBOEMBOLISM;VENOUS THROMBOSIS;WHITE MATTER","3;3;3;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CORONAVIRUS DISEASE 2019 (COVID-19);INFLUENZA SEASON;ABDOMINOPERINEAL RESECTION;BENDAMUSTINE;CORONARY CALCIUM SCORE;CORRECTED TRANSPOSITION;HISTONE DEACETYLASE;HORMONE RECEPTOR;INTRACYTOPLASMIC SPERM INJECTION;OOCYTE ACTIVATION;PROSTATECTOMY;RIBONUCLEOTIDE REDUCTASE;SPERM WASHING;TOTAL MESORECTAL EXCISION;TRASTUZUMAB;VENETOCLAX","3;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;FEMALE;MIDDLE AGED;AGED;ADULT;TREATMENT OUTCOME;;ANTINEOPLASTIC AGENTS;INFLUENZA, HUMAN;HYPERCHOLESTEROLEMIA;ADENOCARCINOMA;AGED, 80 AND OVER;CORONARY DISEASE;INFLUENZA VACCINES;PROSTATIC NEOPLASMS;ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;AZETIDINES;FLUOROBENZENES;HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS","26;19;18;16;12;10;10;9;8;8;7;6;6;6;6;6;5;5;5;5","GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS;CHOLESTEROL-LOWERING TREATMENT;INFLUENZA VIRUS RESEARCH AND EPIDEMIOLOGY;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;ADVANCEMENTS IN PROSTATE CANCER RESEARCH;ASTHMA;CATHETER ABLATION OF CARDIAC ARRHYTHMIAS;COLORECTAL CANCER RESEARCH AND TREATMENT;DIAGNOSIS AND MANAGEMENT OF AORTIC DISEASES;DIAGNOSIS AND MANAGEMENT OF CHYLOTHORAX AND CHYLOUS ASCITES;DIAGNOSIS AND TREATMENT OF CAROTID ARTERY DISEASE;DISEASES RELATED TO BLOOD GROUP VARIANTS;EPIDEMIOLOGY AND MANAGEMENT OF SEXUAL DYSFUNCTION;ETIOLOGY AND MANAGEMENT OF ABDOMINAL WALL DEFECTS;FACIAL FILLERS AND REJUVENATION TECHNIQUES;GENOMIC ABERRATIONS AND TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA;HER2 SIGNALING IN BREAST CANCER TREATMENT;HERPESVIRUSES: EPIDEMIOLOGY, PATHOGENESIS, AND MANAGEMENT;HUMAN PAPILLOMAVIRUS AND CERVICAL CANCER EPIDEMIOLOGY;MAGNETIC RESONANCE IMAGING APPLICATIONS IN MEDICINE","4;3;3;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CHOLESTEROL-LOWERING;EZETIMIBE;IRON DEFICIENCY;PANDEMIC;TREATMENT;ANGIOLOGY;CONCORDANCE;DEFERASIROX;DEFERIPRONE;INFLUENZA SEASON;MULTISLICE;POST-HOC ANALYSIS;VACCINATION INTENTION;VACCINE HESITANCY;2019-20 CORONAVIRUS OUTBREAK;ABDOMINOPERINEAL RESECTION;ADULT CONGENITAL HEART DISEASE;AFFECT (LINGUISTICS);AGING FACE;ANEURYSM RUPTURE","3;3;3;3;3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1","PATIENTS TREATED;THALASSEMIA MAJOR;MAJOR PATIENTS;COMPUTED TOMOGRAPHY;EZETIMIBESIMVASTATIN MG;HIGH-RISK PATIENTS;MEDICAL RESIDENTS;MG VERSUS;MRI PROSPECTIVE;PANDEMIC INFLUENZA;PROSPECTIVE SURVEY;RETROSPECTIVE STUDY;ROSUVASTATIN MG;VERSUS ROSUVASTATIN;ACUTE URINARY;ADVANCE SLING;AFFECT LONGEVITY;AHN SEASON;ALPHA PROSTHESIS;ANTITUMOR EFFECTS;AORTIC ANEURYSMS;APRIL DECEMBER;ARTERY DISEASE;ARTERY STENOSIS;ASYMPTOMATIC CAROTID;BASAL CEREBRAL;BEHAVIOURAL PROFILES;BIFOCAL STIMULATION;BIOMOLECULAR CHARACTERISTICS;BREAST CARCINOMAS","4;4;3;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","GLOBAL HEART;FERTILIZATION FAILURE;TOTAL FERTILIZATION;MYOCARDIAL IRON;CONVENTIONAL IVF;IRON BURDEN;IRON OVERLOAD;PREGNANCY RATE;RATE VERSUS;DONOR CYCLES;HOMOGENEOUS MIO;OOCYTE DONOR;POST-HOC ANALYSIS;TM PATIENTS;CHIMNEY GRAFTS;EZETIMIBESIMVASTATIN MG;HETEROGENEOUS MIO;LIPOPROTEIN CHOLESTEROL;LIVER IRON;MID-VENTRICULAR SEPTUM;RESCUE ICSI;ROSUVASTATIN MG;SIGNIFICANT DIFFERENCES;VALUES MS;ACUTE PHASE;ANTERIOR RESECTION;DFX VERSUS;HDAC INHIBITORS;HOSPITALISED PATIENTS;INFLUENZA AHN","11;8;8;7;6;6;6;6;6;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3",7,0.2,3,2.5,2,1,0,0,0,0,1,3,0,0,2,0,3,1,0,1.5,0,0,0,41.5,41.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,4.8,139.2,7.14,0,0,32.4,0,0,3,0,0,0,0,2,0,3,2,0,0,0,0,0,0,5,0,0,5,0,0,0,0,0,0,0,0,0,"Italy","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;3202 CLINICAL SCIENCES;3204 IMMUNOLOGY;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS","4;2;2;1;1;1;1","CLINICAL RESEARCH;CANCER;HEMATOLOGY;RARE DISEASES;LYMPHOMA;AGING;AUTOIMMUNE DISEASE;BEHAVIORAL AND SOCIAL SCIENCE;BIOTECHNOLOGY;CHILDHOOD LEUKEMIA;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;DIGESTIVE DISEASES;HEALTH SERVICES;NUTRITION;ORPHAN DRUG;PEDIATRIC;PEDIATRIC CANCER;PEDIATRIC RESEARCH INITIATIVE","4;3;3;3;2;1;1;1;1;1;1;1;1;1;1;1;1;1","CANCER;INFLAMMATORY AND IMMUNE SYSTEM","1;1","6.1 PHARMACEUTICALS;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;6.2 CELLULAR AND GENE THERAPIES;7.1 INDIVIDUAL CARE NEEDS","3;1;1;1","NON-HODGKIN'S LYMPHOMA;LEUKEMIA / LEUKAEMIA","2;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","2",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_GIACCONE",2012,46,12.1739130434783,2.73913043478261,0.41304347826087,0.369565217391304,0.41304347826087,1.21359223300971,1.05555555555556,1,1.05555555555556,0.456521739130435,1,20,5,7,8,0.43,0.11,0.15,0.17,34.98,0.837434889726884,3.47272727272727,0.173913043478261,0.826086956521739,0.365,0.364,0.362,0.364,"SALVATORE NOVO;GIUSEPPINA NOVO;EGLE CORRADO;SALVATORE EVOLA;GIUSEPPE COPPOLA;VINCENZO SUCATO;GIUSEPPE BADALAMENTI;FRANCESCA MACAIONE;ANTONIO RUSSO;GIUSEPPA CACCAMO;NICOLA NORMANNO;YOON‐KOO KANG;MASSIMO DI MAÏO;TOSHIROU NISHIDA;MARTIN E. BLACKSTEIN;GIORGIO GUGLIOTTA;FEDERICA PERRONE;LUIGI MARIA LAROCCA;ELENA ROZ;MARCELLA MOTTOLESE","7;5;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2","CARMELO RADELLINI;SALVATORE NOVO;GIUSEPPINA NOVO;EGLE CORRADO;ANGELO QUAGLIANA;VINCENZO SUCATO;ORESTE FABIO TRIOLO;CONCETTA LA SETA;SALVATORE EVOLA;GIUSEPPE COPPOLA;GIORGIO GUGLIOTTA;ADRIANA CORDOVA;SALVATORE D’ARPA;CARLO M. BARBAGALLO;GIORGIO ADILE;SALVATORE EVOL;GIUSEPPINA SANFILIPPO;FRANCESCO MOSCHELLA;BIAGIO ADILE;FABIO TRIOLO","1;0.85;0.65;0.48;0.43;0.43;0.43;0.39;0.34;0.34;0.33;0.33;0.33;0.33;0.33;0.33;0.33;0.33;0.33;0.33","SALVATORE NOVO;GIUSEPPINA NOVO;EGLE CORRADO;SALVATORE EVOLA;GIUSEPPE COPPOLA;VINCENZO SUCATO;GIUSEPPE BADALAMENTI;FRANCESCA MACAIONE;ANTONIO RUSSO;CARLO M. BARBAGALLO;ANGELO QUAGLIANA;CLAUDIA COLOMBA;GIORGIO ADILE;CONCETTA LA SETA;ANGELICA PERITORE;GIUSEPPINA SANFILIPPO;ALESSANDRA MALATO;FRANCESCO CUTTITTA;FABIO TRIOLO;ORESTE FABIO TRIOLO","7;5;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2","CARMELO RADELLINI;SALVATORE NOVO;GIUSEPPINA NOVO;EGLE CORRADO;ANGELO QUAGLIANA;VINCENZO SUCATO;ORESTE FABIO TRIOLO;CONCETTA LA SETA;SALVATORE EVOLA;GIUSEPPE COPPOLA;ADRIANA CORDOVA;SALVATORE D’ARPA;CARLO M. BARBAGALLO;GIORGIO ADILE;SALVATORE EVOL;GIUSEPPINA SANFILIPPO;FRANCESCO MOSCHELLA;FABIO TRIOLO;FRANCESCA MACAIONE;ALESSANDRA MALATO","1;0.85;0.65;0.48;0.43;0.43;0.43;0.39;0.34;0.34;0.33;0.33;0.33;0.33;0.33;0.33;0.33;0.33;0.31;0.27","SERGIO SIRAGUSA;ALESSANDRA IURLO;ALESSANDRO MARIA VANNUCCHI;ALESSIA TIEGHI;ANNA RITA SCORTECHINI;ANTONIO SPADEA;ARIANNA MASCIULLI;CATERINA MUSOLINO;DANIELA CILLONI;DAVIDE RAPEZZI;ELENA MARIA ELLI;ELISA RUMI;EMANUELE ANGELUCCI;FRANCESCA LUNGHI;GIORGINA SPECCHIA;GIOVANNI QUARTA;GIUSEPPE VISANI;GUIDO FINAZZI;MARCO RUGGERI;MARCO SCARANO","742;719;719;719;719;719;719;719;719;719;719;719;719;719;719;719;719;719;719;719","SERGIO SIRAGUSA;GIUSEPPE BADALAMENTI;MARIA ENZA MITRA;GIUSEPPINA CAPRA;LUCIA GIOVANNELLI;SALVATORE NOVO;SALVATORE EVOLA;ANGELICA PERITORE;FRANCESCA MACAIONE;EGLE CORRADO;GIUSEPPINA NOVO;FRANCESCO PAOLO GUARNERI;LORENZO NALBONE;EMILIO IANNITTO;ROSARIO DI MAGGIO;ANTONINO AGRUSA;GIOVANNI MAZZOLA;GIUSEPPE COPPOLA;FRANCESCO VITALE;MARIA FATIMA MASSENTI","742;130;81;60;60;57;56;55;55;51;47;45;39;38;35;27;27;26;25;25","SALVATORE NOVO;ANTONIO RUSSO;GIUSEPPE BADALAMENTI;GIUSEPPINA NOVO;SALVATORE EVOLA;ALESSANDRA MALATO;ANGELICA PERITORE;ANGELO QUAGLIANA;CARLO M. BARBAGALLO;CONCETTA LA SETA;EGLE CORRADO;FRANCESCA MACAIONE;FRANCESCO CUTTITTA;GIUSEPPE COPPOLA;GIUSEPPINA SANFILIPPO;ORESTE FABIO TRIOLO;SERGIO SIRAGUSA;VINCENZO SUCATO;A PASQUALE;ADRIANA CORDOVA","4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1","MEDICINE;BIOLOGY;PHYSICS;ENGINEERING;MATHEMATICS;COMPUTER SCIENCE;MATERIALS SCIENCE;GEOLOGY;PHILOSOPHY;SOCIOLOGY","45;11;9;3;3;2;2;1;1;1","INTERNAL MEDICINE;SURGERY;ONCOLOGY;CARDIOLOGY;ENVIRONMENTAL HEALTH;OPTICS;DERMATOLOGY;GENETICS;INTENSIVE CARE MEDICINE;GASTROENTEROLOGY;IMMUNOLOGY;RADIOLOGY;ANESTHESIA;ENDOCRINOLOGY;PATHOLOGY;ANATOMY;BIOINFORMATICS;ECOLOGY;GENERAL SURGERY;GEOMETRY;MECHANICAL ENGINEERING;PHARMACOLOGY;UROLOGY","36;21;10;9;6;6;5;5;5;4;4;4;3;3;3;2;2;2;2;2;2;2;2","CANCER;ADVERSE EFFECT;INCIDENCE (GEOMETRY);MYOCARDIAL INFARCTION;POPULATION;RETROSPECTIVE COHORT STUDY;ASYMPTOMATIC;CHEMOTHERAPY;DIABETES MELLITUS;DISEASE;GENE;OBESITY;RANDOMIZED CONTROLLED TRIAL;ANTIBODY;ANTIFUNGAL;ARTERY;ATRIAL FIBRILLATION;CLINICAL TRIAL;CONFIDENCE INTERVAL;EYELID;HEART FAILURE;LAPAROSCOPY;LESION;LYMPHOMA;MYELOID LEUKEMIA;OSTEOPOROSIS;REGIMEN;SEQUENCE (BIOLOGY);STROMAL CELL;SUBCLINICAL INFECTION;THROMBOSIS;TRUNK;URINARY SYSTEM","9;6;5;5;5;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","COLORECTAL CANCER;ANGINA;DYSLIPIDEMIA;EJECTION FRACTION;FLUCONAZOLE;FOLLICULAR LYMPHOMA;GIST;IMATINIB;MANTLE CELL LYMPHOMA;METABOLIC SYNDROME;MUTATION;SALVAGE THERAPY;STROMAL TUMOR;SUNITINIB;TOLERABILITY;ACUTE CHOLECYSTITIS;ACUTE CORONARY SYNDROME;ADENOCARCINOMA;ANISAKIS SIMPLEX;AORTIC ANEURYSM;AORTIC ARCH;ASCENDING AORTA;B CELL;BISPHOSPHONATE;BLOOD CULTURE;BONE DENSITY;BONE DISEASE;BONE MINERAL;BORTEZOMIB;BOWEL PERFORATION;BREAST CANCER;CANTHUS;CERVICAL CANCER;CHEMOKINE;CHOLECYSTITIS;CLINICAL ENDPOINT;COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENTS;CONTRAINDICATION;CORONARY ARTERIES;CYCLOPHOSPHAMIDE;DEFERIPRONE;DESCENDING AORTA;DRUG ERUPTION;DRUG REACTION;DYSURIA;ENOPHTHALMOS;EPIDERMAL GROWTH FACTOR RECEPTOR;ESOPHAGEAL STRICTURE;ESSENTIAL HYPERTENSION;EXON;FORESKIN;FUNGEMIA;GOITER;HAZARD RATIO;IMMUNOGLOBULIN E;IMMUNOTHERAPY;INTERPOLATION (COMPUTER GRAPHICS);ITRACONAZOLE;LOW MOLECULAR WEIGHT HEPARIN;MARAVIROC;METASTASIS;MOLECULAR PATHOLOGY;MUCOSAL MELANOMA;NEUTROPENIA;NOCTURIA;NON-HODGKIN'S LYMPHOMA;OVERACTIVE BLADDER;PEPTIC;PERFORATION;PEYRONIE'S DISEASE;PHASES OF CLINICAL RESEARCH;PHYLOGENETIC TREE;PROCALCITONIN;QUARTILE;REFLUX;RITUXIMAB;SEROLOGY;SORAFENIB;STABLE ANGINA;SUPERIOR MESENTERIC ARTERY SYNDROME;THROMBOLYSIS;THYROIDECTOMY;TROPISM;URINALYSIS;VIRAL LOAD;WARFARIN;WEIGHT LOSS","6;4;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","KRAS;REGORAFENIB;SANGER SEQUENCING;ANTHRACYCLINE;BENDAMUSTINE;BONE METASTASIS;CERVICAL INTRAEPITHELIAL NEOPLASIA;CHEMOKINE RECEPTOR;GEFITINIB;HIATAL HERNIA;INVASIVE CANDIDIASIS;IPILIMUMAB;MARGINAL ZONE;METASTATIC BREAST CANCER;NITROGEN MUSTARD;OSTEOPOROTIC FRACTURE;PENILE CURVATURE;POSACONAZOLE;RESPONSE EVALUATION CRITERIA IN SOLID TUMORS;SEROPREVALENCE;SUNITINIB MALATE;TIMI;TRASTUZUMAB;VITAMIN K ANTAGONIST","2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;;MALE;FEMALE;MIDDLE AGED;METABOLIC SYNDROME;AGED;LYMPHOMA, NON-HODGKIN;ABDOMEN, ACUTE;ADULT;ATHEROSCLEROSIS;CEREBROVASCULAR DISORDERS;CAROTID ARTERY DISEASES;HERNIA, HIATAL;ITALY;ANTIBODIES, MONOCLONAL, MURINE-DERIVED;ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;CHEST PAIN;GENITAL DISEASES, FEMALE;HYPERTENSION","25;21;18;15;14;10;9;9;7;7;7;7;6;6;6;5;5;5;5;5","ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;DIAGNOSIS AND MANAGEMENT OF APPENDICITIS;DIAGNOSIS AND TREATMENT OF GASTROINTESTINAL STROMAL TUMORS;LYMPHOID NEOPLASMS;PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM;ADVANCEMENTS IN COLORECTAL CANCER RESEARCH;ADVANCEMENTS IN LUNG CANCER RESEARCH;ARTERIAL STIFFNESS AND CARDIOVASCULAR HEALTH;ATRIAL FIBRILLATION;BISPHOSPHONATES IN CANCER TREATMENT AND BONE HEALTH;CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY IN CANCER TREATMENT;CRANIOFACIAL RECONSTRUCTION TECHNIQUES;DIAGNOSIS AND MANAGEMENT OF AORTIC DISEASES;DIAGNOSIS AND MANAGEMENT OF FOOD ALLERGY;DIAGNOSIS AND MANAGEMENT OF FUNGAL INFECTIONS;DIAGNOSIS AND MANAGEMENT OF GASTROESOPHAGEAL REFLUX DISEASE;DIAGNOSIS AND MANAGEMENT OF PERICARDIAL DISEASES;ECOLOGICAL INTERACTIONS OF PARASITES IN ECOSYSTEMS;EPIDEMIOLOGY AND MANAGEMENT OF SEPSIS AND SEPTIC SHOCK;GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS","2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CARDIAC IMAGING;TREATMENT;CARDIOVASCULAR RISK ASSESSMENT;DYSLIPIDEMIA;ECHOCARDIOGRAPHY;FOLLICULAR LYMPHOMA;LIPID METABOLISM;METABOLIC SYNDROME;REGIMEN;REGORAFENIB;RITUXIMAB THERAPY;SALVAGE THERAPY;SANGER SEQUENCING;SEQUENCE (BIOLOGY);STROMAL TUMOR;SUBCLINICAL INFECTION;TOLERABILITY;ACUTE ABDOMEN;ACUTE MEDICINE;ADVERSE DRUG REACTIONS","3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1","DI CHIRURGIA;ITALIANA DI;SOCIETÀ ITALIANA;COLORECTAL CANCER;PATIENTS PTS;CANCER PATIENTS;DIETARY STRATEGY;DYSLIPIDEMIA INTERNATIONAL;GASTROINTESTINAL STROMAL;GRID TRIAL;HEAVILY PRETREATED;IMATINIB IM;INTERNATIONAL GUIDELINES;LAPAROSCOPIC APPROACH;LYMPHOMA PATIENTS;MEDITERRANEAN SUBJECTS;METABOLIC SYNDROME;MICROVASCULAR ANGINA;RANDOMIZED PHASE;STROMAL TUMOR;SUNITINIB SU;TUMOR GIST;ABDOMINAL EMERGENCIES;ACCESS PROGRAMME;ACCIDENTAL LESION;ACOI SOCIETÀ;ACUTE ABDOMEN;ACUTE MYELOID;ADVANCED GASTROINTESTINAL;ADVANCED HEPATOCELLULAR","4;4;4;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1","NOVARTIS PFIZER;SUPRATROCHLEAR ARTERY;PALERMO ITALY;ARTERY PROPELLER;PERFORATOR FLAP;PROPELLER PERFORATOR;HYPERTENSIVE SUBJECTS;OCULAR MELANOMA;RESEARCH FUNDING;SEQUENTIAL DFP-DFO;ADVERSE EVENTS;BRISTOL-MYERS SQUIBB;NASAL BLADE;PALERMO PALERMO;ASCENDING AORTA;CALCIUM INTAKE;CI P-VALUE;COEFFICIENT CI;CONSULTANTADVISORY BAYER;CONSULTANTADVISORY NOVARTIS;FRONTAL BLADE;HONORARIA NOVARTIS;PFIZER PHARMAMAR;STATISTICALLY SIGNIFICANT;BOTALLI ANEURYSM;CANCER PATIENTS;CD T-CELL;DUCTUS BOTALLI;HIGH-RISK PATIENTS;INVASIVE CANDIDEMIA","11;11;8;7;7;7;6;6;6;6;5;5;5;5;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3",9,0.2,3.1,4,11,3,0,4,3.5,0,1,4,0,1,8,0,1,3,8.5,5,8,0,0,87,87,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,10,6.3,207.7,10.1,4,0.4,25.4,0,0,2,0,2,0,0,6,0,6,4,0,0,0,0,0,0,9,1,0,10,0,0,0,0,0,0,0,0,0,"Italy","4","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;31 BIOLOGICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;3215 REPRODUCTIVE MEDICINE","9;6;3;3;1;1;1","CLINICAL RESEARCH;CANCER;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;HEMATOLOGY;DIGESTIVE DISEASES;NUTRITION;RARE DISEASES;AUTOIMMUNE DISEASE;PEDIATRIC;PREVENTION;LYMPHOMA;PAIN RESEARCH;BIOMEDICAL IMAGING;CHILDHOOD LEUKEMIA;CHRONIC PAIN;EMERGING INFECTIOUS DISEASES;HEPATITIS;INFECTIOUS DISEASES;LIVER DISEASE;PEDIATRIC CANCER","10;5;5;5;4;4;4;3;3;3;2;2;1;1;1;1;1;1;1;1","CANCER;INFLAMMATORY AND IMMUNE SYSTEM;ORAL AND GASTROINTESTINAL","3;3;3","6.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.4 POPULATION SCREENING;5.2 CELLULAR AND GENE THERAPIES","5;3;2;1;1;1","LEUKEMIA / LEUKAEMIA;NON-HODGKIN'S LYMPHOMA","4;2","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;4.3 TECHNOLOGY AND/OR MARKER TESTING IN A CLINICAL SETTING","5;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_GIACCONE",2013,58,9.8448275862069,2.48275862068966,0.362068965517241,0.431034482758621,0.448275862068966,1.28571428571429,1.10526315789474,1.08695652173913,1.08333333333333,0.568965517241379,0,25,7,10,10,0.43,0.12,0.17,0.17,16.5,0.472880114900448,3.75539568345324,0.172413793103448,0.793103448275862,0.344,0.274,0.359,0.256,"SALVATORE NOVO;MICHELE DEL VECCHIO;ANTONELLA MELONI;ALESSIA PEPE;PAOLO A. ASCIERTO;VANNA CHIARION‐SILENI;MASSIMO LOMBARDI;PAOLA QUEIROLO;GIUSEPPINA NOVO;MARIO MANDALÁ;L. GULINO;MICHELE GUIDA;GIORGIO PARMIANI;FELICE PECORARO;MÁRIO LACHAT;VINCENZO POSITANO;MASSIMO AGLIETTA;MARIA GRAZIA BERNENGO;GAETANA RINALDI;FRANK J. VEITH","7;5;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;3","SALVATORE NOVO;GIUSEPPINA NOVO;VITO BONOMO;CALOGERO CIPOLLA;ROSSELLA SCHICCHI;SALVATORE EVOLA;FELICE PECORARO;MÁRIO LACHAT;DANIELA CABIBI;ANTONELLA MELONI;ALESSIA PEPE;MASSIMO LOMBARDI;VINCENZO SUCATO;FRANK J. VEITH;L. GULINO;VINCENZO POSITANO;DIETER MAYER;ZORAN RANČIĆ;MARIACONCETTA DI PIAZZA;CONCETTA LA SETA","1.29;1.05;0.71;0.62;0.58;0.58;0.55;0.55;0.5;0.47;0.47;0.47;0.45;0.42;0.39;0.39;0.38;0.38;0.38;0.33","SALVATORE NOVO;GIUSEPPINA NOVO;FELICE PECORARO;GAETANA RINALDI;VITO BONOMO;CHIARA TUDISCA;SALVATORE EVOLA;MASSIMO MIDIRI;EMILIO IANNITTO;CARLO PAVONE;PASQUALE ASSENNATO;CALOGERO CIPOLLA;VINCENZO SUCATO;ALESSANDRA MURABITO;FRANCESCA MONTALTO;GIUSEPPE BADALAMENTI;GRAZIA FORESTA;LAURA AJELLO;GIUSEPPE MONTALTO;SANTI MAURIZIO RAINERI","7;5;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2","SALVATORE NOVO;GIUSEPPINA NOVO;VITO BONOMO;CALOGERO CIPOLLA;SALVATORE EVOLA;FELICE PECORARO;DANIELA CABIBI;VINCENZO SUCATO;MARIACONCETTA DI PIAZZA;CONCETTA LA SETA;E TAORMINA;A PASQUALE;MASSIMO MIDIRI;FRANCESCA MONTALTO;GRAZIA FORESTA;SANTI MAURIZIO RAINERI;MARIA TERESA STRANO;CHIARA TUDISCA;PASQUALE ASSENNATO;LAURA AJELLO","1.29;1.05;0.71;0.62;0.58;0.55;0.5;0.45;0.38;0.33;0.33;0.33;0.31;0.29;0.29;0.29;0.29;0.28;0.28;0.28","F. FORLANI;GIUSEPPE CALÌ;GIUSEPPE PUCCIO;LAURA GIAMBANCO;MICHELE DEL VECCHIO;PAOLA QUEIROLO;PAOLO A. ASCIERTO;VANNA CHIARION‐SILENI;GAETANA RINALDI;LORENZA DI GUARDO;PIER FRANCESCO FERRUCCI;RICCARDO MARCONCINI;ALESSANDRO TESTORI;FEDERICA DE GALITIIS;JACOPO PIGOZZO;MICHELE MAIO;VIRGINIA FERRARESI;ANTONIO M. GRIMALDI;LUANA CALABRÒ;PAOLO MARCHETTI","207;207;207;207;188;188;188;188;183;168;168;168;166;166;162;162;162;161;157;157","F. FORLANI;GAETANA RINALDI;FELICE PECORARO;GIUSEPPINA NOVO;A PERINO;ALESSANDRO SVELATO;GASPARE CUCINELLA;GLORIA CALAGNA;DANIELA DI LISI;ROSARIA LINDA TROVATO;LUIGI DI ROSA;ETTORE PIRO;FORTUNATO SIRACUSA;GIOVANNI CORSELLO;GIUSEPPA PINELLO;GIUSEPPE BADALAMENTI;INGRID ANNE MANDY SCHIERZ;MARIO GIUFFRÈ;RITA ORTOLANO;SIMONA LA PLACA","207;183;112;60;52;52;52;52;43;43;39;34;34;34;34;34;34;34;34;34","FELICE PECORARO;GIUSEPPINA NOVO;GAETANA RINALDI;SALVATORE NOVO;VITO BONOMO;ALESSANDRA MURABITO;ANDREA CORTEGIANI;ANTONIO RUSSO;CALOGERO CIPOLLA;CARLO PAVONE;ELUISA LA FRANCA;EMILIO IANNITTO;FRANCESCA MONTALTO;GIUSEPPA GAMBINO;GRAZIA FORESTA;LAURA AJELLO;MARIA TERESA STRANO;PASQUALE ASSENNATO;SANTI MAURIZIO RAINERI;VINCENZO SUCATO","4;4;4;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;PSYCHOLOGY;COMPUTER SCIENCE;ENGINEERING;GEOLOGY","57;7;3;3;3;2;1;1","INTERNAL MEDICINE;SURGERY;RADIOLOGY;CARDIOLOGY;ONCOLOGY;ENVIRONMENTAL HEALTH;CANCER RESEARCH;ENDOCRINOLOGY;GASTROENTEROLOGY;IMMUNOLOGY;NUCLEAR MEDICINE;PATHOLOGY;GENETICS;INTENSIVE CARE MEDICINE;OBSTETRICS;PALEONTOLOGY;PEDIATRICS;ANATOMY;ANDROLOGY;ARTIFICIAL INTELLIGENCE;ASTRONOMY;CELL BIOLOGY;CHROMATOGRAPHY;COMPUTATIONAL CHEMISTRY;COMPUTER VISION;CRYSTALLOGRAPHY;DERMATOLOGY;ECOLOGY;GEOMORPHOLOGY;GYNECOLOGY;MECHANICAL ENGINEERING;MEDICAL EDUCATION;MULTIMEDIA;NUCLEAR MAGNETIC RESONANCE;OPERATING SYSTEM;OPHTHALMOLOGY;OPTICS;ORGANIC CHEMISTRY;PHYSICAL THERAPY;PHYSIOLOGY;PSYCHIATRY;PSYCHOANALYSIS;QUANTUM MECHANICS;SOCIAL PSYCHOLOGY;STEREOCHEMISTRY;TOXICOLOGY;UROLOGY;VETERINARY MEDICINE;VIROLOGY","46;26;22;16;10;7;6;6;6;5;4;4;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CANCER;DISEASE;COHORT;MYOCARDIAL INFARCTION;POPULATION;CLINICAL TRIAL;MELANOMA;ADVERSE EFFECT;ANEURYSM;ASYMPTOMATIC;COMPLICATION;DIABETES MELLITUS;HEART FAILURE;MAGNETIC RESONANCE IMAGING;CAROTID ARTERIES;CHEST PAIN;COMPUTED TOMOGRAPHY;EXPANDED ACCESS;FIBROSIS;NATURAL HISTORY;PREGNANCY;PROSPECTIVE COHORT STUDY;STENT;THALASSEMIA;ULTRASOUND","9;8;7;7;7;6;5;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3","IMMUNOTHERAPY;CORONARY ANGIOGRAPHY;ABDOMINAL AORTIC ANEURYSM;CARDIAC MAGNETIC RESONANCE;COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENTS;INTIMA-MEDIA THICKNESS;AIR TRAPPING;BRONCHIAL OBSTRUCTION;BRONCHIOLITIS;CARDIAC FUNCTION CURVE;CHRONIC LYMPHOCYTIC LEUKEMIA;CLINICAL ENDPOINT;COMMON CAROTID ARTERY;FETUS;HEPATITIS C VIRUS;METABOLIC SYNDROME;METASTASIS;MYOCARDIAL FIBROSIS;PERCUTANEOUS CORONARY INTERVENTION;REFLUX","5;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2","IPILIMUMAB;BONE METASTASIS;ENDOVASCULAR ANEURYSM REPAIR;RIGHT CORONARY ARTERY;TIMI;ANTIRETROVIRAL THERAPY;BENDAMUSTINE;CHLORAMBUCIL;CHOLESTERYLESTER TRANSFER PROTEIN;CITALOPRAM;COLECTOMY;CORONARY ARTERY ANEURYSM;DECOMPRESSION ILLNESS;ENOS;ESOPHAGEAL MOTILITY DISORDER;ESOPHAGEAL SPHINCTER;FAMILY PLANNING;FIRST TRIMESTER;FLUDARABINE;HIATAL HERNIA;IGHV@;IIF;INTERNATIONAL PROGNOSTIC INDEX;KRAS;MYOTOMY;NATIONAL CHOLESTEROL EDUCATION PROGRAM;PLACENTA;RANIBIZUMAB;SENTINEL LYMPH NODE;SENTINEL NODE;SEROTONIN REUPTAKE INHIBITOR;TOXIC MEGACOLON;TRANSIENT ELASTOGRAPHY;UROTHELIAL CARCINOMA;VEMURAFENIB","5;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",";HUMANS;FEMALE;MIDDLE AGED;ADULT;MALE;AGED;BLOOD VESSEL PROSTHESIS IMPLANTATION;CAROTID ARTERY DISEASES;ENDOVASCULAR PROCEDURES;MYOCARDIAL INFARCTION;RISK FACTORS;AGED, 80 AND OVER;TREATMENT OUTCOME;ANTIBODIES, MONOCLONAL;AORTIC ANEURYSM, THORACIC;CAROTID ARTERY, COMMON;FATTY LIVER;HEPATITIS C, CHRONIC;HIV INFECTIONS","29;27;19;17;16;16;12;8;8;8;7;7;6;6;5;5;5;5;5;5","GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS;MANAGEMENT AND PATHOPHYSIOLOGY OF ABDOMINAL AORTIC ANEURYSMS;ARTERIAL STIFFNESS AND CARDIOVASCULAR HEALTH;GENOMIC ABERRATIONS AND TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;CANCER OF UNKNOWN PRIMARY SITE;CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY;DIAGNOSIS AND MANAGEMENT OF GASTROESOPHAGEAL REFLUX DISEASE;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;ABDOMINAL COMPARTMENT SYNDROME AND INTRA-ABDOMINAL HYPERTENSION;CANCER IMMUNOTHERAPY;CILIOPATHIES: GENETIC DISORDERS INVOLVING PRIMARY CILIA;COMPLICATIONS AND TECHNIQUES IN THYROID SURGERY;CONGENITAL CORONARY ARTERY ANOMALIES AND THEIR MANAGEMENT;DIAGNOSIS AND MANAGEMENT OF CONGENITAL DIAPHRAGMATIC HERNIA;DIAGNOSIS AND MANAGEMENT OF ENDOMETRIOSIS;DIAGNOSIS AND MANAGEMENT OF KAWASAKI DISEASE;EFFECTS OF BLOOD TRANSFUSION IN CLINICAL PRACTICE;EPIDEMIOLOGY AND IMPLICATIONS OF MULTIMORBIDITY IN HEALTHCARE;EPIDEMIOLOGY AND MANAGEMENT OF NEUROENDOCRINE TUMORS","5;4;3;3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1","CARDIAC MAGNETIC RESONANCE;CAROTID INTIMA-MEDIA THICKNESS;ECHOCARDIOGRAPHY;EXPANDED ACCESS;INTIMA-MEDIA THICKNESS;IRON OVERLOAD;MELANOMA;AIR TRAPPING;ANEURYSM RUPTURE;ANEURYSM SCREENING;ARTERIAL STIFFNESS;BONE METASTASIS;BRONCHIAL OBSTRUCTION;CARDIAC IMAGING;CARDIOVASCULAR RISK ASSESSMENT;CLINICAL ENDPOINT;CORONARY ARTERY ANOMALIES;ENDOVASCULAR ANEURYSM REPAIR;FEMORAL ACCESS;HEPATITIS C","3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2","ACCESS PROGRAMME;CT SCAN;EXPANDED ACCESS;IPILIMUMAB EXPANDED;ITALIAN COHORT;PROGRAMME EAP;NATURAL HISTORY;ADVANCED MELANOMA;ANEURYSM REPAIR;ARTERY ANEURYSM;BONE DISEASE;BONE METASTASIS;BRONCHIOLAR OBSTRUCTION;CARDIAC SYNDROME;CHRONIC LYMPHOCYTIC;CMR SURVEY;COMPUTED TOMOGRAPHY;CORONARY ARTERY;DIABETIC PATIENTS;ELDERLY PATIENTS;EXPIRATORY CT;INSPIRATORY CT;INTERNAL MEDICINE;INTIMA-MEDIA THICKNESS;LYMPHOCYTIC LEUKEMIA;MALIGNANT BONE;METABOLIC SYNDROME;METASTASIS SURVEY;METASTATIC MELANOMA;MULTICENTER BONE","4;4;4;4;4;4;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","MYOCARDIAL FIBROSIS;CRY BC-PLTS;FEMORAL ARTERY;IRON OVERLOAD;CARDIAC OUTPUT;MYOCARDIAL IRON;TI PATIENTS;BONE METASTASIS;CT SCAN;DEEP FEMORAL;LOCAL ANAESTHESIA;PRECLINICAL ATHEROSCLEROSIS;TB-CT SCAN;CARDIOVASCULAR EVENTS;EVENTS OCCURRED;INCLUDED PATIENTS;ADVANCED FIBROSIS;ARTERIAL CONTROL;BONE METASTASES;CORONARY ARTERY;EXPIRATORY CT;GLOBAL HEART;HYPERTENSIVE PATIENTS;INSPIRATORY CT;LEFT VENTRICULAR;LIMITED DISSECTION;LV DYSFUNCTION;MAGNETIC RESONANCE;MEDIAN SURVIVAL;MEDIAN TIME","12;8;8;8;7;7;7;6;6;6;6;6;6;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;4",11,0.19,6.22,5.5,2.5,1,0,0,1,0,1,6,0,0,5,0,1,1.5,1,3.5,1,0,0,56.5,56.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,13,5.92,1046.5,12.15,2,0.15,84.85,0,0,2,0,3,0,0,8,0,5,8,0,0,0,0,0,0,13,0,0,13,0,0,0,0,0,0,0,0,0,"United States;Germany;Italy","4;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3202 CLINICAL SCIENCES;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3215 REPRODUCTIVE MEDICINE;35 COMMERCE, MANAGEMENT, TOURISM AND SERVICES;3505 HUMAN RESOURCES AND INDUSTRIAL RELATIONS;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;4205 NURSING","12;5;4;2;2;1;1;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;HEMATOLOGY;RARE DISEASES;PATIENT SAFETY;CARDIOVASCULAR;DIGESTIVE DISEASES;PREVENTION;AGING;ATHEROSCLEROSIS;AUTOIMMUNE DISEASE;LYMPHOMA;ORPHAN DRUG;PEDIATRIC;REHABILITATION;ARTHRITIS;BEHAVIORAL AND SOCIAL SCIENCE;CHILDHOOD LEUKEMIA;CHRONIC LIVER DISEASE AND CIRRHOSIS","13;8;6;6;6;4;3;3;3;2;2;2;2;2;2;2;1;1;1;1","CANCER;CARDIOVASCULAR;BLOOD;INFLAMMATORY AND IMMUNE SYSTEM;ORAL AND GASTROINTESTINAL;REPRODUCTIVE HEALTH AND CHILDBIRTH","4;2;1;1;1;1","6.1 PHARMACEUTICALS;5.3 MEDICAL DEVICES;6.2 CELLULAR AND GENE THERAPIES;6.4 SURGERY","7;1;1;1","LEUKEMIA / LEUKAEMIA;NON-HODGKIN'S LYMPHOMA;COLON AND RECTAL CANCER;HODGKIN'S DISEASE;LUNG CANCER;MYELOMA","5;2;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT","4;3;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,"THE CAMBRIDGE STRUCTURAL DATABASE","1",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_GIACCONE",2014,73,11.8630136986301,2.89041095890411,0.342465753424658,0.342465753424658,0.452054794520548,1.47552447552448,1.38888888888889,1.19047619047619,1.26923076923077,0.493150684931507,0,33,11,4,10,0.45,0.15,0.05,0.14,33.97,0.898943465753498,3.88268156424581,0.205479452054795,0.863013698630137,0.397,0.359,0.346,0.34,"ANTONELLA MELONI;ALESSIA PEPE;VINCENZO POSITANO;VINCENZO DAVIDE PALUMBO;MARIA GIOVANNA NERI;GIOVANNI TOMASELLO;GREGORY DENDRAMIS;SALVATORE NOVO;A PERINO;MASSIMO MIDIRI;GLORIA CALAGNA;CLAUDIA PALEOLOGO;ATTILIO IGNAZIO LO MONTE;ANTONIO BRUNO;GENNARO RESTAINO;AURELIO MAGGIO;PAOLO MARCHETTI;ALIDA ABRUZZO;ANTONIO CRAXÌ;GAETANA RINALDI","9;9;8;6;6;5;5;5;5;5;5;5;5;4;4;4;4;4;4;4","GREGORY DENDRAMIS;CLAUDIA PALEOLOGO;A PERINO;SALVATORE NOVO;GLORIA CALAGNA;ANTONELLA MELONI;ALESSIA PEPE;VINCENZO POSITANO;GIANFRANCO CIARAMITARO;GIUSEPPINA NOVO;VINCENZO DAVIDE PALUMBO;DARIO ORLANDO;MARIA GIOVANNA NERI;GASPARE CUCINELLA;MASSIMO MIDIRI;ANGELO B. CEFALÙ;MAURIZIO AVERNA;PASQUALE ASSENNATO;GIOVANNI TOMASELLO;ATTILIO IGNAZIO LO MONTE","1.2;1.2;0.78;0.76;0.74;0.71;0.71;0.66;0.62;0.54;0.53;0.5;0.45;0.43;0.43;0.42;0.42;0.42;0.42;0.42","VINCENZO DAVIDE PALUMBO;GREGORY DENDRAMIS;SALVATORE NOVO;A PERINO;MASSIMO MIDIRI;GLORIA CALAGNA;CLAUDIA PALEOLOGO;ALIDA ABRUZZO;ANTONIO CRAXÌ;GAETANA RINALDI;GIUSEPPINA NOVO;CALOGERO CAMMÀ;GIUSEPPE FRAZZETTA;EMANUELE GRASSEDONIO;PATRIZIA TOIA;PASQUALE ASSENNATO;CHIARA TUDISCA;GIANFRANCO CIARAMITARO;GASPARE CUCINELLA;GIUSEPPE DAMIANO","6;5;5;5;5;5;5;4;4;4;4;3;3;3;3;3;3;3;3;3","GREGORY DENDRAMIS;CLAUDIA PALEOLOGO;A PERINO;SALVATORE NOVO;GLORIA CALAGNA;GIANFRANCO CIARAMITARO;GIUSEPPINA NOVO;VINCENZO DAVIDE PALUMBO;DARIO ORLANDO;GASPARE CUCINELLA;MASSIMO MIDIRI;ANGELO B. CEFALÙ;MAURIZIO AVERNA;PASQUALE ASSENNATO;F. FORLANI;ANTONIO CRAXÌ;ETTORE DINOTO;MARIA D. PANNO;G BAJARDI;FELICE PECORARO","1.2;1.2;0.78;0.76;0.74;0.62;0.54;0.53;0.5;0.43;0.43;0.42;0.42;0.42;0.41;0.36;0.33;0.33;0.33;0.33","GAETANA RINALDI;PAOLA QUEIROLO;PAOLO A. ASCIERTO;PAOLO MARCHETTI;ANTONIO CRAXÌ;GRAHAM R. FOSTER;GREGORY J. DORE;GUY DE LA ROSA;IRA M. JACOBSON;JANE SCOTT;MARIA BEUMONT‐MAUVIEL;MICHAEL FRIED;MONICA RADU;MONIKA PEETERS;OLIVER LENZ;REKHA SINHA;RONALD KALMEIJER;SIVI OUWERKERK‐MAHADEVAN;V. V. RAFALSKY;Л. В. МОРОЗ","519;494;494;494;478;432;432;432;432;432;432;432;432;432;432;432;432;432;432;432","GAETANA RINALDI;ANTONIO CRAXÌ;SALVATRICE MANCUSO;F. FORLANI;A PERINO;VINCENZO SERRETTA;GLORIA CALAGNA;GASPARE CUCINELLA;ALESSANDRO SVELATO;CORRADO TIBERIO;MASSIMO MIDIRI;C SARNO;ANGELO B. CEFALÙ;MAURIZIO AVERNA;ANDREA CORTEGIANI;FRANCESCA DI GAUDIO;MARIA RASO;PATRIZIA TOIA;GIUSEPPINA NOVO;SALVATORE NOVO","519;473;306;297;223;220;201;200;176;176;128;56;50;50;47;46;46;46;45;45","A PERINO;CLAUDIA PALEOLOGO;GLORIA CALAGNA;GREGORY DENDRAMIS;MASSIMO MIDIRI;GAETANA RINALDI;SALVATORE NOVO;PATRIZIA TOIA;ANTONINO AGRUSA;DANIELA CHIANETTA;F. FORLANI;GASPARE GULOTTA;GIANFRANCO CIARAMITARO;GIUSEPPE FRAZZETTA;GIUSEPPINA NOVO;ANTONIO CRAXÌ;CHIARA TUDISCA;GASPARE CUCINELLA;MARCELLO NOTO;ANDREA CORTEGIANI","5;5;5;5;5;4;4;3;3;3;3;3;3;3;3;3;3;3;3;2","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;COMPUTER SCIENCE;MATERIALS SCIENCE;ECONOMICS;GEOGRAPHY;PSYCHOLOGY","69;13;7;7;3;2;1;1;1","INTERNAL MEDICINE;SURGERY;RADIOLOGY;CARDIOLOGY;GASTROENTEROLOGY;PATHOLOGY;GENETICS;ENDOCRINOLOGY;ONCOLOGY;ENVIRONMENTAL HEALTH;IMMUNOLOGY;BIOCHEMISTRY;CANCER RESEARCH;GENERAL SURGERY;VIROLOGY;ANESTHESIA;INTENSIVE CARE MEDICINE;NUCLEAR MEDICINE;NURSING;OBSTETRICS;PEDIATRICS;THERMODYNAMICS","54;25;18;15;14;11;10;9;9;7;7;4;4;4;4;3;3;3;3;3;3;3","HEART FAILURE;CANCER;MAGNETIC RESONANCE IMAGING;DISEASE;PROSPECTIVE COHORT STUDY;THALASSEMIA;ADVERSE EFFECT;GENE;POPULATION;CLINICAL TRIAL;DIABETES MELLITUS;COHORT;MULTISLICE;VIRUS;ALTERNATIVE MEDICINE;ASYMPTOMATIC;CHEMOTHERAPY;COMPLICATION;ESOPHAGUS;IMMUNE SYSTEM;LOGISTIC REGRESSION;LYMPHOMA;MELANOMA;PREGNANCY;PRESENTATION (OBSTETRICS);RANDOMIZED CONTROLLED TRIAL;REGIMEN;STENT;ULTRASOUND","11;10;10;9;8;8;7;7;7;5;5;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","CARDIOMYOPATHY;EJECTION FRACTION;DEFERIPRONE;CHELATION THERAPY;DEFERASIROX;GENOTYPE;IMMUNOTHERAPY;ACUTE CORONARY SYNDROME;ADENOCARCINOMA;AORTOGRAPHY;APOLIPOPROTEIN B;CANCER PAIN;CARDIAC FUNCTION CURVE;CARDIAC MAGNETIC RESONANCE;CARDIAC MAGNETIC RESONANCE IMAGING;CULPRIT;FETUS;HEPATITIS C VIRUS;INFLAMMATORY BOWEL DISEASE;INSULIN RESISTANCE;LIPOPROTEIN;MULTICENTER STUDY;TYPE 2 DIABETES;ULCERATIVE COLITIS","5;5;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA;IPILIMUMAB;RIBAVIRIN;ACUTE AORTIC SYNDROME;ACUTE PROMYELOCYTIC LEUKEMIA;ADULT STEM CELL;ANDROGEN DEPRIVATION THERAPY;ANDROGEN RECEPTOR;ANTIRETROVIRAL THERAPY;ATRIAL TACHYCARDIA;BENDAMUSTINE;BRADYCARDIA;CARDIAC RESYNCHRONIZATION THERAPY;CHIARI MALFORMATION;CHOLESTERYLESTER TRANSFER PROTEIN;CLAUDICATION;DESMIN;DISCOVERY AND DEVELOPMENT OF MTOR INHIBITORS;ENOS;ESOPHAGITIS;FEMALE INFERTILITY;FETAL HEART;FIRST TRIMESTER;FLUDARABINE;FOCUSED ASSESSMENT WITH SONOGRAPHY FOR TRAUMA;GASTROESOPHAGEAL JUNCTION;GERD;HERPESVIRIDAE;HIATAL HERNIA;HISTONE DEACETYLASE;HOMEOSTATIC MODEL ASSESSMENT;HYPOPNEA;KRAS;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS SALIVARIUS;LDL RECEPTOR;LIVER STEATOSIS;MAMMOGRAPHY;MESALAZINE;MESODERM;MULTIPOTENT STEM CELL;NATURAL KILLER CELL;NISSEN FUNDOPLICATION;PLACENTA;POSACONAZOLE;PRENATAL DIAGNOSIS;RIBONUCLEOTIDE;RIBONUCLEOTIDE REDUCTASE;RIGHT CORONARY ARTERY;SINGLE-NUCLEOTIDE POLYMORPHISM;TRABECTEDIN;VERY LOW-DENSITY LIPOPROTEIN","3;3;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",";HUMANS;MALE;FEMALE;MIDDLE AGED;ADULT;AGED;TREATMENT OUTCOME;YOUNG ADULT;ADOLESCENT;AGED, 80 AND OVER;ANTIBODIES, MONOCLONAL;ANTINEOPLASTIC AGENTS;ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA;HEART FAILURE;HEART VENTRICLES;PROSPECTIVE STUDIES;RISK FACTORS;VENTRICULAR DYSFUNCTION, LEFT;ANEURYSM","38;35;27;24;22;18;16;12;10;8;8;7;7;7;7;7;7;7;7;6","GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS;CANCER IMMUNOTHERAPY;DIAGNOSIS AND MANAGEMENT OF ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY;GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;CARDIAC RESYNCHRONIZATION THERAPY IN HEART FAILURE;CHALLENGES IN PAIN MANAGEMENT AND TREATMENT;DIAGNOSIS AND MANAGEMENT OF GASTROESOPHAGEAL REFLUX DISEASE;EPIDEMIOLOGY AND MANAGEMENT OF CONGENITAL HEART DISEASE;HEPATITIS C INFECTION AND TREATMENT;LYMPHOID NEOPLASMS;ADVANCEMENTS IN PROSTATE CANCER RESEARCH;ANALYTICAL CHEMISTRY TECHNIQUES;APPLICATIONS OF PLATELET-RICH PLASMA IN REGENERATIVE MEDICINE;CHOLESTEROL-LOWERING TREATMENT;CLINICAL IMPLICATIONS OF UTERINE ANOMALIES AND TREATMENT;DEEP LEARNING IN MEDICAL IMAGE ANALYSIS;DEVELOPMENTAL PHARMACOLOGY IN PEDIATRIC DRUG USE;DIAGNOSIS AND MANAGEMENT OF AORTIC DISEASES;DIAGNOSIS AND MANAGEMENT OF CARDIAC TUMORS;DIAGNOSIS AND MANAGEMENT OF FUNGAL INFECTIONS","8;3;3;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1","DEFERIPRONE;IRON OVERLOAD;MULTISLICE;TREATMENT;ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY;CARDIAC REMODELING;CHELATION THERAPY;DEFERASIROX;ECHOCARDIOGRAPHY;PRESENTATION (OBSTETRICS);REGIMEN;ANEURYSM RUPTURE;ANEURYSM SCREENING;AORTOGRAPHY;CANCER PAIN;CARDIAC MAGNETIC RESONANCE;CARDIAC RESYNCHRONIZATION THERAPY;CULPRIT;ENDOTHELIAL DYSFUNCTION;ESOPHAGEAL PERFORATION","4;4;4;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2","THALASSEMIA MAJOR;MAJOR PATIENTS;HEPATIC IRON;PATIENTS TREATED;ACCESS PROGRAMME;ADVANCED MELANOMA;CANCER PAIN;CARDIAC FUNCTION;CHRONIC HEPATITIS;ELDERLY PATIENTS;EXPANDED ACCESS;MAGNETIC RESONANCE;MRI PROSPECTIVE;MULTICENTER STUDY;PROSPECTIVE MULTICENTER;PROSPECTIVE SURVEY;RETROSPECTIVE MULTICENTER;VENTRICULAR DYSPLASIACARDIOMYOPATHY;ACCORDION PHENOMENON;ACCRETA INCRETA;ACHALASIA SECONDARY;ACUTE AORTIC;ACUTE CORONARY;ACUTE PROMYELOCYTIC;ACUTE-PHASE REACTANTS;ADENOCARCINOMAS RESISTANT;ADIPOSE TISSUE;ANATOMICAL FEATURES;ANDROGEN-DEPRIVATION THERAPY;ANESTHETICS DETERMINATION","6;4;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","IRON OVERLOAD;RISK FACTORS;ELDERLY PATIENTS;MS GT;PAIN CONTROL;PAIN INTENSITY;TM PATIENTS;ADVERSE EFFECTS;CANCER PATIENTS;DEFICIENCY ANEMIA;HIATAL HERNIA;INSULIN RESISTANCE;IRON DEFICIENCY;METASTATIC MELANOMA;URINE CULTURE;ABSTRACT AIM;ADVANCED CANCER;ADVERSE EVENTS;ASYMPTOMATIC BACTERIURIA;CARDIAC IRON;CARDIOVASCULAR RISK;CD CELL;CD COUNT;CETP DEFICIENCY;CLINICAL TRIAL;CONTROL HDL;CRURAL CLOSURE;DIASTOLIC DYSFUNCTION;DISEASE CONTROL;DOSAGE MGKGDIE","7;7;6;6;5;5;5;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3",22,0.3,4.2,3.75,1,1,0,1.25,0,0,2.5,3.75,0,1,3.25,0,0,1.5,2,3,1.5,0,0,83,83,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,15,6.07,444.4,10.79,4,0.27,69.53,0,0,2,0,4,0,1,8,0,8,7,0,0,0,0,0,0,15,0,0,13,0,0,2,0,0,0,0,0,0,"Italy;Germany;United States","6;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;31 BIOLOGICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3204 IMMUNOLOGY;3205 MEDICAL BIOCHEMISTRY AND METABOLOMICS;3207 MEDICAL MICROBIOLOGY;3210 NUTRITION AND DIETETICS;3211 ONCOLOGY AND CARCINOGENESIS;4206 PUBLIC HEALTH;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","14;8;3;2;1;1;1;1;1;1;1;1;1;1;1","CLINICAL RESEARCH;DIGESTIVE DISEASES;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;NUTRITION;PREVENTION;CANCER;HEMATOLOGY;AUTOIMMUNE DISEASE;CARDIOVASCULAR;INFECTIOUS DISEASES;PATIENT SAFETY;PEDIATRIC;RARE DISEASES;INFLAMMATORY BOWEL DISEASE;LIVER DISEASE;ORPHAN DRUG;ATHEROSCLEROSIS;BIOMEDICAL IMAGING;CHILDHOOD LEUKEMIA;CHRONIC LIVER DISEASE AND CIRRHOSIS","14;6;5;5;5;4;4;3;3;3;3;3;3;2;2;2;1;1;1;1","CANCER;INFECTION;METABOLIC AND ENDOCRINE;ORAL AND GASTROINTESTINAL;BLOOD;CARDIOVASCULAR;INFLAMMATORY AND IMMUNE SYSTEM;STROKE","3;2;2;2;1;1;1;1","6.1 PHARMACEUTICALS;2.3 PSYCHOLOGICAL, SOCIAL AND ECONOMIC FACTORS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;5.1 PHARMACEUTICALS;5.2 CELLULAR AND GENE THERAPIES;6.4 SURGERY","6;1;1;1;1;1","LEUKEMIA / LEUKAEMIA;BLOOD CANCER;COLON AND RECTAL CANCER;LIVER CANCER;SARCOMA","3;2;2;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES;3.3 CHEMOPREVENTION;5.2 LOCALIZED THERAPIES - CLINICAL APPLICATIONS;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT","5;2;1;1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,"PUBLIC LIBRARY OF SCIENCE","2","31 BIOLOGICAL SCIENCES;32 BIOMEDICAL AND CLINICAL SCIENCES;3105 GENETICS;49 MATHEMATICAL SCIENCES;4904 PURE MATHEMATICS","2;2;1;1;1","CANCER;GENETICS;PEDIATRIC;PEDIATRIC CANCER;RARE DISEASES","1;1;1;1;1","CANCER","1","5.1 PHARMACEUTICALS","1","BIOMEDICAL","1","BASIC SCIENCE","1",NA,NA,NA,NA
"AOUSSN_GIACCONE",2015,94,12.7021276595745,2.56382978723404,0.265957446808511,0.297872340425532,0.329787234042553,1.42603550295858,1.13636363636364,1.12,1.14814814814815,0.648936170212766,1,55,18,8,5,0.59,0.19,0.09,0.05,44.9,1.20489440945271,5.42995169082125,0.25531914893617,0.882978723404255,0.44,0.43,0.321,0.412,"DAVIDE PIRAINO;DARIO BUCCHERI;GLORIA CALAGNA;VINCENZO MONTESARCHIO;A.F. ATTILI;TERESA ZOLFINO;C. ERMINERO;ERICA VILLA;A PERINO;GIUSEPPE ANDOLINA;PETROS GIOVANIS;BERNARDO CORTESE;A. BENEDETTI;DOMENICO SANSONNO;PASQUALE ASSENNATO;ANTONIO GASBARRINI;GREGORY DENDRAMIS;SALVATORE D’ANGELO;ANGELA BUONADONNA;SANDRO BARNI","8;8;7;6;6;6;6;6;6;6;6;6;5;5;5;5;5;5;5;5","DAVIDE PIRAINO;DARIO BUCCHERI;GLORIA CALAGNA;BERNARDO CORTESE;GIUSEPPE ANDOLINA;A PERINO;GREGORY DENDRAMIS;ATTILIO DI SPIEZIO SARDO;PASQUALE ASSENNATO;ROMANO SEREGNI;PEDRO SILVA ORREGO;ANDREA CORTEGIANI;FRANCESCO VITALE;ALESSANDRA CASUCCIO;CLAUDIA PALEOLOGO;MAURIZIO AVERNA;GASPARE GULOTTA;DANILO DI BONA;GIUSEPPE BADALAMENTI;SANTI MAURIZIO RAINERI","2.02;1.22;1.17;0.99;0.82;0.77;0.74;0.68;0.62;0.49;0.49;0.49;0.47;0.47;0.44;0.43;0.4;0.39;0.37;0.37","DAVIDE PIRAINO;DARIO BUCCHERI;GLORIA CALAGNA;A PERINO;GIUSEPPE ANDOLINA;PASQUALE ASSENNATO;GREGORY DENDRAMIS;MAURIZIO AVERNA;ANTONELLA MELONI;ALESSIA PEPE;GIUSEPPE BADALAMENTI;ANDREA CORTEGIANI;VINCENZO POSITANO;ROMANO SEREGNI;LYDIA GIANNITRAPANI;FRANCESCO VITALE;SALVATORE NOVO;LORENA INCORVAIA;GASPARE GULOTTA;FABIO FULFARO","8;8;7;6;6;5;5;5;4;4;4;4;4;3;3;3;3;3;3;3","DAVIDE PIRAINO;DARIO BUCCHERI;GLORIA CALAGNA;GIUSEPPE ANDOLINA;A PERINO;GREGORY DENDRAMIS;PASQUALE ASSENNATO;ROMANO SEREGNI;ANDREA CORTEGIANI;FRANCESCO VITALE;CLAUDIA PALEOLOGO;MAURIZIO AVERNA;GASPARE GULOTTA;DANILO DI BONA;GIUSEPPE BADALAMENTI;SANTI MAURIZIO RAINERI;ANTONELLA MELONI;ALESSIA PEPE;VINCENZO POSITANO;LIGIA J. DOMÍNGUEZ","2.02;1.22;1.17;0.82;0.77;0.74;0.62;0.49;0.49;0.47;0.44;0.43;0.4;0.39;0.37;0.37;0.33;0.33;0.33;0.33","MAURIZIO AVERNA;MICHEL FARNIER;ERIK S.G. STROES;CHRISTELLE LORENZATO;FREDERICK J. RAAL;GISLE LANGSLET;GÉRALD LUC;JEAN BERGERON;JENNIFER G. ROBINSON;JOHN J.P. KASTELEIN;MAHFOUZ EL SHAHAWY;MICHAEL J. KOREN;MICHEL KREMPF;NORMAN E. LEPOR;ROBERT PORDY;UMESH CHAUDHARI;GLORIA CALAGNA;A PERINO;ELISABETH STEINHAGEN‐THIESSEN;ANDREA CORTEGIANI","2286;2280;2110;2108;2108;2108;2108;2108;2108;2108;2108;2108;2108;2108;2108;2108;199;188;178;173","MAURIZIO AVERNA;GLORIA CALAGNA;ANDREA CORTEGIANI;GIANFRANCO COCORULLO;A PERINO;DAVIDE PIRAINO;DARIO BUCCHERI;GIUSEPPE ANDOLINA;GIUSEPPE CARUSO;ANNA GIAMMANCO;AMANDA CARUSELLI;MARIA ENZA MITRA;ALDO FILOSA;ALESSIA PEPE;ANTONELLA MELONI;ANTONELLA QUARTA;AURELIO MAGGIO;CRISTINA SALVATORI;DOMENICO GIUSEPPE D’ASCOLA;GIANLUCA VALERI","2286;199;173;171;153;139;138;133;120;92;85;77;73;73;73;73;73;73;73;73","DAVIDE PIRAINO;GLORIA CALAGNA;DARIO BUCCHERI;A PERINO;MAURIZIO AVERNA;ANDREA CORTEGIANI;GIUSEPPE ANDOLINA;GIUSEPPE BADALAMENTI;FRANCESCO VITALE;GREGORY DENDRAMIS;LYDIA GIANNITRAPANI;PASQUALE ASSENNATO;ANTONIO CRAXÌ;ALICE MULÈ;CINZIA NUGARA;CLAUDIA PALEOLOGO;CLEMENTINA CARACCIOLO;CONCETTA LA SETA;DANILO DI BONA;EMILIO IANNITTO","7;7;6;5;5;4;4;4;3;3;3;3;3;2;2;2;2;2;2;2","MEDICINE;BIOLOGY;PHYSICS;CHEMISTRY;COMPUTER SCIENCE;ENGINEERING;MATHEMATICS;ECONOMICS;MATERIALS SCIENCE;ART;PHILOSOPHY;POLITICAL SCIENCE;PSYCHOLOGY;GEOGRAPHY;GEOLOGY;SOCIOLOGY","91;18;7;5;5;5;5;4;4;2;2;2;2;1;1;1","INTERNAL MEDICINE;SURGERY;CARDIOLOGY;GASTROENTEROLOGY;RADIOLOGY;PATHOLOGY;INTENSIVE CARE MEDICINE;ENVIRONMENTAL HEALTH;GENETICS;ONCOLOGY;IMMUNOLOGY;BIOCHEMISTRY;VIROLOGY;FAMILY MEDICINE;GYNECOLOGY;PHARMACOLOGY;CANCER RESEARCH;NURSING;PEDIATRICS;PHYSICAL THERAPY;PSYCHIATRY","72;31;19;16;16;14;11;9;9;9;8;7;7;5;5;5;4;4;4;4;4","CANCER;ADVERSE EFFECT;POPULATION;DISEASE;HEPATOCELLULAR CARCINOMA;ALTERNATIVE MEDICINE;CHEMOTHERAPY;GENE;MYOCARDIAL INFARCTION;VIRUS;CONFIDENCE INTERVAL;HEART FAILURE;PROSPECTIVE COHORT STUDY;STENT;ARTERY;CLINICAL TRIAL;COHORT;EPIDEMIOLOGY;MAGNETIC RESONANCE IMAGING;MYELOID LEUKEMIA;OBSERVATIONAL STUDY;RANDOMIZED CONTROLLED TRIAL","11;9;9;7;7;6;6;6;6;6;5;5;5;5;4;4;4;4;4;4;4;4","SORAFENIB;CARDIAC FUNCTION CURVE;CHRONIC HEPATITIS;CLINICAL ENDPOINT;COLORECTAL CANCER;CORONARY ANGIOGRAPHY;GIST;HAZARD RATIO;LIPOPROTEIN;PLACEBO;RESTENOSIS;ANGINA;BETA THALASSEMIA;BLADDER CANCER;CARDIAC MAGNETIC RESONANCE;CHELATION THERAPY;CORONARY ARTERIES;CYCLOPHOSPHAMIDE;DEFERIPRONE;DIASTOLE;IMATINIB;LAPAROSCOPIC SURGERY;RITUXIMAB;SUBGROUP ANALYSIS;TOLERABILITY;TYROSINE KINASE;UNIVARIATE ANALYSIS","7;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","RIBAVIRIN;ABL;APOLIPOPROTEIN A1;CORONARY STEAL;IMATINIB MESYLATE;RIGHT CORONARY ARTERY;ALLERGEN IMMUNOTHERAPY;ANTIRETROVIRAL THERAPY;ARTERY DISSECTION;ASPARTATE TRANSAMINASE;BARE METAL;BENDAMUSTINE;BREAKTHROUGH PAIN;CEREBRAL VASOSPASM;COLONOSCOPY;CORONARY STENT;CROSSOVER STUDY;CYSTECTOMY;DOPPLER IMAGING;DRUG-ELUTING STENT;ENDOTHELIAL PROGENITOR CELL;ESOPHAGEAL MOTILITY DISORDER;ESOPHAGEAL SPASM;FLUDARABINE;FUSION PROTEIN;GASTRIC ADENOCARCINOMA;GENOTYPING;HEARTBURN;HPV INFECTION;HYDROMORPHONE;IMMATURE TERATOMA;KLEBSIELLA PNEUMONIAE;KRAS;LDL RECEPTOR;LEFT MAIN CORONARY ARTERY DISEASE;LIPOPROTEIN(A);LONG NON-CODING RNA;MEAN ARTERIAL PRESSURE;MEASLES VACCINE;MEASLES VIRUS;MEMORY SPAN;MODIFIED RANKIN SCALE;MONOCLONAL;MYOCARDIAL BRIDGE;NODULAR SCLEROSIS;PDGFRA;PHILADELPHIA CHROMOSOME;SPLENIC MARGINAL ZONE LYMPHOMA;SUBLINGUAL IMMUNOTHERAPY;TRABECTEDIN;VINCRISTINE","4;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;;FEMALE;MALE;MIDDLE AGED;AGED;ADULT;ITALY;AGED, 80 AND OVER;NEOPLASMS;RETROSPECTIVE STUDIES;ADOLESCENT;CARDIOMYOPATHIES;CARDIOVASCULAR DISEASES;PROSPECTIVE STUDIES;POSTOPERATIVE COMPLICATIONS;TREATMENT OUTCOME;YOUNG ADULT;ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;LIVER","52;41;38;34;29;22;21;21;12;11;11;10;10;10;9;8;8;8;7;7","EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;CLINICAL IMPLICATIONS OF UTERINE ANOMALIES AND TREATMENT;CLINICAL STUDIES ON CORONARY STENTS AND REVASCULARIZATION;GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS;HEPATOCELLULAR CARCINOMA;CHOLESTEROL-LOWERING TREATMENT;CONGENITAL CORONARY ARTERY ANOMALIES AND THEIR MANAGEMENT;CARDIAC RESYNCHRONIZATION THERAPY IN HEART FAILURE;CLASSIFICATION AND MANAGEMENT OF VASCULITIDES;DIAGNOSIS AND MANAGEMENT OF ENDOMETRIOSIS;DIAGNOSIS AND MANAGEMENT OF GASTROESOPHAGEAL REFLUX DISEASE;DIAGNOSIS AND TREATMENT OF BLADDER CANCER;DIAGNOSIS AND TREATMENT OF GASTROINTESTINAL STROMAL TUMORS;EFFICACY AND RESISTANCE IN CML TREATMENT;HEPATITIS C INFECTION AND TREATMENT;LIPID METABOLISM AND CARDIOVASCULAR DISEASE;LYMPHOID NEOPLASMS;ADVANCEMENTS IN COLORECTAL CANCER RESEARCH;ALLERGIC RHINITIS AND ITS IMPACT ON ASTHMA;ANKLE INJURIES AND DISORDERS IN SPORTS MEDICINE","5;4;4;4;4;3;3;2;2;2;2;2;2;2;2;2;2;1;1;1","SORAFENIB;CORONARY ARTERY ABNORMALITIES;CORONARY STENTS;ANGIOLOGY;CLINICAL ENDPOINT;CORONARY ARTERY ANOMALIES;HYSTEROSCOPIC TREATMENT;REGIMEN;TREATMENT;ABL;ALIROCUMAB;BETA THALASSEMIA;CARDIAC MAGNETIC RESONANCE;CHELATION THERAPY;CHOLESTEROL-LOWERING;CONCOMITANT;CORONARY ARTERIES;CORONARY STEAL;CROSS-SECTIONAL STUDY;DACLATASVIR","5;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2","CORONARY ARTERY;FINAL RESULTS;HEPATOCELLULAR CARCINOMA;ELDERLY PATIENTS;GIDEON STUDY;THERAPEUTIC DECISIONS;ADVANCED CANCER;ARTERY DISEASE;ARTERY FISTULAS;CANCER PATIENTS;CARDIAC IRON;CARDIAC MAGNETIC;DISEASE LEFT;DRUG-COATED BALLOONS;GENOTYPE PATIENTS;GIDEON GLOBAL;GLOBAL INVESTIGATIONAL;ITALIAN COHORT;ITALIAN EXPERIENCE;LIPASE DEFICIENCY;LIPOPROTEIN LIPASE;LIVER FUNCTION;MAGNETIC RESONANCE;MEDITERRANEAN DIET;NATIVE CORONARY;OMBITASVIRPARITAPREVIRR DASABUVIR;PATIENT ETIOLOGY;PATIENTS FINAL;PATIENTS TREATED;PHASE II","4;4;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","PISA ITALY;ITALY AB;PALERMO ITALY;ADVERSE EVENTS;CLINICAL PRACTICE;UNIVERSITY HOSPITAL;Μ DS;MAGNETIC RESONANCE;CNRREGIONE TOSCANA;MEDIAN AGE;MONASTERIO CNRREGIONE;AB FONDAZIONE;AB GT;ATA UNIVERSITY;CARDIAC THORACIC;CHIETI-PESCARA ITALY;CN CARDIAC;DANNUNZIO UNIVERSITY;DEPARTMENT VB;EM SR;GDA UNIVERSITY;GIACCONE PALERMO;GT GDA;HOSPITAL PAOLO;IRON OVERLOAD;ITALY ATE;ITALY CN;ITALY EM;ITALY INSTITUTE;MESSINA ITALY","28;18;14;12;12;12;12;11;10;10;10;9;9;9;9;9;9;9;9;9;9;9;9;9;9;9;9;9;9;9",24,0.26,9.61,6.25,3.5,6.5,1,4.25,14,0,2.5,7,1,1,5,2,3,2.5,1,3,1,0,0,101,101,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,9,4.22,1006.78,5.66,4,0.44,87.78,0,0,1,0,3,0,1,4,0,5,4,0,0,0,0,0,0,7,1,1,9,0,0,0,0,0,0,0,0,0,"Italy;United States;Japan;United Kingdom","5;2;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;48 LAW AND LEGAL STUDIES;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","8;6;3;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;DIGESTIVE DISEASES;AGING;AUTOIMMUNE DISEASE;CARDIOVASCULAR;NUTRITION;PATIENT SAFETY;PEDIATRIC;ACQUIRED COGNITIVE IMPAIRMENT;ALZHEIMER'S DISEASE;ALZHEIMER'S DISEASE INCLUDING ALZHEIMER'S DISEASE RELATED DEMENTIAS (AD/ADRD);ATHEROSCLEROSIS;BRAIN DISORDERS;BREAST CANCER;CHILDHOOD LEUKEMIA;CHRONIC PAIN;CROHN'S DISEASE;DEMENTIA","9;6;3;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1","CANCER;ORAL AND GASTROINTESTINAL;METABOLIC AND ENDOCRINE;NEUROLOGICAL","2;2;1;1","6.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES","6;1","BREAST CANCER;COLON AND RECTAL CANCER;LEUKEMIA / LEUKAEMIA","1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","3",2,13096830,501065.48,5,30,10.5,1,168.5,200426.193126023,0.46900057589227,"AZIENDA OSPEDALIERA UNIVERSITARIA POLICLINICO ""PAOLO GIACCONE"" DI PALERMO;DEPARTMENT OF HEALTH;INSTITUT D'INVESTIGACIÓ EN CIÈNCIES DE LA SALUT GERMANS TRIAS I PUJOL;AERAS;AFRICA HEALTH RESEARCH INSTITUTE;ASTON UNIVERSITY;BANGOR UNIVERSITY;BIOMEDICAL PRIMATE RESEARCH CENTRE;DEPARTMENT FOR ENVIRONMENT, FOOD AND RURAL AFFAIRS;DÉLÉGATION PARIS 11;ETH ZURICH;FRENCH NATIONAL CENTRE FOR SCIENTIFIC RESEARCH;FRIEDRICH-LOEFFLER-INSTITUT;GHENT UNIVERSITY;GLAXOSMITHKLINE (BELGIUM);IMPERIAL COLLEGE LONDON;INSTITUT PASTEUR;INSTITUTE OF MICROBIOLOGY;INSTITUTO NACIONAL DE SAÚDE;INTERNATIONAL TUBERCULOSIS RESEARCH CENTER","2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","EUROPEAN COMMISSION","2","COALITION S;EC & ERC - EUROPEAN UNION","2;2","H2020-EU.3.1. - SOCIETAL CHALLENGES - HEALTH, DEMOGRAPHIC CHANGE AND WELL-BEING (PROGRAMME);H2020-PHC-2014-SINGLE-STAGE (CALL FOR PROPOSAL);RIA - RESEARCH AND INNOVATION ACTION (FUNDING SCHEME)","2;2;2","32 BIOMEDICAL AND CLINICAL SCIENCES;3204 IMMUNOLOGY;3207 MEDICAL MICROBIOLOGY","2;2;1","IMMUNIZATION;PREVENTION;RARE DISEASES;TUBERCULOSIS;VACCINE RELATED;BIODEFENSE;BIOTECHNOLOGY;EMERGING INFECTIOUS DISEASES;HIV/AIDS;INFECTIOUS DISEASES;LUNG;ORPHAN DRUG;TUBERCULOSIS VACCINE","2;2;2;2;2;1;1;1;1;1;1;1;1","INFECTION","2","3.4 VACCINES;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES","1;1",NA,NA,NA,NA,"A03 ALLIED HEALTH PROFESSIONS, DENTISTRY, NURSING AND PHARMACY","2","3 GOOD HEALTH AND WELL BEING","2",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_GIACCONE",2016,97,11.6288659793814,2.87628865979381,0.505154639175258,0.298969072164948,0.577319587628866,1.46073298429319,1.36111111111111,1.45,1.27272727272727,0.443298969072165,4,52,13,12,11,0.54,0.13,0.12,0.11,14.09,0.433850910085053,5.99209486166007,0.247422680412371,0.824742268041237,0.541,0.439,0.388,0.428,"DAVIDE PIRAINO;DARIO BUCCHERI;SALVATORE NOVO;GIUSEPPE ANDOLINA;F. FORLANI;FRANCESCA FOTI;G. MINNECI;GIUSEPPE CALÌ;GIUSEPPINA NOVO;EGLE CORRADO;T. IZZO;PATRIZIA CARITÀ;GIOVANNI SCAMBIA;PASQUALE ASSENNATO;GIUSEPPE COPPOLA;GIANFRANCO CIARAMITARO;BERNARDO CORTESE;GIUSEPPE LO RE;FRANCESCO DIELI;VITO CHIÀNTERA","11;10;7;7;6;6;6;6;6;5;5;5;4;4;4;4;4;3;3;3","DAVIDE PIRAINO;DARIO BUCCHERI;GIUSEPPE ANDOLINA;CRISTINA RASPANTI;GIUSEPPE SALAMONE;NICOLÒ FALCO;GABRIELLA MILITELLO;F. FORLANI;FRANCESCA FOTI;G. MINNECI;GIUSEPPE CALÌ;BERNARDO CORTESE;T. IZZO;SALVATORE NOVO;GIUSEPPINA NOVO;PASQUALE ASSENNATO;SERGIO PISCITELLO;GREGORY DENDRAMIS;MARIA VADALÀ;CLAUDIA PALEOLOGO","3.14;2.98;1.99;1.09;1;1;1;0.99;0.99;0.99;0.99;0.98;0.87;0.73;0.64;0.55;0.5;0.5;0.5;0.5","DAVIDE PIRAINO;DARIO BUCCHERI;SALVATORE NOVO;GIUSEPPE ANDOLINA;FRANCESCA FOTI;G. MINNECI;GIUSEPPINA NOVO;EGLE CORRADO;T. IZZO;PATRIZIA CARITÀ;PASQUALE ASSENNATO;GIUSEPPE COPPOLA;GIANFRANCO CIARAMITARO;GIUSEPPE LO RE;FRANCESCO DIELI;VITO CHIÀNTERA;SILVIO BUSCEMI;GIUSEPPE CICERO;LORENA INCORVAIA;SERGIO SALERNO","11;10;7;7;6;6;6;5;5;5;4;4;4;3;3;3;3;3;3;3","DAVIDE PIRAINO;DARIO BUCCHERI;GIUSEPPE ANDOLINA;CRISTINA RASPANTI;GIUSEPPE SALAMONE;NICOLÒ FALCO;GABRIELLA MILITELLO;FRANCESCA FOTI;G. MINNECI;T. IZZO;SALVATORE NOVO;GIUSEPPINA NOVO;PASQUALE ASSENNATO;SERGIO PISCITELLO;GREGORY DENDRAMIS;MARIA VADALÀ;CLAUDIA PALEOLOGO;EGLE CORRADO;FRANCESCO DIELI;SERGIO SALERNO","3.14;2.98;1.99;1.09;1;1;1;0.99;0.99;0.87;0.73;0.64;0.55;0.5;0.5;0.5;0.5;0.43;0.41;0.4","A. LAURI;B. BORGATTA;C. LONDONI;CAROLINA TOMBA;DARIO CONTE;DONATELLA BARISANI;EDOARDO FORTI;ELISABETTA BUSCARINI;FEDERICA BRANCHI;FLAVIO VALIANTE;FRANCESCA FERRETTI;FRANCESCO SOMALVICO;GAETANO CRISTIAN MORREALE;GIOACCHINO LEANDRO;GIOVANNI FORNACIARI;GUIDO BASILISCO;LEDA RONCORONI;LUCA ELLI;LUCIA FINI;MARIA TERESA BARDELLA","167;167;167;167;167;167;167;167;167;167;167;167;167;167;167;167;167;167;167;167","GAETANO CRISTIAN MORREALE;GIUSEPPINA NOVO;MAURIZIO AVERNA;VITO CHIÀNTERA;DARIO BUCCHERI;EGLE CORRADO;GIUSEPPE COPPOLA;PATRIZIA CARITÀ;SALVATORE NOVO;DAVIDE PIRAINO;SERGIO SALERNO;VINCENZO SERRETTA;GIUSEPPE LO RE;MARCO PETRILLO;ANTONIO RUSSO;FEDERICA VERNUCCIO;DARIO PICONE;F. MUSCARNERI;GIUSEPPE CICERO;GIUSEPPE LA TONA","167;120;113;97;95;83;83;83;80;67;67;62;56;54;48;48;47;47;47;47","DARIO BUCCHERI;DAVIDE PIRAINO;GIUSEPPE ANDOLINA;GIUSEPPINA NOVO;SALVATORE NOVO;FRANCESCA FOTI;G. MINNECI;EGLE CORRADO;PATRIZIA CARITÀ;T. IZZO;GIANFRANCO CIARAMITARO;GIUSEPPE COPPOLA;PASQUALE ASSENNATO;ANTONIO RUSSO;SERGIO SALERNO;GIUSEPPE LO RE;LORENA INCORVAIA;VITO CHIÀNTERA;ALICE MULÈ;ANTONIO CRAXÌ","10;10;7;6;6;6;6;5;5;5;4;4;3;3;3;3;3;3;2;2","MEDICINE;BIOLOGY;PHYSICS;CHEMISTRY;COMPUTER SCIENCE;MATERIALS SCIENCE;POLITICAL SCIENCE;SOCIOLOGY;ECONOMICS;ENGINEERING;GEOGRAPHY;GEOLOGY;MATHEMATICS;PSYCHOLOGY","95;23;8;4;4;4;2;2;1;1;1;1;1;1","INTERNAL MEDICINE;SURGERY;CARDIOLOGY;ONCOLOGY;RADIOLOGY;PATHOLOGY;ENVIRONMENTAL HEALTH;GENETICS;GASTROENTEROLOGY;INTENSIVE CARE MEDICINE;IMMUNOLOGY;OBSTETRICS;PEDIATRICS;PSYCHIATRY;ENDOCRINOLOGY;GENERAL SURGERY;GYNECOLOGY;OPTICS;PALEONTOLOGY;UROLOGY","69;36;26;15;14;11;10;10;7;6;5;5;5;5;4;4;4;4;4;4","CANCER;MYOCARDIAL INFARCTION;POPULATION;ARTERY;CONFIDENCE INTERVAL;CORONARY ARTERY DISEASE;DISEASE;DISSECTION (MEDICAL);HEART FAILURE;PREGNANCY;COHORT;PROPORTIONAL HAZARDS MODEL;STENOSIS;ADVERSE EFFECT;CLINICAL TRIAL;ETIOLOGY;GENE;IMMUNE SYSTEM;INCIDENCE (GEOMETRY);REGIMEN","20;12;9;8;8;6;6;6;6;6;5;5;5;4;4;4;4;4;4;4","CORONARY ANGIOGRAPHY;HAZARD RATIO;ACUTE CORONARY SYNDROME;BREAST CANCER;COLORECTAL CANCER;ANGINA;EJECTION FRACTION;FETUS;GESTATION;PERCUTANEOUS CORONARY INTERVENTION;PERFORATION;ARTERIAL STIFFNESS;CERVICAL CANCER;CLINICAL ENDPOINT;CORONARY ARTERIES;DOCETAXEL;GESTATIONAL AGE;IMATINIB;LYMPHADENECTOMY;METASTASIS;REVASCULARIZATION;SCAD;SORAFENIB;T CELL;UNSTABLE ANGINA;VENTRICULAR REMODELING","7;7;6;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","ARTERY DISSECTION;COLONOSCOPY;BIORESORBABLE SCAFFOLD;CARDIAC RESYNCHRONIZATION THERAPY;DASATINIB;ESTROGEN RECEPTOR;LYMPHOCYTE SUBSETS;NILOTINIB;PLACENTA;RIGHT CORONARY ARTERY;ANDROGEN DEPRIVATION THERAPY;AORTIC VALVE REPAIR;APGAR SCORE;AXITINIB;BEDAQUILINE;CARDIAC SYNDROME X;CLADE;CORONARY ARTERY ECTASIA;CORONARY STEAL;CROSSOVER STUDY;CRYOGLOBULINEMIA;DISCOVERY AND DEVELOPMENT OF MTOR INHIBITORS;DRUG-ELUTING STENT;ELEPHANT TRUNKS;ERLOTINIB;FETAL GROWTH;FIBROMUSCULAR DYSPLASIA;GEFITINIB;GENEXPERT MTB/RIF;GESTATIONAL SAC;HPV INFECTION;HYPERTRIGLYCERIDEMIA;IMATINIB MESYLATE;IN SITU HYBRIDIZATION;LACHMAN TEST;LYMPHEDEMA;MASTECTOMY;MOLECULAR EPIDEMIOLOGY;MULTICENTER TRIAL;OSTEONECROSIS OF THE JAW;OXALIPLATIN;PARAMETRIUM;PAZOPANIB;PHILADELPHIA CHROMOSOME;RADICAL HYSTERECTOMY;SPONTANEOUS CONCEPTION;TAMOXIFEN;TIMI;TWIN PREGNANCY;UTERINE ARTERY;VESICOURETERAL REFLUX","4;3;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;;FEMALE;MIDDLE AGED;MALE;AGED;POSTOPERATIVE COMPLICATIONS;ITALY;VASCULAR DISEASES;TREATMENT OUTCOME;ADULT;CORONARY VESSEL ANOMALIES;LAPAROSCOPY;HYSTERECTOMY;RETROSPECTIVE STUDIES;AGED, 80 AND OVER;CORONARY VESSELS;LYMPH NODE EXCISION;TOMOGRAPHY, OPTICAL COHERENCE;PROSPECTIVE STUDIES","54;43;42;35;34;29;21;20;20;16;15;15;14;12;10;9;9;9;9;8","MANAGEMENT OF CARDIOVASCULAR DISEASES DURING PREGNANCY;ARTERIAL STIFFNESS AND CARDIOVASCULAR HEALTH;CARDIAC RESYNCHRONIZATION THERAPY IN HEART FAILURE;CLINICAL STUDIES ON CORONARY STENTS AND REVASCULARIZATION;DIAGNOSIS AND MANAGEMENT OF AORTIC DISEASES;DIAGNOSIS AND MANAGEMENT OF APPENDICITIS;DIAGNOSIS AND MANAGEMENT OF ECTOPIC PREGNANCY;EFFICACY AND RESISTANCE IN CML TREATMENT;EPIDEMIOLOGY AND TREATMENT OF HEAD AND NECK CANCER;GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS;HEPATITIS C INFECTION AND TREATMENT;INNOVATIONS IN TRANSGASTRIC SURGICAL TECHNIQUES;INTESTINAL MALROTATION AND OBSTRUCTION DISORDERS;MATERNAL MORBIDITY ASSOCIATED WITH PREGNANCY AND CHILDBIRTH;SURGICAL SIMULATION AND TRAINING TECHNIQUES;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;ADVANCEMENTS IN PROSTATE CANCER RESEARCH;ADVANCEMENTS IN TRANSPLANTATION PROCEDURES AND OUTCOMES;ADVANCES IN METABOLOMICS RESEARCH;ANKLE INJURIES AND DISORDERS IN SPORTS MEDICINE","6;4;3;3;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1","SPONTANEOUS CORONARY ARTERY DISSECTION;AORTIC DISSECTION;AORTIC ROOT REPLACEMENT;ARTERY DISSECTION;CARDIAC IMAGING;CORONARY ARTERY ANOMALIES;ETIOLOGY;INTRAVASCULAR ULTRASOUND;MYOCARDIAL BRIDGING;REGIMEN;AORTIC ANEURYSMS;CARDIAC RUPTURE;CARDIAC SUPPORT DEVICE;PERFORATION;TREATMENT;ARTERIAL STIFFNESS;BIORESORBABLE SCAFFOLD;CARDIAC RESYNCHRONIZATION THERAPY;CARDIOVASCULAR RISK ASSESSMENT;CLINICAL ENDPOINT","6;4;4;4;4;4;4;4;4;4;3;3;3;3;3;2;2;2;2;2","CORONARY ARTERY;SPONTANEOUS CORONARY;ARTERY DISSECTION;LOCALLY ADVANCED;ABNORMALLY INVASIVE;ACUTE CORONARY;ADVANCED BREAST;AORTIC VALVE;BIORESORBABLE VASCULAR;BIVENTRICULAR PACING;BREAST CANCER;CARDIAC RESYNCHRONIZATION;CELL CARCINOMA;ELDERLY PATIENTS;ERΑ EXPRESSION;ESTROGEN RECEPTOR-Α;ICD REPLACEMENT;IDENTIFIES RESPONDERS;INTRAVASCULAR IMAGING;INVASIVE PLACENTA;LIGAMENT RECONSTRUCTION;LYMPHOCYTE SUBSETS;MAGNETIC RESONANCE;MULTICENTER STUDY;MULTIPLE SCLEROSIS;NULLIPAROUS WOMEN;PACING IDENTIFIES;PLACENTA SCPAIPSCP;PRELIMINARY RESULTS;PROSPECTIVE SINGLE-CENTER","8;6;5;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","MPI SCORE;BILE DUCT;CD T-CELL;GESTATIONAL AGE;NEUROENDOCRINE TUMORS;ROMAN SERIFGTLTSPAN;SERIFGTLTSPAN STYLEFONT-SIZE;STYLEFONT-FAMILY TIMES;STYLEFONT-SIZE MEDIUMGTLTSPAN;ABDOMINAL PAIN;INTENSIVE CARE;MANUFACTURER CHANGE;MIR- MIR-;PREGNANCIES COMPLICATED;XPERT CARBA-R;BCG CONNAUGHT;CARBAPENEM RESISTANCE;COMMON BILE;CORONARY ARTERY;EVE EXE;FETAL GROWTH;GTLTSPAN STYLEFONT-FAMILY;ICD REPLACEMENT;LOCALLY ADVANCED;MEDIUMGTLTSPAN LANGEN-GBGT;RESPONSE RATE;STYLECOLOR GTLTSPAN;SUPPORTING INFORMATION;T-CELL COUNT;VASCULAR INVASION","8;7;7;7;7;6;6;6;6;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4",19,0.2,6,9.5,1,2,0,7.5,1,0,1,12.5,1,1,7.5,3,3,2,3,7.75,6.25,0,0,63,63,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,13,4.85,4294.38,7.3,3,0.23,48.92,0,0,0,0,2,0,1,10,0,4,9,0,0,0,0,0,0,11,2,0,13,0,0,0,0,0,0,0,0,0,"Italy;Japan;United States","4;2;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;42 HEALTH SCIENCES;52 PSYCHOLOGY;30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3207 MEDICAL MICROBIOLOGY;35 COMMERCE, MANAGEMENT, TOURISM AND SERVICES;3505 HUMAN RESOURCES AND INDUSTRIAL RELATIONS;4203 HEALTH SERVICES AND SYSTEMS;4205 NURSING;50 PHILOSOPHY AND RELIGIOUS STUDIES;5002 HISTORY AND PHILOSOPHY OF SPECIFIC FIELDS","12;9;4;2;2;1;1;1;1;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;DIGESTIVE DISEASES;NUTRITION;CANCER;HEMATOLOGY;PAIN RESEARCH;AUTOIMMUNE DISEASE;CHRONIC PAIN;PEDIATRIC;PREVENTION;RARE DISEASES;AGING;BEHAVIORAL AND SOCIAL SCIENCE;BREAST CANCER;CARDIOVASCULAR;CHRONIC LIVER DISEASE AND CIRRHOSIS;COMPARATIVE EFFECTIVENESS RESEARCH;COST EFFECTIVENESS RESEARCH;DIABETES","12;7;5;5;4;3;3;2;2;2;2;2;1;1;1;1;1;1;1;1","INFLAMMATORY AND IMMUNE SYSTEM;ORAL AND GASTROINTESTINAL;CANCER;INFECTION;METABOLIC AND ENDOCRINE","3;3;2;1;1","6.1 PHARMACEUTICALS;2.2 FACTORS RELATING TO THE PHYSICAL ENVIRONMENT;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;7.3 MANAGEMENT AND DECISION MAKING;8.1 ORGANISATION AND DELIVERY OF SERVICES","7;1;1;1;1","LEUKEMIA / LEUKAEMIA;BREAST CANCER;COLON AND RECTAL CANCER;ENDOMETRIAL CANCER;SARCOMA","2;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;5.7 RESOURCES AND INFRASTRUCTURE RELATED TO TREATMENT AND THE PREVENTION OF RECURRENCE;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","2;1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_GIACCONE",2017,122,14.7950819672131,3.05737704918033,0.368852459016393,0.344262295081967,0.524590163934426,1.75943396226415,1.32352941176471,1.68,1.25490196078431,0.639344262295082,4,50,25,15,12,0.41,0.2,0.12,0.1,19.66,0.667138807373743,4.86335403726709,0.172131147540984,0.860655737704918,0.467,0.366,0.339,0.401,"ANDREA CORTEGIANI;MARCELLO ARCA;CESARE GREGORETTI;MAURIZIO AVERNA;V. CALVARUSO;SANTI MAURIZIO RAINERI;VALERIA CENTO;S. CALANDRA;MASSIMO PUOTI;GIULIANO RIZZARDINI;M. MELIS;SERGIO BABUDIERI;M. ANGÉLICO;V.C. DI MAIO;GASPARE GULOTTA;FRANCESCA CECCHERINI‐SILBERSTEIN;GIUSTINO PARRUTI;VALERIA MICHELI;CARLO FEDERICO PERNO;ANTONIO CRAXÌ","11;9;9;8;7;7;6;6;6;6;6;6;6;6;6;6;6;6;6;6","GIUSEPPE SALAMONE;ANDREA CORTEGIANI;CESARE GREGORETTI;SANTI MAURIZIO RAINERI;VINCENZO RUSSOTTO;C CHIARAMONTE;GL MAURO;GASPARE GULOTTA;ANTONINO GIARRATANO;VINCENZO ARGANO;CALOGERA PISANO;ORESTE FABIO TRIOLO;CARLA GIORDANO;PASQUALE IOZZO;CAROLA BUSCEMI;SILVIO BUSCEMI;DAVIDE CORLEO;PASQUALE TOTARO;WALTER MAZZUCCO;EMANUELE AMODIO","2.19;1.69;1.2;1.15;1.02;1;1;0.81;0.77;0.7;0.7;0.7;0.64;0.57;0.53;0.53;0.53;0.5;0.49;0.48","ANDREA CORTEGIANI;CESARE GREGORETTI;MAURIZIO AVERNA;V. CALVARUSO;SANTI MAURIZIO RAINERI;GASPARE GULOTTA;ANTONIO CRAXÌ;VINCENZO RUSSOTTO;GIANFRANCO CIARAMITARO;CARLA GIORDANO;FRANCESCO PASSIGLIA;CAROLA BUSCEMI;GIUSEPPE SALAMONE;MARTA CASTIGLIA;ANTONINO GIARRATANO;NADIA BARRACO;SILVIO BUSCEMI;PASQUALE IOZZO;DAVIDE CORLEO;ANGELA LISTÌ","11;9;8;7;7;6;6;6;5;5;4;4;4;4;4;4;4;4;4;4","GIUSEPPE SALAMONE;ANDREA CORTEGIANI;CESARE GREGORETTI;SANTI MAURIZIO RAINERI;VINCENZO RUSSOTTO;C CHIARAMONTE;GL MAURO;GASPARE GULOTTA;ANTONINO GIARRATANO;VINCENZO ARGANO;CALOGERA PISANO;ORESTE FABIO TRIOLO;CARLA GIORDANO;PASQUALE IOZZO;CAROLA BUSCEMI;SILVIO BUSCEMI;DAVIDE CORLEO;PASQUALE TOTARO;FRANCESCO VITALE;MARIA ROSARIA VALERIO","2.19;1.69;1.2;1.15;1.02;1;1;0.81;0.77;0.7;0.7;0.7;0.64;0.57;0.53;0.53;0.53;0.5;0.47;0.46","MARCELLO ARCA;MAURIZIO AVERNA;S. CALANDRA;ALICE MULÈ;ANDREA TORTELLI;ANDREÏ SZÖKE;ANTONIO LASALVIA;BART P. F. RUTTEN;CAITLIN TURNER;CELSO ARANGO;CHARLOTTE GAYER‐ANDERSON;CRAIG MORGAN;CRISTINA MARTA DEL‐BEN;DIEGO QUATTRONE;DOMENICO BERARDI;EVA VELTHORST;HANNAH E. JONGSMA;ILARIA TARRICONE;JAMES B. KIRKBRIDE;JEAN‐PAUL SELTEN","533;422;399;289;288;288;288;288;288;288;288;288;288;288;288;288;288;288;288;288","ALICE MULÈ;FRANCESCO VITALE;FABIO TRAMUTO;MAURIZIO AVERNA;CESARE GREGORETTI;ANDREA CORTEGIANI;DAVIDE CORLEO;SANTI MAURIZIO RAINERI;GASPARE GULOTTA;ANTONINO GIARRATANO;ELISA ZAMBAITI;VINCENZO RUSSOTTO;V. CALVARUSO;ANTONIO CRAXÌ;MASSIMO MIDIRI;ANNA MARIA BARILE;CARLA GIORDANO;CAROLA BUSCEMI;GIUSEPPE ROSAFIO;SILVIO BUSCEMI","289;231;228;226;203;182;145;144;137;127;120;112;105;104;92;90;90;90;90;90","ANDREA CORTEGIANI;CESARE GREGORETTI;ANTONINO GIARRATANO;SANTI MAURIZIO RAINERI;V. CALVARUSO;VINCENZO RUSSOTTO;GASPARE GULOTTA;ANTONIO CRAXÌ;GIANFRANCO CIARAMITARO;MAURIZIO AVERNA;ANGELA LISTÌ;ANTONIO RUSSO;DAVIDE CORLEO;FRANCESCO PASSIGLIA;GIUSEPPE SALAMONE;MARTA CASTIGLIA;NADIA BARRACO;PASQUALE IOZZO;PROVVIDENZA DAMIANI;GRÉGORIO SCERRINO","10;9;7;7;7;6;6;6;5;5;4;4;4;4;4;4;4;4;4;3","MEDICINE;BIOLOGY;COMPUTER SCIENCE;PHYSICS;CHEMISTRY;MATHEMATICS;GEOGRAPHY;POLITICAL SCIENCE;PSYCHOLOGY;ENGINEERING;ECONOMICS;MATERIALS SCIENCE;PHILOSOPHY;SOCIOLOGY;BUSINESS;ENVIRONMENTAL SCIENCE;HISTORY","118;25;8;6;5;5;4;4;4;3;2;2;2;2;1;1;1","INTERNAL MEDICINE;SURGERY;CARDIOLOGY;ONCOLOGY;PATHOLOGY;ENVIRONMENTAL HEALTH;RADIOLOGY;INTENSIVE CARE MEDICINE;GENETICS;IMMUNOLOGY;BIOCHEMISTRY;GASTROENTEROLOGY;PHYSICAL THERAPY;VIROLOGY;DERMATOLOGY;FAMILY MEDICINE;NURSING;ENDOCRINOLOGY;CANCER RESEARCH;PALEONTOLOGY","88;32;20;17;17;16;14;12;11;11;10;10;9;9;8;8;8;7;6;6","CANCER;POPULATION;DISEASE;CHEMOTHERAPY;COHORT;GENE;RANDOMIZED CONTROLLED TRIAL;CLINICAL TRIAL;CONFIDENCE INTERVAL;REGIMEN;ALTERNATIVE MEDICINE;DIABETES MELLITUS;MYOCARDIAL INFARCTION;BIOMARKER;RANGE OF MOTION;VIRUS;ADVERSE EFFECT;ANTIFUNGAL;CHOLESTEROL;CONTEXT (ARCHAEOLOGY);EPIDEMIOLOGY;HEART FAILURE;ISCHEMIA;MAGNETIC RESONANCE IMAGING;MORTALITY RATE;MYELOID LEUKEMIA;RESUSCITATION","25;15;13;10;9;9;9;7;7;7;6;6;6;5;5;5;4;4;4;4;4;4;4;4;4;4;4","COLORECTAL CANCER;CLINICAL ENDPOINT;INFLAMMATORY BOWEL DISEASE;BREAST CANCER;PROGRESSION-FREE SURVIVAL;FLUCONAZOLE;IMATINIB;ANTIFUNGAL DRUGS;CARDIOPULMONARY RESUSCITATION;HEPATITIS C VIRUS;PHASES OF CLINICAL RESEARCH;TYPE 2 DIABETES;ULCERATIVE COLITIS;ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION;AORTIC VALVE REPLACEMENT;CARDIAC MAGNETIC RESONANCE;CARDIAC MAGNETIC RESONANCE IMAGING;CARDIOMYOPATHY;CHEMOTHERAPY REGIMEN;COMPUTED TOMOGRAPHIC;COMPUTED TOMOGRAPHIC ANGIOGRAPHY;CORONARY ANGIOGRAPHY;DOCETAXEL;ENZYME REPLACEMENT THERAPY;FABRY DISEASE;FAMILIAL HYPERCHOLESTEROLEMIA;FIXATION (POPULATION GENETICS);GENOTYPE;GIST;HAZARD RATIO;HEAD AND NECK CANCER;IMMUNIZATION;MESENTERIC ISCHEMIA;METASTASIS;OSTEOARTHRITIS;OVERWEIGHT;PACLITAXEL;PROGRESSIVE DISEASE;RETURN TO SPORT;SPLENECTOMY;TOLERABILITY;TRIGLYCERIDE;UNIVARIATE ANALYSIS","10;7;6;5;5;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","IMATINIB MESYLATE;INVASIVE CANDIDIASIS;HEPACIVIRUS;RESPONSE EVALUATION CRITERIA IN SOLID TUMORS;BASIC LIFE SUPPORT;CETUXIMAB;HYPERTRIGLYCERIDEMIA;INFLAMMATORY BOWEL DISEASES;LACHMAN TEST;OXALIPLATIN;PIVOT-SHIFT TEST;RIBAVIRIN;TAXANE;ABL;ACTIVE TUBERCULOSIS;ANTHRACYCLINE;ANTIGENIC DRIFT;ANTIRETROVIRAL THERAPY;AROMATASE;BENDAMUSTINE;CAPECITABINE;CERVICAL INTRAEPITHELIAL NEOPLASIA;CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY;COLONOSCOPY;COMPOUND HETEROZYGOSITY;CONTROLLED OVARIAN HYPERSTIMULATION;CORONAVIRUS DISEASE 2019 (COVID-19);DIROFILARIA;ESTROGEN RECEPTOR;FACET (PSYCHOLOGY);FUNNEL PLOT;GENOTYPING;GLOBOTRIAOSYLCERAMIDE;GLYCATED HEMOGLOBIN;GOLIMUMAB;GONADOTROPIN-RELEASING HORMONE;HEAD AND NECK SQUAMOUS-CELL CARCINOMA;HEART-TYPE FATTY ACID BINDING PROTEIN;HETEROZYGOTE ADVANTAGE;HORMONE ANTAGONIST;INNATE LYMPHOID CELL;INTRACYTOPLASMIC SPERM INJECTION;IRINOTECAN;KRAS;LATENT TUBERCULOSIS;LDL RECEPTOR;LONG NON-CODING RNA;MASTECTOMY;MEN WHO HAVE SEX WITH MEN;METASTATIC BREAST CANCER;MISSENSE MUTATION;MYOCARDIAL REPERFUSION INJURY;NIVOLUMAB;NORMAL WEIGHT;NS3;OVARIAN HYPERSTIMULATION SYNDROME;PDGFRA;PILON FRACTURE;PNEUMOCOCCAL CONJUGATE VACCINE;PNEUMOCOCCAL INFECTIONS;PNEUMOCOCCAL VACCINE;PREDIABETES;SAPS II;SENTINEL LYMPH NODE;SENTINEL NODE;SONOPORATION;SPLENIC DISEASE;SPLENIC MARGINAL ZONE LYMPHOMA;THEAFLAVIN;VEDOLIZUMAB;VESICOURETERAL REFLUX","4;4;3;3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;;FEMALE;MALE;MIDDLE AGED;AGED;ADULT;ITALY;AGED, 80 AND OVER;OBESITY;TREATMENT OUTCOME;ADOLESCENT;RISK FACTORS;YOUNG ADULT;HYPERLIPOPROTEINEMIA TYPE II;RETROSPECTIVE STUDIES;ATHEROSCLEROSIS;HYPERTENSION;INFLAMMATORY BOWEL DISEASES;DIABETES MELLITUS, TYPE 2","62;60;46;44;34;25;22;21;14;14;14;11;11;11;10;10;9;9;9;8","HEPATITIS C INFECTION AND TREATMENT;DIAGNOSIS AND MANAGEMENT OF FUNGAL INFECTIONS;MANAGEMENT OF CARDIAC ARREST AND RESUSCITATION;MANAGEMENT OF VALVULAR HEART DISEASE;EFFICACY AND RESISTANCE IN CML TREATMENT;GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;ADVANCEMENTS IN COLORECTAL CANCER RESEARCH;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;CARDIAC RESYNCHRONIZATION THERAPY IN HEART FAILURE;CHOLESTEROL-LOWERING TREATMENT;COMPLICATIONS AND TECHNIQUES IN THYROID SURGERY;DIAGNOSIS AND MANAGEMENT OF HYPERTROPHIC CARDIOMYOPATHY;GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS;GENOMIC LANDSCAPE OF CANCER AND MUTATIONAL SIGNATURES;LIPID METABOLISM AND CARDIOVASCULAR DISEASE;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;MANAGEMENT OF MESENTERIC ISCHEMIA AND ANEURYSMS;MANAGEMENT OF SPLEEN TRAUMA IN POLYTRAUMA PATIENTS","6;4;4;4;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2","CLINICAL ENDPOINT;REGIMEN;PROGRESSION-FREE SURVIVAL;ANTIFUNGAL RESISTANCE;ANTIFUNGAL THERAPY;CARDIAC IMAGING;CPR QUALITY;IMATINIB MESYLATE;INVASIVE CANDIDIASIS;ANTIFUNGAL DRUGS;ANTIVIRAL THERAPY;NS5A;PROSTHETIC VALVES EVALUATION;TRANSCATHETER AORTIC-VALVE REPLACEMENT;ANTERIOR CRUCIATE LIGAMENT;AORTIC ROOT REPLACEMENT;ATRIOVENTRICULAR BLOCK;BOWEL RESECTION;CANCER THERAPY;CARDIAC MAGNETIC RESONANCE","7;7;5;4;4;4;4;4;4;3;3;3;3;3;2;2;2;2;2;2","INFLAMMATORY BOWEL;COLORECTAL CANCER;COMPUTED TOMOGRAPHIC;MAGNETIC RESONANCE;BOWEL DISEASE;BREAST CANCER;CARDIAC MAGNETIC;CORONARY ARTERY;CRITICALLY ILL;ILL PATIENTS;INVASIVE FUNGAL;OBESE PATIENTS;RANDOMIZED PHASE;ABCD STUDY;ACCESS VERSUS;ANTERIOR CRUCIATE;AORTIC VALVE;ARTERY DISEASE;ATRIOVENTRICULAR BLOCK;BIOLOGICAL THERAPY;BLOCK RESULTS;BOWEL DISEASES;CANCER PATIENTS;CARDIAC COMPLICATIONS;CARDIAC DEATH;CARE UNIT;COLON CANCER;CONTRALATERAL HAMSTRING;CONVENTIONAL AORTIC;CORONARY COMPUTED","5;4;4;4;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","ADJUVANT CHEMOTHERAPY;BREAST CANCER;CHEST COMPRESSIONS;OBESE PATIENTS;INTENSIVE CARE;PSYCHOTIC DISORDERS;RATE CONTROL;DIABETIC FOOT;PATIENTS UNDERGOING;PRIMARY MALIGNANCIES;TTP MONTHS;CLINICAL PRACTICE;GIST PATIENTS;HEMORRHAGIC TRANSFORMATION;MEDIAN AGE;ACTIVE TB;ALL-CAUSE DEATH;ANNUAL PERCENT;CD PATIENTS;MEDIAN PFS;PATHOGENIC VARIANTS;PATIENTS AFFECTED;PATIENTS RECEIVING;PATIENTS UNDERWENT;RHYTHM CONTROL;STATISTICALLY SIGNIFICANT;SURVIVAL OS;ANAPLUS HP;CANCER TREATED;CHRONIC MYELOID","10;10;10;10;9;9;9;8;8;8;8;7;7;7;7;6;6;6;6;6;6;6;6;6;6;6;6;5;5;5",37,0.3,2.85,4,1.25,2,2,54.5,2,0,1,6,1,0,3,0,1,1,1,3,2.75,0,0,64,64,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,20,3.75,395.15,10.1,4,0.2,37.85,0,0,4,0,4,0,1,11,0,13,7,0,0,0,0,0,0,19,1,0,20,0,0,0,0,0,0,0,0,0,"Italy;United Kingdom;United States","10;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;42 HEALTH SCIENCES;4205 NURSING;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY;30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;3006 FOOD SCIENCES;3212 OPHTHALMOLOGY AND OPTOMETRY;3213 PAEDIATRICS;4203 HEALTH SERVICES AND SYSTEMS;50 PHILOSOPHY AND RELIGIOUS STUDIES","18;13;4;3;2;2;2;1;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;RARE DISEASES;DIGESTIVE DISEASES;NUTRITION;PATIENT SAFETY;LIVER DISEASE;BEHAVIORAL AND SOCIAL SCIENCE;CARDIOVASCULAR;CHRONIC LIVER DISEASE AND CIRRHOSIS;CHRONIC PAIN;GENETICS;HEMATOLOGY;PAIN RESEARCH;AGING;ATHEROSCLEROSIS;BIOMEDICAL IMAGING;BREAST CANCER;COMPARATIVE EFFECTIVENESS RESEARCH","19;7;6;6;5;5;4;3;2;2;2;2;2;2;2;1;1;1;1;1","CANCER;ORAL AND GASTROINTESTINAL;CARDIOVASCULAR;EYE;INFLAMMATORY AND IMMUNE SYSTEM","5;4;1;1;1","6.1 PHARMACEUTICALS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;7.1 INDIVIDUAL CARE NEEDS;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;6.2 CELLULAR AND GENE THERAPIES;8.4 RESEARCH DESIGN AND METHODOLOGIES (HEALTH SERVICES)","10;2;2;1;1;1","BREAST CANCER;HEAD AND NECK CANCER;LEUKEMIA / LEUKAEMIA;LUNG CANCER;MYELOMA;ORAL CAVITY AND LIP CANCER;PHARYNGEAL CANCER;SALIVARY GLAND CANCER;SARCOMA","2;1;1;1;1;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","3;2",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,6,"PUBLIC LIBRARY OF SCIENCE","6","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3202 CLINICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;3204 IMMUNOLOGY;33 BUILT ENVIRONMENT AND DESIGN","5;2;2;1;1;1","INFECTIOUS DISEASES;BEHAVIORAL AND SOCIAL SCIENCE;CHRONIC LIVER DISEASE AND CIRRHOSIS;CLINICAL RESEARCH;DIGESTIVE DISEASES;EMERGING INFECTIOUS DISEASES;HEPATITIS;HEPATITIS - C;HIV/AIDS;LIVER DISEASE;PEDIATRIC;PEDIATRIC AIDS;PREVENTION","2;1;1;1;1;1;1;1;1;1;1;1;1","INFECTION","3","5.1 PHARMACEUTICALS;6.1 PHARMACEUTICALS","1;1","HEALTH SERVICES & SYSTEMS","1","CLINICAL MEDICINE AND SCIENCE;PUBLIC HEALTH","2;1","LIVER CANCER","2","3 GOOD HEALTH AND WELL BEING","1"
"AOUSSN_GIACCONE",2018,116,15.3965517241379,2.68965517241379,0.387931034482759,0.301724137931034,0.491379310344828,1.59183673469388,1.21621621621622,1.34615384615385,1.1875,0.620689655172414,0,53,35,11,6,0.46,0.3,0.09,0.05,22.47,0.736657618207902,4.72559366754617,0.267241379310345,0.887931034482759,0.416,0.413,0.447,0.414,"ANDREA CORTEGIANI;CESARE GREGORETTI;DANIELE ANDREINI;ANTONIO L. BARTORELLI;MAURO PEPI;ANTONINO GIARRATANO;MARK RABBAT;GIANLUCA PONTONE;ANDREA IGOREN GUARICCI;ANTONIO CRAXÌ;AMBROGIO ORLANDO;FABIO FAZZARI;V. CALVARUSO;MARCO GUGLIELMO;EDOARDO CONTE;GIUSEPPE MUSCOGIURI;FABIO SALVATORE MACALUSO;GASPARE GULOTTA;ANDREA BAGGIANO;SAIMA MUSHTAQ","15;8;7;7;7;7;7;7;7;7;6;6;6;6;6;6;6;6;6;6","ANDREA CORTEGIANI;CESARE GREGORETTI;GASPARE GULOTTA;ALBERTO FIRENZE;OMAR ENZO SANTANGELO;SANDRO PROVENZANO;ANDRZEJ L. KOMOROWSKI;MARCO V. MARINO;ANTONINO GIARRATANO;DARIO PIAZZA;SALVATORE NOVO;SANTI MAURIZIO RAINERI;EGLE CORRADO;GALYNA SHABAT;FRANCESCO DISPENZA;SEBASTIANO MERCADANTE;VINCENZO ARGANO;DAVIDE PIRAINO;ANTONIO CASCIO;SALVATORE GALLINA","2.36;1.25;1.18;1;1;1;0.98;0.98;0.95;0.86;0.79;0.68;0.67;0.65;0.61;0.6;0.58;0.55;0.55;0.53","ANDREA CORTEGIANI;CESARE GREGORETTI;ANTONINO GIARRATANO;ANTONIO CRAXÌ;FABIO FAZZARI;V. CALVARUSO;GASPARE GULOTTA;V. DI MARCO;ANTONIO CASCIO;MARIA CAPPELLO;DAVIDE PIRAINO;GIOVANNI MAZZOLA;VINCENZO ARGANO;SALVATORE NOVO;SALVATORE PETTA;MARCO V. MARINO;SANTI MAURIZIO RAINERI;NADIA CACCAMO;DARIO PIAZZA;EGLE CORRADO","15;8;7;7;6;6;6;5;5;5;4;4;4;4;4;4;4;4;4;3","ANDREA CORTEGIANI;CESARE GREGORETTI;GASPARE GULOTTA;MARCO V. MARINO;ANTONINO GIARRATANO;DARIO PIAZZA;SALVATORE NOVO;SANTI MAURIZIO RAINERI;EGLE CORRADO;GALYNA SHABAT;FRANCESCO DISPENZA;VINCENZO ARGANO;DAVIDE PIRAINO;ANTONIO CASCIO;SALVATORE GALLINA;FRANCESCO LORUSSO;GIOVANNI CORSELLO;FILIPPO VITALE;INA MACAIONE;EUGENIO FIORENTINO","2.36;1.25;1.18;0.98;0.95;0.86;0.79;0.68;0.67;0.65;0.61;0.58;0.55;0.55;0.53;0.53;0.45;0.43;0.42;0.42","ANTONIO CRAXÌ;V. DI MARCO;SALVATORE PETTA;V. CALVARUSO;GIOVANNI MAZZOLA;TULLIO PRESTILEO;A. AVERNA;A. DAVÌ;A. DIGIACOMO;CALOGERO CAMMÀ;CARMELO IACOBELLO;F. CARTABELLOTTA;GAETANO BERTINO;GIOVANNI RAIMONDO;IRENE CACCIOLA;MARCO DISTEFANO;MAURIZIO RUSSELLO;LYDIA GIANNITRAPANI;ANNA LICATA;F. BENANTI","780;743;738;698;657;657;652;652;652;652;652;652;652;652;652;652;652;649;646;646","GIOVANNI MAZZOLA;LYDIA GIANNITRAPANI;ANNA LICATA;ANDREA CORTEGIANI;ANTONINO GIARRATANO;FABIO FAZZARI;GIANFRANCO COCORULLO;CESARE GREGORETTI;GASPARE GULOTTA;MARCO PIO LA MANNA;VALENTINA ORLANDO;MARIA CAPPELLO;NADIA CACCAMO;SILVIO BUSCEMI;WALTER MAZZUCCO;SANTI MAURIZIO RAINERI;FRANCESCO DIELI;GUIDO SIRECI;GIULIA LETIZIA MAURO;GIUSEPPE SALEMI","652;649;646;392;314;260;258;252;140;111;111;92;89;86;75;72;61;61;60;57","ANDREA CORTEGIANI;CESARE GREGORETTI;ANTONINO GIARRATANO;GASPARE GULOTTA;FABIO FAZZARI;MARIA CAPPELLO;ANTONIO CRAXÌ;DARIO PIAZZA;DAVIDE PIRAINO;SANTI MAURIZIO RAINERI;VINCENZO ARGANO;FABIO TRIOLO;SALVATORE NOVO;FILIPPO VITALE;GIANFRANCO COCORULLO;GIOVANNI MAZZOLA;MARCO PIO LA MANNA;PASQUALE IOZZO;VALENTINA ORLANDO;LYDIA GIANNITRAPANI","15;8;7;6;6;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3","MEDICINE;BIOLOGY;COMPUTER SCIENCE;ENGINEERING;PHYSICS;PSYCHOLOGY;CHEMISTRY;POLITICAL SCIENCE;MATHEMATICS;SOCIOLOGY;ECONOMICS;PHILOSOPHY;HISTORY;MATERIALS SCIENCE","114;21;14;7;7;7;6;6;5;5;3;3;1;1","INTERNAL MEDICINE;SURGERY;CARDIOLOGY;GASTROENTEROLOGY;RADIOLOGY;ENVIRONMENTAL HEALTH;PSYCHIATRY;IMMUNOLOGY;PATHOLOGY;GENETICS;PEDIATRICS;ANESTHESIA;INTENSIVE CARE MEDICINE;VIROLOGY;ONCOLOGY;GENERAL SURGERY;NUCLEAR MEDICINE;LAW;NURSING;ARTIFICIAL INTELLIGENCE;BIOCHEMISTRY;CLINICAL PSYCHOLOGY;DEMOGRAPHY;EMERGENCY MEDICINE;MECHANICAL ENGINEERING;OPTICS;PHYSICAL THERAPY","74;34;19;15;15;13;13;12;11;10;10;9;9;9;8;7;7;6;6;5;5;5;5;5;5;5;5","CANCER;POPULATION;DISEASE;COHORT;GENE;MYOCARDIAL INFARCTION;HEART FAILURE;VIRUS;OBSERVATIONAL STUDY;RANDOMIZED CONTROLLED TRIAL;RETROSPECTIVE COHORT STUDY;ADVERSE EFFECT;ANTIBODY;ANESTHESIOLOGY;CHEMOTHERAPY;HEPATITIS C;INCIDENCE (GEOMETRY);LUNG;MAGNETIC RESONANCE IMAGING;PALLIATIVE CARE;ROBOTIC SURGERY;VENTILATION (ARCHITECTURE)","14;12;10;9;8;8;7;7;6;6;6;5;5;4;4;4;4;4;4;4;4;4","CLINICAL ENDPOINT;PERCUTANEOUS CORONARY INTERVENTION;CROHN'S DISEASE;GENOTYPE;HEPATITIS C VIRUS;INFLAMMATORY BOWEL DISEASE;ADALIMUMAB;CARDIOMYOPATHY;COMPUTED TOMOGRAPHY ANGIOGRAPHY;EJECTION FRACTION;INFORMED CONSENT;MEASLES;NEUTROPENIA;REVASCULARIZATION;TOLERABILITY;ULCERATIVE COLITIS;AORTIC ARCH;AORTIC DISSECTION;BISPHOSPHONATE;BREAST CANCER;CARDIOPULMONARY RESUSCITATION;CISPLATIN;COLORECTAL CANCER;CONVENTIONAL PCI;CORONARY ANGIOGRAPHY;DIMETHYL FUMARATE;DOCETAXEL;FINGOLIMOD;GLATIRAMER ACETATE;HEPATECTOMY;IMAGE QUALITY;IMMUNIZATION;INFLIXIMAB;LIVER FIBROSIS;MYCOBACTERIUM TUBERCULOSIS;MYOCARDIAL PERFUSION IMAGING;PERFUSION SCANNING;POSITIVE PREDICATIVE VALUE;PROSTATE CANCER;REFLUX;T CELL","6;5;4;4;4;4;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","RUBELLA;CARBOPLATIN;FRACTIONAL FLOW RESERVE;HEPACIVIRUS;OSTEONECROSIS OF THE JAW;POUCHITIS;TAKOTSUBO SYNDROME;TERIFLUNOMIDE;TRANSIENT ELASTOGRAPHY;VEDOLIZUMAB;ACUTE PULMONARY EDEMA;AEDES ALBOPICTUS;ANTIVIRAL THERAPY;ANTIVIRAL TREATMENT;AROMATASE;BASIC LIFE SUPPORT;BENDAMUSTINE;BENTALL PROCEDURE;BONE METASTASIS;BOOSTER DOSE;BRACHIOCEPHALIC ARTERY;CAPECITABINE;DELTA-9-TETRAHYDROCANNABINOL;DEPERSONALIZATION;DNA METHYLATION;ESOPHAGITIS;EXHALED NITRIC OXIDE;FEBRILE NEUTROPENIA;GADOXETIC ACID;GERD;GOLIMUMAB;HAPLOTYPE;HIATAL HERNIA;HIV ANTIGENS;HYPOPNEA;IRINOTECAN;LARYNGOPHARYNGEAL REFLUX;LATENT TUBERCULOSIS;MAMMOGRAPHY;MEASLES VACCINE;MEASLES VIRUS;MIGRAINE WITH AURA;MOLECULAR EPIDEMIOLOGY;NEUROGENIC CLAUDICATION;NONALCOHOLIC FATTY LIVER DISEASE;NS3;PEMETREXED;PERIPARTUM CARDIOMYOPATHY;PRASUGREL;PRIMARY MOTOR CORTEX;REFLUX ESOPHAGITIS;RIBAVIRIN;SANGER SEQUENCING;SPLENIC MARGINAL ZONE LYMPHOMA;SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS;TARGET CONTROLLED INFUSION;TETRAHYDROCANNABINOL;TIMI;UVULOPALATOPHARYNGOPLASTY;VECTOR (MOLECULAR BIOLOGY)","3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;;MIDDLE AGED;AGED;ADULT;ITALY;TREATMENT OUTCOME;PROSPECTIVE STUDIES;ST ELEVATION MYOCARDIAL INFARCTION;LIVER CIRRHOSIS;RETROSPECTIVE STUDIES;AGED, 80 AND OVER;CORONARY ARTERY DISEASE;YOUNG ADULT;NEOPLASMS;ROBOTIC SURGICAL PROCEDURES;REPRODUCIBILITY OF RESULTS;BIOMARKERS","66;52;52;50;39;33;30;23;17;16;16;13;13;12;12;11;10;10;9;8","ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;HEPATITIS C INFECTION AND TREATMENT;MECHANICAL VENTILATION IN RESPIRATORY FAILURE AND ARDS;CLINICAL STUDIES ON CORONARY STENTS AND REVASCULARIZATION;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;HEPATOCELLULAR CARCINOMA;INTEGRATION OF PALLIATIVE CARE IN END-OF-LIFE;ADVANCEMENTS IN PROSTATE CANCER RESEARCH;DIAGNOSIS AND MANAGEMENT OF AORTIC DISEASES;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;FACTORS AFFECTING VACCINE HESITANCY AND ACCEPTANCE;GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS;MANAGEMENT OF CARDIAC ARREST AND RESUSCITATION;NATURAL KILLER CELLS IN IMMUNITY;PATHOPHYSIOLOGY AND CLINICAL CHARACTERISTICS OF STRESS-INDUCED CARDIOMYOPATHY;PEDIATRIC CANCER AND QUALITY OF LIFE;SLEEP-DISORDERED BREATHING AND HEALTH OUTCOMES;SURGICAL VENTRICULAR RECONSTRUCTION IN MYOCARDIAL INFARCTION;TUBERCULOSIS","6;5;5;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2","CARDIAC IMAGING;CARDIOVASCULAR RISK ASSESSMENT;CLINICAL ENDPOINT;COMPUTED TOMOGRAPHY ANGIOGRAPHY;HEPATITIS C;CANCER INCIDENCE;DISCONTINUATION;NONINVASIVE VENTILATION;ST-SEGMENT ELEVATION;TOLERABILITY;TREATMENT;ADVANCED LIFE SUPPORT;ANTIVIRAL THERAPY;AORTIC DISSECTION;CARBOPLATIN;CARDIOVASCULAR MRI;COMPUTED TOMOGRAPHY;CONCOMITANT;CPR QUALITY;DEPRESSION","8;6;6;5;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2","COMPUTED TOMOGRAPHY;MYOCARDIAL INFARCTION;ARTERY DISEASE;CORONARY ARTERY;INFLAMMATORY BOWEL;STRESS COMPUTED;UNIVERSITY STUDENTS;ACTIVE IMMUNIZATION;ADOPTED CHILDREN;ADVANCED CANCER;BOWEL DISEASE;CANCER PATIENTS;CARDIOPULMONARY RESUSCITATION;CARE UNIT;CHILDREN SURVEYED;CLINICAL PRACTICE;CORONARY COMPUTED;CROHNS DISEASE;DEPRESSIVE SYMPTOMATOLOGY;DIMETHYL FUMARATE;ELEVATION MYOCARDIAL;HYPOXEMIC PATIENTS;IMAGE QUALITY;IMMUNIZATION STATUS;INTERNATIONALLY ADOPTED;MAGNETIC RESONANCE;MEASLES MUMPS;MUMPS RUBELLA;NON-NAÏVE PATIENTS;NONINVASIVE VENTILATION","5;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","POSITIVE PREDICTIVE;PALLIATIVE CARE;PREDICTIVE VALUES;CD T-CELLS;DEPRESSIVE SYMPTOMATOLOGY;INTENSIVE CARE;PATIENTS UNDERWENT;ACTIVE TB;COMPUTED TOMOGRAPHY;MAGNETIC RESONANCE;RISK FACTORS;SENSITIVITY SPECIFICITY;STATISTICALLY SIGNIFICANT;ACUTE RESPIRATORY;AOR CI;IRON OVERLOAD;OBSERVATIONAL STUDY;RESPIRATORY FAILURE;ADVERSE EVENTS;CANCER PATIENTS;CARE UNIT;CERVICAL CANCER;DIAGNOSTIC ACCURACY;HYPOXEMIC PATIENTS;IMMUNOCOMPROMISED PATIENTS;LOCAL NECK;NECK SYMPTOMS;NEGATIVE PREDICTIVE;NON-NAÏVE PATIENTS;PROPENSITY SCORE","12;9;9;8;8;8;8;7;7;7;7;7;7;6;6;6;6;6;5;5;5;5;5;5;5;5;5;5;5;5",52,0.45,9.31,10.25,1,1,1,1,0,0,1,12,0,0,10.25,1,1,2.5,3,8,5,0,0,67,69.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,16,2.38,1596.08,8.6,6,0.38,94.19,0,0,0,0,7,1,0,8,0,12,1,0,0,0,0,0,0,15,1,0,12,3,0,1,0,0,0,0,0,0,"Italy;United States","5;4","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY;31 BIOLOGICAL SCIENCES;3107 MICROBIOLOGY;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3207 MEDICAL MICROBIOLOGY;3210 NUTRITION AND DIETETICS;3211 ONCOLOGY AND CARCINOGENESIS;3212 OPHTHALMOLOGY AND OPTOMETRY;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;42 HEALTH SCIENCES;5203 CLINICAL AND HEALTH PSYCHOLOGY","16;9;3;2;1;1;1;1;1;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;NUTRITION;PREVENTION;AGING;DIABETES;DIGESTIVE DISEASES;BIOENGINEERING;BRAIN DISORDERS;CARDIOVASCULAR;CHRONIC PAIN;COMPLEMENTARY AND INTEGRATIVE HEALTH;EMERGING INFECTIOUS DISEASES;INFECTIOUS DISEASES;NEURODEGENERATIVE;OBESITY;PAIN RESEARCH;ACQUIRED COGNITIVE IMPAIRMENT;ALZHEIMER'S DISEASE;ALZHEIMER'S DISEASE INCLUDING ALZHEIMER'S DISEASE RELATED DEMENTIAS (AD/ADRD)","13;8;5;5;3;3;3;2;2;2;2;2;2;2;2;2;2;1;1;1","INFECTION;CANCER;CARDIOVASCULAR;INFLAMMATORY AND IMMUNE SYSTEM;METABOLIC AND ENDOCRINE;ORAL AND GASTROINTESTINAL;EYE;MENTAL HEALTH;MUSCULOSKELETAL;NEUROLOGICAL;RESPIRATORY;STROKE","3;2;2;2;2;2;1;1;1;1;1;1","6.1 PHARMACEUTICALS;5.1 PHARMACEUTICALS;6.4 SURGERY;6.6 PSYCHOLOGICAL AND BEHAVIOURAL","9;1;1;1","LIVER CANCER;BREAST CANCER;OVARIAN CANCER","2;1;1","2.1 EXOGENOUS FACTORS IN THE ORIGIN AND CAUSE OF CANCER","1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_GIACCONE",2019,108,17.2592592592593,2.53703703703704,0.296296296296296,0.305555555555556,0.342592592592593,1.59302325581395,1.33333333333333,1.57142857142857,1.27586206896552,0.564814814814815,0,33,39,9,13,0.31,0.36,0.08,0.12,15.52,0.638178659742166,5.01385681293302,0.240740740740741,0.907407407407407,0.49,0.43,0.377,0.415,"SERGIO SIRAGUSA;VINCENZO ACCURSO;MARCO SANTORO;ANDREA CORTEGIANI;ANTONIO RUSSO;SIMONA RASO;V. CALVARUSO;ANTONIO CRAXÌ;GIUSEPPINA NOVO;ANTONELLA MELONI;SALVATRICE MANCUSO;FRANCESCO DI RAIMONDO;RODOLFO MAUCERI;MARIASANTA NAPOLITANO;V. DI MARCO;LAURA PISTOIA;GIULIA LETIZIA MAURO;OLGA DI FEDE;GIUSEPPINA CAMPISI;MELANIA CARLISI","11;10;8;8;7;6;6;6;6;5;5;5;5;5;5;5;5;5;5;5","SERGIO SIRAGUSA;VINCENZO ACCURSO;MARIASANTA NAPOLITANO;MARCO SANTORO;GIUSEPPINA NOVO;RODOLFO MAUCERI;GIUSEPPINA CAMPISI;GIULIA LETIZIA MAURO;FRANCESCO DISPENZA;SIMONA RASO;OLGA DI FEDE;ANDREA CORTEGIANI;SALVATORE NOVO;VERA PANZARELLA;ROBERTO CANNELLA;DALILA SCATURRO;EGLE CORRADO;ANTONIO RUSSO;F. DI PIAZZA;SALVATRICE MANCUSO","1.15;1;0.99;0.97;0.9;0.89;0.89;0.82;0.81;0.79;0.79;0.77;0.73;0.7;0.67;0.66;0.6;0.55;0.53;0.51","SERGIO SIRAGUSA;VINCENZO ACCURSO;MARCO SANTORO;ANDREA CORTEGIANI;ANTONIO RUSSO;SIMONA RASO;V. CALVARUSO;ANTONIO CRAXÌ;GIUSEPPINA NOVO;SALVATRICE MANCUSO;RODOLFO MAUCERI;MARIASANTA NAPOLITANO;V. DI MARCO;GIULIA LETIZIA MAURO;GIUSEPPINA CAMPISI;MELANIA CARLISI;ROBERTO CANNELLA;EGLE CORRADO;VERA PANZARELLA;ANNA LICATA","11;10;8;8;7;6;6;6;6;5;5;5;5;5;5;5;4;4;4;4","SERGIO SIRAGUSA;VINCENZO ACCURSO;MARIASANTA NAPOLITANO;MARCO SANTORO;GIUSEPPINA NOVO;RODOLFO MAUCERI;GIUSEPPINA CAMPISI;GIULIA LETIZIA MAURO;FRANCESCO DISPENZA;SIMONA RASO;ANDREA CORTEGIANI;SALVATORE NOVO;VERA PANZARELLA;ROBERTO CANNELLA;DALILA SCATURRO;EGLE CORRADO;ANTONIO RUSSO;SALVATRICE MANCUSO;G BIONDO;A. MAFFONGELLI","1.15;1;0.99;0.97;0.9;0.89;0.89;0.82;0.81;0.79;0.77;0.73;0.7;0.67;0.66;0.6;0.55;0.51;0.5;0.48","ANDREA CORTEGIANI;V. DI MARCO;ANTONIO CRAXÌ;F. CARTABELLOTTA;IRENE CACCIOLA;V. CALVARUSO;A. AVERNA;ANNA LICATA;CALOGERO CAMMÀ;GAETANO BERTINO;GIOVANNI RAIMONDO;GIOVANNI SQUADRITO;GIUSEPPE ALAIMO;GIUSEPPE MALIZIA;I. SCALISI;MARCO DISTEFANO;MAURIZIO RUSSELLO;SALVATORE MADONIA;SALVATORE PETTA;TULLIO PRESTILEO","280;210;209;209;209;209;208;208;208;208;208;208;208;208;208;208;208;208;208;208","ANDREA CORTEGIANI;ANNA LICATA;GIOVANNI MAZZOLA;SANTI MAURIZIO RAINERI;VINCENZO ACCURSO;SERGIO SIRAGUSA;GAETANA RINALDI;ANTONINO GIARRATANO;GIUSEPPINA NOVO;DAVIDE PIRAINO;GIULIA LETIZIA MAURO;DALILA SCATURRO;CESARE GREGORETTI;GIOVANNI MISSERI;A. CORTEGIANI;GIANFRANCO COCORULLO;TOMMASO FONTANA;ROBERTA TUTINO;SALVO STORNIOLO;SILVIA SARULLO","280;208;168;158;150;89;84;78;75;74;68;65;63;61;53;50;50;49;48;48","VINCENZO ACCURSO;ANDREA CORTEGIANI;SERGIO SIRAGUSA;GIULIA LETIZIA MAURO;ANTONINO GIARRATANO;DALILA SCATURRO;GAETANA RINALDI;GIUSEPPINA NOVO;SALVATORE NOVO;ANNA LICATA;ANGELO DAVIDE CONTRINO;CESARE GREGORETTI;FRANCESCO DISPENZA;GIOVANNI MISSERI;MASSIMO MIDIRI;ROBERTA TUTINO;ROBERTO CANNELLA;ANTONIO CRAXÌ;EMANUELE GRASSEDONIO;MELANIA CARLISI","9;8;7;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3","MEDICINE;BIOLOGY;PHYSICS;MATHEMATICS;COMPUTER SCIENCE;ENGINEERING;CHEMISTRY;MATERIALS SCIENCE;PSYCHOLOGY;SOCIOLOGY;ECONOMICS;GEOLOGY;POLITICAL SCIENCE;ART;HISTORY;PHILOSOPHY","108;21;15;8;7;7;5;5;5;5;4;2;2;1;1;1","INTERNAL MEDICINE;SURGERY;PATHOLOGY;ONCOLOGY;CARDIOLOGY;GASTROENTEROLOGY;RADIOLOGY;INTENSIVE CARE MEDICINE;ANESTHESIA;ENVIRONMENTAL HEALTH;IMMUNOLOGY;OPTICS;PEDIATRICS;GENETICS;NURSING;PALEONTOLOGY;VIROLOGY;BIOCHEMISTRY;DERMATOLOGY;EMERGENCY MEDICINE;PHYSICAL THERAPY;PSYCHIATRY;STATISTICS","80;31;19;17;15;14;13;12;9;9;9;8;8;7;7;7;7;6;6;6;6;6;6","CANCER;DISEASE;ADVERSE EFFECT;GENE;POPULATION;COHORT;HEART FAILURE;BLOOD PRESSURE;INCIDENCE (GEOMETRY);RANDOMIZED CONTROLLED TRIAL;PROSPECTIVE COHORT STUDY;MYELOID LEUKEMIA;MYOCARDIAL INFARCTION;THALASSEMIA;VIRUS;ARTERY;BONE MARROW;CHEMOTHERAPY;CIRRHOSIS;HEPATOCELLULAR CARCINOMA;MAGNETIC RESONANCE IMAGING;OBSERVATIONAL STUDY;ODDS RATIO;QUALITY OF LIFE (HEALTHCARE);REGIMEN;SINGLE CENTER","16;14;12;9;9;8;8;7;7;7;6;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4","EJECTION FRACTION;HEPATITIS C VIRUS;IMATINIB;ESSENTIAL THROMBOCYTHEMIA;GENOTYPE;IMMUNOTHERAPY;BREAST CANCER;INFLAMMATORY BOWEL DISEASE;METASTASIS;MYELOFIBROSIS;ADENOCARCINOMA;ARTERIAL STIFFNESS;BETA THALASSEMIA;CARDIAC FUNCTION CURVE;CONVENTIONAL PCI;CROHN'S DISEASE;HAEMATOPOIESIS;HEART RATE;HEPATECTOMY;INFLIXIMAB;LENALIDOMIDE;MANDIBLE (ARTHROPOD MOUTHPART);MICRORNA;MYOCARDIAL FIBROSIS;PANCREATIC CANCER;PERCUTANEOUS CORONARY INTERVENTION;PLACEBO;RELIABILITY (SEMICONDUCTOR);RESPIRATORY ACIDOSIS;THYROID CANCER;TIDAL VOLUME;TOLERABILITY;TROPONIN I;TYROSINE KINASE;ULCERATIVE COLITIS;VALSARTAN","7;5;5;4;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HEPACIVIRUS;MYELOPROLIFERATIVE NEOPLASM;NIVOLUMAB;CARFILZOMIB;DASATINIB;DISTANT METASTASIS;IMATINIB MESYLATE;LENVATINIB;MACE;METASTATIC BREAST CANCER;NILOTINIB;PORTAL VEIN EMBOLIZATION;SACUBITRIL;SACUBITRIL, VALSARTAN;STROKE VOLUME;ABL;ACROMEGALY;BARTONELLA HENSELAE;BONE METASTASIS;BREAKPOINT;CARDIAC INDEX;COLONOSCOPY;CORONARY ARTERY ANEURYSM;DRUG-ELUTING STENT;ENALAPRIL;ENDOLYMPHATIC HYDROPS;ESOPHAGEAL VARICES;EXTRAMEDULLARY HEMATOPOIESIS;FACTOR VIIA;FORAMEN SECUNDUM;FUSION TRANSCRIPT;HAEMOPHILIA B;HEAD AND NECK SQUAMOUS-CELL CARCINOMA;HEART FAILURE WITH PRESERVED EJECTION FRACTION;HETEROZYGOTE ADVANTAGE;INTERATRIAL SEPTUM;INVASIVE CANDIDIASIS;LYMPH NODE METASTASIS;MENIERE DISEASE;MICROARRAY;OSTEONECROSIS OF THE JAW;PANCREATIC CARCINOMA;PANCREATIC DUCTAL ADENOCARCINOMA;PHILADELPHIA CHROMOSOME;POUCHITIS;RADIAL HEAD FRACTURE;REGURGITANT FRACTION;RESPIRATORY RATE;RIBAVIRIN;SECUKINUMAB;SF-36;TAMOXIFEN;TARGET LESION;TRANSIENT ELASTOGRAPHY;TUMOR-INFILTRATING LYMPHOCYTES;VO2 MAX","3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",";HUMANS;FEMALE;MALE;MIDDLE AGED;AGED;ADULT;ITALY;LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE;PROTEIN KINASE INHIBITORS;TREATMENT OUTCOME;AGED, 80 AND OVER;RETROSPECTIVE STUDIES;ANTINEOPLASTIC AGENTS;IRON OVERLOAD;LIVER NEOPLASMS;MAGNETIC RESONANCE IMAGING;RISK FACTORS;YOUNG ADULT;FUSION PROTEINS, BCR-ABL","61;46;35;34;33;24;20;16;14;12;12;10;10;9;9;9;9;9;9;8","HEPATITIS C INFECTION AND TREATMENT;MOLECULAR PATHOGENESIS OF MYELOPROLIFERATIVE DISORDERS;EFFICACY AND RESISTANCE IN CML TREATMENT;GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS;ARTERIAL STIFFNESS AND CARDIOVASCULAR HEALTH;CANCER IMMUNOTHERAPY;DIAGNOSIS AND TREATMENT OF HEART FAILURE;HEPATOCELLULAR CARCINOMA;MANAGEMENT AND TREATMENT OF HEMOPHILIA;ATRIAL FIBRILLATION;BISPHOSPHONATES IN CANCER TREATMENT AND BONE HEALTH;DIAGNOSIS AND MANAGEMENT OF BILIARY TRACT DISORDERS;DIAGNOSIS AND MANAGEMENT OF FIBROMYALGIA SYNDROME;DIAGNOSIS AND TREATMENT OF MULTIPLE MYELOMA;GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;GLOBAL BURDEN OF CHRONIC PAIN;MECHANICAL VENTILATION IN RESPIRATORY FAILURE AND ARDS;SHOULDER PATHOLOGY AND TREATMENT OUTCOMES;ANESTHESIA AND SEDATION MANAGEMENT;ANOMALOUS DIFFUSION MODELING AND ANALYSIS","6;6;5;5;3;3;3;3;3;2;2;2;2;2;2;2;2;2;1;1","TREATMENT;REFRACTORY (PLANETARY SCIENCE);REGIMEN;SINGLE CENTER;DIAGNOSIS;HEPATITIS C;MANTLE CELL LYMPHOMA;MYELOPROLIFERATIVE NEOPLASM;NS5A;PATHOGENESIS;ANTICOAGULANT THERAPY;ARTERIAL STIFFNESS;BETA THALASSEMIA;BREAST CANCER;CLINICAL GUIDELINES;DECOMPENSATION;DEMOGRAPHICS;DICLOFENAC;DICLOFENAC SODIUM;DISTANT METASTASIS","8;4;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2","OBSERVATIONAL STUDY;CANCER PATIENTS;INFLAMMATORY BOWEL;BOWEL DISEASE;BREAST CANCER;CARDIOVASCULAR RISK;CELL CARCINOMA;CLINICAL TRIAL;DIRECT ORAL;EJECTION FRACTION;ELDERLY PATIENTS;ESSENTIAL THROMBOCYTHEMIA;MYELOPROLIFERATIVE NEOPLASMS;SINGLE CENTER;SQUAMOUS CELL;THALASSEMIA MAJOR;ACTING ANTIVIRALS;ACUTE LEUKAEMIA;ACUTE PANCREATITIS;ADVANCED BREAST;ADVERSE EVENTS;CARCINOMA IMPROVE;CARE UNITS;CENTER EXPERIENCE;CHOLANGIO-PANCREATOGRAPHY ERCP;CHRONIC MYELOID;CLINICAL IMPLICATIONS;CORONARY ARTERY;DICLOFENAC ADMINISTRATION;DIRECT ACTING","5;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2","DI FEDE;GRANT FUNDING;RESEARCH GRANT;RODOLFO MAUCERI;FUNDING INSTITUTION;OLGA DI;GIUSEPPINA CAMPISI;CLINICAL TRIAL;FEDE GIUSEPPINA;FEDERICA CANEPA;MAUCERI VERA;VERA PANZARELLA;ADVERSE EVENTS;DI PALERMO;MEDIAN AGE;PALERMO ITALY;CARBON DIOXIDE;ITALIAN SOCIETY;ORAL HEALTH;ORAL PATHOLOGY;ACCOMMODATION EXPENSES;DIOXIDE REMOVAL;EXTRACORPOREAL CARBON;ORAL SCIENCES;PAOLO GIACCONE;SURGICAL ONCOLOGICAL;TRAVEL ACCOMMODATION;ADVISORY CONSULTANCY;ALBERTO CAPONIO;CAMPISI GOOGLE","20;18;18;17;16;16;15;14;12;11;10;10;9;9;9;9;8;8;8;8;7;7;7;7;7;7;7;6;6;6",41,0.38,5.25,5,2,1,1,2,0,1,1,7,0,1,5,0,0,2,5.5,6,4.25,0,0,54,54,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,10,4.22,1137.56,6.54,5,0.5,88.5,0,0,2,0,4,0,1,3,0,8,1,0,0,0,0,0,0,10,0,0,8,1,0,1,0,0,0,0,0,0,"United States;Germany;Italy;Japan;United Kingdom","3;1;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;40 ENGINEERING","10;8;2;2;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;AUTOIMMUNE DISEASE;CANCER;CARDIOVASCULAR;CHRONIC PAIN;DIGESTIVE DISEASES;NEUROSCIENCES;NUTRITION;PAIN RESEARCH;PATIENT SAFETY;ARTHRITIS;CHRONIC LIVER DISEASE AND CIRRHOSIS;COMPLEMENTARY AND INTEGRATIVE HEALTH;HEADACHES;HEART DISEASE;HEPATITIS;INFLAMMATORY BOWEL DISEASE;KIDNEY DISEASE;LIVER DISEASE","9;8;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1","CANCER;CARDIOVASCULAR;INFLAMMATORY AND IMMUNE SYSTEM;ORAL AND GASTROINTESTINAL;RENAL AND UROGENITAL;RESPIRATORY","1;1;1;1;1;1","6.1 PHARMACEUTICALS;5.1 PHARMACEUTICALS;6.4 SURGERY","8;1;1","KIDNEY CANCER;LIVER CANCER","1;1","3.3 CHEMOPREVENTION;5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","1;1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_GIACCONE",2020,118,14.3559322033898,2.66949152542373,0.313559322033898,0.364406779661017,0.38135593220339,1.67553191489362,1.19354838709677,1.53571428571429,1.32352941176471,0.64406779661017,0,49,29,14,8,0.42,0.25,0.12,0.07,17.76,0.704909615987639,5.45559845559846,0.296610169491525,0.940677966101695,0.437,0.41,0.401,0.41,"ANDREA CORTEGIANI;MARCO VENTIMIGLIA;WALTER FRIES;SERENA GARUFI;FABIO SALVATORE MACALUSO;ANNA VIOLA;AMBROGIO ORLANDO;SARA RENNA;CARMELO BERTOLAMI;S. CAMILLERI;MARIA CAPPELLO;CESARE GREGORETTI;GIUSEPPINA NOVO;ALBERTO FIRENZE;ROSALBA ORLANDO;MARIACHIARA IPPOLITO;GIULIA RIZZUTO;ANTONIO RUSSO;VINCENZO ACCURSO;ROBERTO DI MITRI","15;10;10;10;10;10;9;9;8;8;8;8;8;7;7;7;7;7;6;6","ANDREA CORTEGIANI;GIUSEPPINA NOVO;CESARE GREGORETTI;MARIACHIARA IPPOLITO;SERGIO SIRAGUSA;ALBERTO FIRENZE;ROBERTO CANNELLA;SIMONA RASO;PASQUALE IOZZO;ETTORE DINOTO;G BAJARDI;FELICE PECORARO;VINCENZO ACCURSO;OMAR ENZO SANTANGELO;SANDRO PROVENZANO;GIUSEPPE D’ANNA;SHARON EINAV;TOMMASO VINCENZO BARTOLOTTA;MARCO SANTORO;ANTONIO RUSSO","2.43;1.08;1.07;1.06;0.95;0.91;0.83;0.7;0.7;0.68;0.68;0.68;0.62;0.6;0.6;0.6;0.58;0.56;0.53;0.5","ANDREA CORTEGIANI;MARIA CAPPELLO;CESARE GREGORETTI;GIUSEPPINA NOVO;ALBERTO FIRENZE;MARIACHIARA IPPOLITO;ANTONIO RUSSO;VINCENZO ACCURSO;SERGIO SIRAGUSA;ROBERTO CANNELLA;MARIA ROSARIA VALERIO;SIMONA RASO;B. SCRIVO;MAURIZIO AVERNA;SANDRO PROVENZANO;GIUSEPPE D’ANNA;DAVIDE NOTO;ROSSELLA SPINA;ANGELO B. CEFALÙ;ETTORE DINOTO","15;8;8;8;7;7;7;6;6;5;5;5;5;5;5;5;4;4;4;4","ANDREA CORTEGIANI;GIUSEPPINA NOVO;CESARE GREGORETTI;MARIACHIARA IPPOLITO;SERGIO SIRAGUSA;ALBERTO FIRENZE;ROBERTO CANNELLA;SIMONA RASO;PASQUALE IOZZO;ETTORE DINOTO;G BAJARDI;FELICE PECORARO;VINCENZO ACCURSO;SANDRO PROVENZANO;GIUSEPPE D’ANNA;TOMMASO VINCENZO BARTOLOTTA;ANTONIO RUSSO;ANTONINO TUTTOLOMONDO;ANTÓNIO PINTO;VINCENZO ARGANO","2.43;1.08;1.07;1.06;0.95;0.91;0.83;0.7;0.7;0.68;0.68;0.68;0.62;0.6;0.6;0.56;0.5;0.5;0.5;0.49","ANDREA CORTEGIANI;CESARE GREGORETTI;ALEXIS TABAH;ANDREW CONWAY MORRIS;GABRIELA PEREIRA VIDAL;GUY FRANÇOIS;JAN J. DE WAELE;JOHANNES MELLINGHOFF;KARIN AMREIN;KEVIN B. LAUPLAND;LENNIE DERDE;LUIGI CAMPOROTA;MAHESH RAMANAN;MATTEO BASSETTI;MUHAMMED ELHADI;NATHALIE SSI YAN KAI;NATHALIE ZAPPELLA;NICCOLÒ BUETTI;PEDRO PÓVOA;MARIACHIARA IPPOLITO","690;304;292;292;292;292;292;292;292;292;292;292;292;292;292;292;292;292;292;178","ANDREA CORTEGIANI;CESARE GREGORETTI;MARIACHIARA IPPOLITO;MARIA CAPPELLO;MARIA ROSARIA VALERIO;SERGIO MAZZOLA;ANTONINO GIARRATANO;DAVIDE PIRAINO;GIULIA ZAMBELLI;CATERINA LA CASCIA;MARCELLO CIACCIO;GIUSEPPE ACCURSO;SANTI MAURIZIO RAINERI;ROBERTO CANNELLA;PASQUALE IOZZO;ALBERTO FIRENZE;FRANCESCO VITALE;BRUNA LO SASSO;ANTONIO RUSSO;E GIUFFRIDA","603;197;148;143;127;127;126;123;121;110;100;92;87;80;77;68;64;63;55;55","ANDREA CORTEGIANI;MARIA CAPPELLO;GIUSEPPINA NOVO;CESARE GREGORETTI;VINCENZO ACCURSO;MARIA ROSARIA VALERIO;ROBERTO CANNELLA;MARIACHIARA IPPOLITO;B. SCRIVO;E GIUFFRIDA;ETTORE DINOTO;FELICE PECORARO;SALVATORE NOVO;ALFREDO R. GALASSI;G VADALÀ;ANTONINO GIARRATANO;EGLE CORRADO;FRANCESCO DISPENZA;G BAJARDI;GIUSEPPE COPPOLA","14;10;8;6;6;5;5;5;4;4;4;4;4;3;3;3;3;3;3;3","MEDICINE;BIOLOGY;COMPUTER SCIENCE;CHEMISTRY;PHYSICS;ENGINEERING;ECONOMICS;POLITICAL SCIENCE;PSYCHOLOGY;SOCIOLOGY;PHILOSOPHY;MATERIALS SCIENCE;MATHEMATICS;BUSINESS;ENVIRONMENTAL SCIENCE;HISTORY","115;23;10;9;9;8;6;6;6;6;5;4;3;1;1;1","INTERNAL MEDICINE;SURGERY;PATHOLOGY;GASTROENTEROLOGY;INTENSIVE CARE MEDICINE;CARDIOLOGY;RADIOLOGY;ENVIRONMENTAL HEALTH;PSYCHIATRY;GENETICS;VIROLOGY;BIOCHEMISTRY;ONCOLOGY;ANESTHESIA;FAMILY MEDICINE;MEDICAL EMERGENCY;PEDIATRICS;EMERGENCY MEDICINE;NURSING;LAW;PHYSICAL THERAPY","90;36;23;18;18;17;16;13;12;11;11;10;10;9;8;8;8;7;7;6;6","DISEASE;CANCER;OUTBREAK;POPULATION;ADVERSE EFFECT;COHORT;OBSERVATIONAL STUDY;ALTERNATIVE MEDICINE;GENE;HEALTH CARE;CLINICAL TRIAL;HEART FAILURE;LOGISTIC REGRESSION;LUNG;MAGNETIC RESONANCE IMAGING;MYOCARDIAL INFARCTION;PROSPECTIVE COHORT STUDY;STENOSIS;STENT;ARTERY;BIOMARKER;BLOOD PRESSURE;CHOLESTEROL;CONTEXT (ARCHAEOLOGY);CORONARY ARTERY DISEASE;HUMAN IMMUNODEFICIENCY VIRUS (HIV);INTENSIVE CARE;INTENSIVE CARE UNIT;ODDS RATIO;PROPENSITY SCORE MATCHING;RANDOMIZED CONTROLLED TRIAL;THROMBOSIS","35;13;12;11;8;8;8;6;6;6;5;5;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4","INFECTIOUS DISEASE (MEDICAL SPECIALTY);2019-20 CORONAVIRUS OUTBREAK;BREAST CANCER;INFLAMMATORY BOWEL DISEASE;ADALIMUMAB;CLINICAL ENDPOINT;CROHN'S DISEASE;ULCERATIVE COLITIS;IMMUNOTHERAPY;CORONARY ARTERIES;EJECTION FRACTION;INFLIXIMAB;LIPOPROTEIN;NEURORADIOLOGY;PSORIATIC ARTHRITIS;ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE;ALCOHOL CONSUMPTION;ARTERIAL DISEASE;CARDIOMYOPATHY;CAROTID ENDARTERECTOMY;CONTINUOUS POSITIVE AIRWAY PRESSURE;DYSLIPIDEMIA;ENDOVASCULAR TREATMENT;ESSENTIAL THROMBOCYTHEMIA;HAZARD RATIO;LDL CHOLESTEROL;MYELOFIBROSIS;ODDS;PERCUTANEOUS CORONARY INTERVENTION;PHENOTYPE;PLACEBO;RESTENOSIS;SPONDYLOARTHROPATHY;SYPHILIS","17;11;7;7;6;6;6;5;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","CORONAVIRUS DISEASE 2019 (COVID-19);VEDOLIZUMAB;GOLIMUMAB;MAMMOGRAPHY;NIVOLUMAB;USTEKINUMAB;CAROTID STENTING;CONDOM;ENTHESITIS;LDL RECEPTOR;TAMOXIFEN;ALCOHOL USE DISORDERS IDENTIFICATION TEST;AMPLICON;AORTIC RUPTURE;APOLIPOPROTEIN A1;AXIAL SPONDYLOARTHRITIS;BASDAI;BREAST SURGERY;CERTOLIZUMAB PEGOL;COMPARATIVE GENOMIC HYBRIDIZATION;COPY-NUMBER VARIATION;CORE BIOPSY;CRITICAL LIMB ISCHEMIA;DASATINIB;DIFFUSING CAPACITY;DRUG-ELUTING STENT;ENALAPRIL;ENDOLYMPHATIC HYDROPS;ESTROGEN RECEPTOR;FECAL BACTERIOTHERAPY;FORAMEN SECUNDUM;GENETIC HETEROGENEITY;HEPACIVIRUS;IMATINIB MESYLATE;INDUCED PLURIPOTENT STEM CELL;INFLAMMATORY BOWEL DISEASES;INTERATRIAL SEPTUM;MASTECTOMY;METASTATIC BREAST CANCER;MONOCLONAL;MYELOPROLIFERATIVE NEOPLASM;NEOADJUVANT THERAPY;NILOTINIB;NONALCOHOLIC FATTY LIVER DISEASE;OSTEONECROSIS OF THE JAW;PHYLOGENETIC RELATIONSHIP;PRENATAL DIAGNOSIS;RENAL ARTERY STENOSIS;RESPONSE EVALUATION CRITERIA IN SOLID TUMORS;RIGHT RENAL ARTERY;RUXOLITINIB;SACUBITRIL;SACUBITRIL, VALSARTAN;SECUKINUMAB;SEXUALLY TRANSMITTED DISEASE;SOX2;SPECKLE TRACKING ECHOCARDIOGRAPHY;TAKOTSUBO SYNDROME;TARGET LESION;TAXANE;TRANSIENT ELASTOGRAPHY;TRASTUZUMAB;UNDERINSURED;VINORELBINE","17;5;3;3;3;3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",";HUMANS;FEMALE;MALE;MIDDLE AGED;AGED;ADULT;ITALY;CORONAVIRUS INFECTIONS;COVID-19;CROHN DISEASE;PNEUMONIA, VIRAL;ANTIBODIES, MONOCLONAL, HUMANIZED;INFLAMMATORY BOWEL DISEASES;RETROSPECTIVE STUDIES;ADALIMUMAB;AGED, 80 AND OVER;BETA-THALASSEMIA;PROSPECTIVE STUDIES;TREATMENT OUTCOME","70;47;32;29;25;18;16;13;12;11;11;11;9;9;9;8;8;8;8;8","GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;MECHANICAL VENTILATION IN RESPIRATORY FAILURE AND ARDS;MOLECULAR PATHOGENESIS OF MYELOPROLIFERATIVE DISORDERS;IMPACT OF COVID-19 ON MENTAL HEALTH;AIRBORNE TRANSMISSION OF RESPIRATORY VIRUSES;CHOLESTEROL-LOWERING TREATMENT;CLASSIFICATION AND TREATMENT OF SPONDYLOARTHRITIS;HEPATITIS C INFECTION AND TREATMENT;IMMUNOGENICITY OF BIOSIMILAR THERAPEUTICS IN DRUG DEVELOPMENT;CYCLIN-DEPENDENT KINASE 4/6 INHIBITORS IN BREAST CANCER;DIAGNOSIS AND TREATMENT OF CAROTID ARTERY DISEASE;DYSPHAGIA AND SWALLOWING DISORDERS;EPIDEMIOLOGY AND MANAGEMENT OF SEPSIS AND SEPTIC SHOCK;GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS;HEPATOCELLULAR CARCINOMA;MULTIPOTENT MESENCHYMAL STEM CELLS;ADOLESCENT SEXUAL HEALTH AND BEHAVIOR PATTERNS;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;ADVANCEMENTS IN LUNG CANCER RESEARCH;ADVANCES IN METABOLOMICS RESEARCH","7;6;5;4;3;3;3;3;3;2;2;2;2;2;2;2;1;1;1;1","2019-20 CORONAVIRUS OUTBREAK;PANDEMIC;TREATMENT;CLINICAL ENDPOINT;VEDOLIZUMAB;HIGH-FLOW OXYGEN THERAPY;PERSONAL PROTECTIVE EQUIPMENT;POSITIVE END-EXPIRATORY PRESSURE;BIOSIMILAR;BREAST IMAGING;BREAST MRI;CARDIAC IMAGING;CORONARY ARTERIES;CROSS-SECTIONAL STUDY;GOLIMUMAB;INTERQUARTILE RANGE;LDL CHOLESTEROL;NEURORADIOLOGY;PANDEMICS;POLYCYTHEMIA VERA","11;10;7;6;5;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3","INFLAMMATORY BOWEL;CARDIOVASCULAR RISK;BOWEL DISEASES;NURSING STUDENTS;SICILIAN NETWORK;BOWEL DISEASE;CROHNS DISEASE;OBSERVATIONAL STUDY;POLYCYTHEMIA VERA;ADVANCED BREAST;BREAST CANCER;COHORT STUDY;CORONARY ARTERY;COVID- PANDEMIC;PROPENSITY SCORE;SCORE WEIGHTED;THROMBOTIC RISK;WEIGHTED COMPARISON;ARTERY DISEASE;BIOSIMILAR SB;CANCER ABC;CARE UNIT;CAROTID ARTERY;COVID- PATIENTS;DISEASE SN-IBD;DISEASES SN-IBD;DISTRIBUTION WIDTH;ENDOVASCULAR TREATMENT;ESSENTIAL THROMBOCYTHEMIA;FLOW NASAL","9;6;5;5;5;4;4;4;4;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2","PUBMED SCOPUS;PATIENTS TREATED;SPEAKERS BUREAU;HEALTH CARE;AIRWAY COLONIZATION;CONSULTANCY HONORARIA;RISK FACTORS;CARDIOVASCULAR RISK;CROSSREF PUBMED;CANDIDA SPP;COVID- PANDEMIC;CRITICALLY ILL;SPP AIRWAY;ACCESSED APRIL;APRIL GOOGLE;HR CI;CLINICAL OUTCOMES;INTENSIVE CARE;CARE WORKERS;CONSECUTIVE PATIENTS;RESEARCH FUNDING;SECOND-LINE TREATMENT;ADVISORY COMMITTEES;CLINICAL PRACTICE;CLINICAL RESPONSE;ENTITYS BOARD;MEDIAN FOLLOW-UP;NONRANDOMIZED STUDIES;THROMBOTIC RISK;ADVERSE EVENTS","18;17;16;15;14;14;14;13;13;12;11;11;11;10;10;10;9;9;8;8;8;8;7;7;7;7;7;7;7;6",48,0.41,9.1,10,1.25,1,0,2,0,0,1,11.25,1,0,9,0,0,2,3.5,7,3,0,0,82.5,82.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,20,3.26,305.85,12.12,13,0.65,59.25,0,0,5,0,5,0,1,9,0,15,4,0,0,0,1,0,0,19,1,0,19,0,0,0,0,1,0,0,0,0,"Italy;United States;United Kingdom","4;4;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;52 PSYCHOLOGY;3204 IMMUNOLOGY;5202 BIOLOGICAL PSYCHOLOGY;30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;3004 CROP AND PASTURE PRODUCTION;31 BIOLOGICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;3203 DENTISTRY;3210 NUTRITION AND DIETETICS;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;5203 CLINICAL AND HEALTH PSYCHOLOGY","17;10;4;4;2;2;1;1;1;1;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;AUTOIMMUNE DISEASE;CANCER;PATIENT SAFETY;DIABETES;DIGESTIVE DISEASES;NEUROSCIENCES;RARE DISEASES;COMPLEMENTARY AND INTEGRATIVE HEALTH;DENTAL/ORAL AND CRANIOFACIAL DISEASE;EMERGING INFECTIOUS DISEASES;INFECTIOUS DISEASES;LUNG;NEURODEGENERATIVE;NUTRITION;PEDIATRIC;PREVENTION;ALS;ARTHRITIS","19;13;6;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;1;1","CANCER;INFLAMMATORY AND IMMUNE SYSTEM;METABOLIC AND ENDOCRINE;MENTAL HEALTH;NEUROLOGICAL;ORAL AND GASTROINTESTINAL;SKIN","4;2;2;1;1;1;1","6.1 PHARMACEUTICALS;5.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;7.1 INDIVIDUAL CARE NEEDS","13;3;2;1","SARCOMA;BREAST CANCER;LUNG CANCER;ORAL CAVITY AND LIP CANCER;PHARYNGEAL CANCER","2;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT","4;1",1,5887274,452867.23,5,13,6,1,29,90573.4461538461,1.30281009513062,"AZIENDA OSPEDALIERA UNIVERSITARIA POLICLINICO ""PAOLO GIACCONE"" DI PALERMO;FEDERAL INSTITUTE FOR MATERIALS RESEARCH AND TESTING;FUNDACIÓN PARA LA FORMACIÓN E INVESTIGACIÓN SANITARIAS DE LA REGIÓN DE MURCIA;GENXPRO (GERMANY);GHEORGHE ASACHI TECHNICAL UNIVERSITY OF IAȘI;INSTITUTUL REGIONAL DE ONCOLOGIE;LUXEMBOURG INSTITUTE OF HEALTH;MALMÖ UNIVERSITY;SERVICIO MURCIANO DE SALUD;UMEÅ UNIVERSITY;UNIVERSIDAD CATÓLICA SAN ANTONIO DE MURCIA;UNIVERSITY OF FLORENCE;UNIVERSITY OF ROME TOR VERGATA","1;1;1;1;1;1;1;1;1;1;1;1;1","EUROPEAN COMMISSION","1","COALITION S;EC & ERC - EUROPEAN UNION","1;1","H2020-EU.3.1. - SOCIETAL CHALLENGES - HEALTH, DEMOGRAPHIC CHANGE AND WELL-BEING (PROGRAMME);RIA - RESEARCH AND INNOVATION ACTION (FUNDING SCHEME)","1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS","1;1","CANCER;DIGESTIVE DISEASES","1;1","CANCER","1","5.9 RESOURCES AND INFRASTRUCTURE (TREATMENT DEVELOPMENT)","1","COLON AND RECTAL CANCER","1","4.4 RESOURCES AND INFRASTRUCTURE RELATED TO DETECTION, DIAGNOSIS, OR PROGNOSIS;5.7 RESOURCES AND INFRASTRUCTURE RELATED TO TREATMENT AND THE PREVENTION OF RECURRENCE","1;1","B11 COMPUTER SCIENCE AND INFORMATICS","1",NA,NA,3,"PUBLIC LIBRARY OF SCIENCE","3","49 MATHEMATICAL SCIENCES;4905 STATISTICS","2;1","NUTRITION","1",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_GIACCONE",2021,156,14.1538461538462,2.54487179487179,0.314102564102564,0.275641025641026,0.365384615384615,1.86384976525822,1.48484848484848,1.72,1.54054054054054,0.75,2,49,32,27,10,0.31,0.21,0.17,0.06,10.51,0.681318127376518,5.68965517241379,0.262820512820513,0.974358974358974,0.517,0.481,0.436,0.452,"MARCELLO CIACCIO;ETTORE DINOTO;FRANCESCA FERLITO;G BAJARDI;FELICE PECORARO;ANDREA CORTEGIANI;ANTONINO GIARRATANO;MARIACHIARA IPPOLITO;BRUNA LO SASSO;ANNA VIOLA;AMBROGIO ORLANDO;WALTER FRIES;MARIA ROSARIA VALERIO;GIUSEPPE COSTANTINO;ROSARIA VINCENZA GIGLIO;DOMENICO MIRABELLA;LUISA AGNELLO;WALTER MAZZUCCO;CONCETTA SCAZZONE;ANNA MARIA CIACCIO","13;12;12;12;12;12;10;9;8;8;7;7;7;7;7;7;7;6;6;6","MARCELLO CIACCIO;ANDREA CORTEGIANI;ETTORE DINOTO;FRANCESCA FERLITO;G BAJARDI;FELICE PECORARO;MARIACHIARA IPPOLITO;DOMENICO MIRABELLA;M BELLISI;OMAR ENZO SANTANGELO;SANDRO PROVENZANO;SALVATORE EVOLA;ANTONINO GIARRATANO;BRUNA LO SASSO;GIUSEPPINA NOVO;FILIPPO BRIGHINA;ROSARIA VINCENZA GIGLIO;LUISA AGNELLO;VINCENZA GIANFREDI;G. TORTOMASI","2.14;1.97;1.94;1.94;1.94;1.94;1.18;1.11;1;0.88;0.88;0.87;0.8;0.79;0.75;0.69;0.67;0.67;0.67;0.67","MARCELLO CIACCIO;ETTORE DINOTO;FRANCESCA FERLITO;G BAJARDI;FELICE PECORARO;ANDREA CORTEGIANI;ANTONINO GIARRATANO;MARIACHIARA IPPOLITO;BRUNA LO SASSO;MARIA ROSARIA VALERIO;DOMENICO MIRABELLA;WALTER MAZZUCCO;ANNA MARIA CIACCIO;CATERINA MARIA GAMBINO;MARIA CAPPELLO;NICOLA SCICHILONE;LAURA GUIDA;SALVATORE EVOLA;FILIPPO BRIGHINA;GIUSEPPINA NOVO","13;12;12;12;12;12;10;9;8;7;7;6;6;6;6;5;5;5;5;5","MARCELLO CIACCIO;ANDREA CORTEGIANI;ETTORE DINOTO;FRANCESCA FERLITO;G BAJARDI;FELICE PECORARO;MARIACHIARA IPPOLITO;DOMENICO MIRABELLA;M BELLISI;SANDRO PROVENZANO;SALVATORE EVOLA;ANTONINO GIARRATANO;BRUNA LO SASSO;GIUSEPPINA NOVO;FILIPPO BRIGHINA;G. TORTOMASI;NICOLA SCICHILONE;MARIA ROSARIA VALERIO;ANNA MARIA CIACCIO;CATERINA MARIA GAMBINO","2.14;1.97;1.94;1.94;1.94;1.94;1.18;1.11;1;0.88;0.87;0.8;0.79;0.75;0.69;0.67;0.63;0.6;0.58;0.56","MARCELLO CIACCIO;ANTONINO GIARRATANO;BRUNA LO SASSO;LUISA AGNELLO;ROSARIA VINCENZA GIGLIO;CATERINA MARIA GAMBINO;CONCETTA SCAZZONE;GIULIA BIVONA;ANNA MARIA CIACCIO;MATTEO VIDALI;ANNA VIOLA;MARIA CAPPELLO;GIUSEPPE COSTANTINO;ANDREA CORTEGIANI;ALESSANDRA IURLO;DAVIDE RAPEZZI;FRANCESCA LUNGHI;MASSIMILIANO BONIFACIO;ANTONIO RUSSO;MARIACHIARA IPPOLITO","335;221;210;195;195;182;182;177;174;174;127;127;125;118;116;116;116;116;113;112","MARCELLO CIACCIO;ANTONINO GIARRATANO;BRUNA LO SASSO;MARIA CAPPELLO;ANDREA CORTEGIANI;ANTONIO RUSSO;SERGIO SIRAGUSA;CATERINA MARIA GAMBINO;MARIA ROSARIA VALERIO;MASSIMO MIDIRI;R. IENZI;LAURA GUIDA;ALESSIA ANGELA MARIA ORLANDO;TOMMASO VINCENZO BARTOLOTTA;ROBERTO CANNELLA;ETTORE DINOTO;SILVIO BUSCEMI;MARIANGELA DIMARCO;WALTER MAZZUCCO;G BAJARDI","307;221;147;127;118;99;93;90;72;60;55;53;52;52;51;47;45;44;44;43","MARCELLO CIACCIO;ANDREA CORTEGIANI;ETTORE DINOTO;G BAJARDI;FELICE PECORARO;ANTONINO GIARRATANO;FRANCESCA FERLITO;MARIA CAPPELLO;DOMENICO MIRABELLA;MARIA ROSARIA VALERIO;ANTONIO RUSSO;GIUSEPPINA NOVO;LAURA GUIDA;SALVATORE EVOLA;FEDERICA VERNUCCIO;MASSIMO MIDIRI;NICOLA SCICHILONE;ROBERTO CANNELLA;WALTER MAZZUCCO;BRUNA LO SASSO","12;12;12;11;10;10;10;8;7;6;5;5;5;5;4;4;4;4;4;4","MEDICINE;BIOLOGY;PHYSICS;COMPUTER SCIENCE;CHEMISTRY;PSYCHOLOGY;ECONOMICS;MATHEMATICS;POLITICAL SCIENCE;BUSINESS;GEOGRAPHY;PHILOSOPHY;SOCIOLOGY;ENGINEERING;HISTORY;MATERIALS SCIENCE;GEOLOGY","152;24;14;13;8;8;7;7;5;4;4;4;4;3;3;3;1","INTERNAL MEDICINE;SURGERY;RADIOLOGY;PATHOLOGY;GASTROENTEROLOGY;PSYCHIATRY;ENVIRONMENTAL HEALTH;CARDIOLOGY;IMMUNOLOGY;ONCOLOGY;VIROLOGY;INTENSIVE CARE MEDICINE;BIOCHEMISTRY;NURSING;OPTICS;PHYSICAL THERAPY;NUCLEAR MEDICINE;ENDOCRINOLOGY;GENETICS;ARTIFICIAL INTELLIGENCE","120;43;28;24;19;19;18;17;16;16;15;11;10;10;10;9;8;7;7;6","DISEASE;CANCER;POPULATION;COHORT;OUTBREAK;INCIDENCE (GEOMETRY);MAGNETIC RESONANCE IMAGING;ADVERSE EFFECT;GENE;MYOCARDIAL INFARCTION;RECEIVER OPERATING CHARACTERISTIC;RETROSPECTIVE COHORT STUDY;PROSPECTIVE COHORT STUDY;ANTIBODY;ARTERY;DIABETES MELLITUS;NEUROLOGY;PUBLIC HEALTH;STENT;CLINICAL TRIAL;HEALTH CARE;IMMUNE SYSTEM;LOGISTIC REGRESSION;OBESITY;OBSERVATIONAL STUDY;ODDS RATIO;QUALITY OF LIFE (HEALTHCARE);SEPSIS;THYROID","44;25;16;14;13;9;9;8;8;8;8;8;7;6;6;6;6;6;6;5;5;5;5;5;5;5;5;5;5","INFECTIOUS DISEASE (MEDICAL SPECIALTY);2019-20 CORONAVIRUS OUTBREAK;BREAST CANCER;ADALIMUMAB;COLORECTAL CANCER;CROHN'S DISEASE;INFLAMMATORY BOWEL DISEASE;ULCERATIVE COLITIS;CLINICAL ENDPOINT;NEURORADIOLOGY;REVASCULARIZATION;ACUTE CORONARY SYNDROME;AORTIC ARCH;CORONARY ARTERIES;ENDOVASCULAR TREATMENT;GENOME;GENOTYPE;METASTASIS;PROSTATE;THYROID CANCER","25;12;10;7;6;6;6;6;4;4;4;3;3;3;3;3;3;3;3;3","CORONAVIRUS DISEASE 2019 (COVID-19);METASTATIC BREAST CANCER;USTEKINUMAB;CAPECITABINE;CRITICAL LIMB ISCHEMIA;ENDOVASCULAR ANEURYSM REPAIR;ESTROGEN RECEPTOR;HEPACIVIRUS;MAMMOGRAPHY;TRASTUZUMAB;TRIPLE-NEGATIVE BREAST CANCER;VEDOLIZUMAB;VINORELBINE;AEDES ALBOPICTUS;ALLELE FREQUENCY;AXIAL SPONDYLOARTHRITIS;BASDAI;BREAST CARCINOMA;CALPROTECTIN;CAROTID STENTING;CERVICAL LYMPH NODES;CLAUDICATION;COGNITIVE DECLINE;COLONOSCOPY;CYP3A4;DEBULKING;DRUG-ELUTING STENT;DYSKINESIA;ENTHESITIS;EXENATIDE;FEMORAL HERNIA;GATA3;GUGLIELMI DETACHABLE COIL;HEAD AND NECK SQUAMOUS-CELL CARCINOMA;IMATINIB MESYLATE;INTERMITTENT CLAUDICATION;KLEBSIELLA PNEUMONIAE;LEFT SUBCLAVIAN ARTERY;LEVODOPA;LIRAGLUTIDE;LOWER URINARY TRACT SYMPTOMS;LYMPHANGIOGENESIS;LYMPHEDEMA;MASTECTOMY;MEK INHIBITOR;MULTILOCUS SEQUENCE TYPING;NEUROGRANIN;NIVOLUMAB;NONALCOHOLIC FATTY LIVER DISEASE;NS3;OPIOID EPIDEMIC;PANCREATIC DUCTAL ADENOCARCINOMA;PAPILLARY THYROID CANCER;PARATHYROIDECTOMY;RIBAVIRIN;RICKETTSIOSIS;RUXOLITINIB;SOLID ORGAN;SURFACTANT PROTEIN D;THORACIC AORTIC ANEURYSM;THORACIC VERTEBRAE;TIMI;TRAMETINIB;VATS LOBECTOMY;VEMURAFENIB;WHOLE GENOME SEQUENCING","24;6;5;3;3;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",";HUMANS;FEMALE;MALE;ADULT;ITALY;AGED;MIDDLE AGED;RETROSPECTIVE STUDIES;COVID-19;BREAST NEOPLASMS;BIOMARKERS;SURVEYS AND QUESTIONNAIRES;CARDIOVASCULAR DISEASES;MAGNETIC RESONANCE IMAGING;SARS-COV-2;TREATMENT OUTCOME;CORONARY ARTERY DISEASE;JANUS KINASE 2;OBESITY","94;62;33;30;22;21;18;18;17;16;13;9;9;8;8;8;8;7;7;7","GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;CORONAVIRUS DISEASE 2019;CORONAVIRUS DISEASE 2019 RESEARCH;CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY IN CANCER TREATMENT;EPIDEMIOLOGY AND MANAGEMENT OF SEPSIS AND SEPTIC SHOCK;HEPATITIS C INFECTION AND TREATMENT;HEPATOCELLULAR CARCINOMA;MANAGEMENT AND DIAGNOSIS OF THYROID CANCER;MANAGEMENT AND TREATMENT OF PERIPHERAL ARTERIAL DISEASE;MECHANICAL VENTILATION IN RESPIRATORY FAILURE AND ARDS;MOLECULAR PATHOGENESIS OF MYELOPROLIFERATIVE DISORDERS;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;APPLICATIONS OF DEEP LEARNING IN MEDICAL IMAGING;BREATH ANALYSIS TECHNOLOGY;DIAGNOSIS AND MANAGEMENT OF AORTIC DISEASES;DIAGNOSIS AND MANAGEMENT OF KAWASAKI DISEASE;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS;GLOBAL IMPACT OF ARBOVIRAL DISEASES;HEPARIN-INDUCED THROMBOCYTOPENIA AND THROMBOSIS","6;5;4;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2","PANDEMIC;2019-20 CORONAVIRUS OUTBREAK;REGIMEN;USTEKINUMAB;BREAST CANCER;CARDIAC IMAGING;CLINICAL ENDPOINT;ENDOVASCULAR REPAIR;METASTATIC BREAST CANCER;NEURORADIOLOGY;SEPSIS;TREATMENT;CANCER IMAGING;CORONARY ARTERIES;CORONAVIRUS INFECTIONS;CRITICAL LIMB ISCHEMIA;CROSS-SECTIONAL STUDY;DIAGNOSIS;DYNAMIC CONTRAST-ENHANCED MRI;HEPATOCELLULAR CARCINOMA","16;11;5;5;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3","BREAST CANCER;COVID- PANDEMIC;INFLAMMATORY BOWEL;OBSERVATIONAL STUDY;BOWEL DISEASES;CANCER PATIENTS;CHRONIC OBSTRUCTIVE;CROHNS DISEASE;INTENSIVE CARE;LUNG ULTRASOUND;SECONDARY ANALYSIS;SICILIAN NETWORK;ADALIMUMAB BIOSIMILAR;ANALGESIA RESUSCITATION;ANESTHESIA ANALGESIA;ARTERIAL PHASE;ARTERIES MINOCA;BIOSIMILAR ABP;BOWEL DISEASE;COLORECTAL CANCER;COMPARATIVE STUDY;CORONARY ARTERIES;CORONAVIRUS DISEASE;COVID- PATIENT;DISEASE TREATED;DISEASES SN-IBD;DYNAMIC POST-CONTRASTOGRAFIC;EMERGENCY DEPARTMENT;FATTY LIVER;HEPATOCELLULAR CARCINOMA","8;6;5;4;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","KIT EXON;SARS-COV- INFECTION;MD PHD;COVID- PANDEMIC;CROSSREF MEDLINE;INTENSIVE CARE;CHRONIC OBSTRUCTIVE;MEDLINE GOOGLE;MGIST PATIENTS;CLINICAL PRACTICE;HR CI;MEDIAN MIN;MIN MAX;RESPIRATORY FAILURE;SD MEDIAN;TC PATIENTS;INCLUDED PATIENTS;LUNG ULTRASOUND;MEDIAN IQR;RETRACTED ARTICLES;SEPSIS INDEX;GROTHOFFS CRITERIA;NEUROLOGY RESIDENTS;OBSTRUCTIVE PULMONARY;PATIENTS TREATED;CARDIAC ADRS;PUBMED SCOPUS;PULMONARY DISEASE;RETROSPECTIVE STUDY;STATISTICALLY SIGNIFICANT","18;17;16;15;15;13;12;12;12;11;11;11;11;11;11;11;10;10;10;10;10;9;9;9;9;8;8;8;8;8",71,0.46,6.72,4,1,2.5,0,2,0,1,0,5,0,0,5,1,0,2,1.75,4,2,0,0,34,34,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,20,3.42,545.74,10.26,11,0.55,116.75,0,0,5,0,7,0,0,8,0,15,4,0,0,0,1,0,0,20,0,0,19,0,0,0,0,1,0,0,0,0,"United States;Italy;Germany;United Kingdom","5;2;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3203 DENTISTRY","19;15;4;3;3;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;DIGESTIVE DISEASES;PATIENT SAFETY;ARTHRITIS;AUTOIMMUNE DISEASE;CHRONIC LIVER DISEASE AND CIRRHOSIS;LIVER DISEASE;LUNG;RARE DISEASES;CARDIOVASCULAR;HEPATITIS;NEUROSCIENCES;PAIN RESEARCH;PSORIASIS;AGING;BREAST CANCER;CHRONIC OBSTRUCTIVE PULMONARY DISEASE;CHRONIC PAIN","17;14;5;4;4;3;3;3;3;3;3;2;2;2;2;2;1;1;1;1","CANCER;INFLAMMATORY AND IMMUNE SYSTEM;ORAL AND GASTROINTESTINAL;CARDIOVASCULAR;NEUROLOGICAL;RESPIRATORY;SKIN","4;3;3;2;1;1;1","6.1 PHARMACEUTICALS;5.1 PHARMACEUTICALS;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;6.7 PHYSICAL;7.3 MANAGEMENT AND DECISION MAKING","11;2;1;1;1;1","SARCOMA;BREAST CANCER;MELANOMA;NOT SITE-SPECIFIC CANCER","2;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","2;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_GIACCONE",2022,132,16.280303030303,2.82575757575758,0.378787878787879,0.265151515151515,0.409090909090909,1.70319634703196,1.47058823529412,1.45833333333333,1.45945945945946,0.81060606060606,3,37,19,12,10,0.28,0.14,0.09,0.08,5.67,0.634792007548173,4.82488479262673,0.212121212121212,0.931818181818182,0.488,0.421,0.432,0.453,"CALOGERO CURATOLO;ANDREA CORTEGIANI;GIUSEPPE LO RE;ALFREDO R. GALASSI;ANTONIO CASCIO;MARCELLO CIACCIO;GIUSEPPINA NOVO;MASSIMO GALIA;ANTONINO GIARRATANO;BRUNA LO SASSO;NICOLA SCICHILONE;ROSARIA VINCENZA GIGLIO;LUISA AGNELLO;GIULIANA GUGGINO;SERGIO SIRAGUSA;G VADALÀ;CRISTINA MADAUDO;VIRGINIA CARUSO;MARIACHIARA IPPOLITO;EGLE CORRADO","12;11;10;10;9;9;9;8;8;8;7;7;7;7;7;6;6;6;6;5","CALOGERO CURATOLO;ANTONINO GIARRATANO;ANTONIO CASCIO;GIUSEPPE LO RE;ALFREDO R. GALASSI;ANDREA CORTEGIANI;MASSIMO GALIA;GIUSEPPINA NOVO;LUCA PIPITÒ;G VADALÀ;MARCELLO CIACCIO;NICOLA SCICHILONE;BRUNA LO SASSO;VIRGINIA CARUSO;LUISA AGNELLO;ROSARIA VINCENZA GIGLIO;CRISTINA MADAUDO;SERGIO SIRAGUSA;CLAUDIA CRIMI;ANNA MARIA CIACCIO","3.46;1.59;1.47;1.46;1.16;1.09;1.06;0.94;0.92;0.92;0.91;0.87;0.86;0.86;0.79;0.72;0.68;0.67;0.62;0.57","CALOGERO CURATOLO;ANDREA CORTEGIANI;ALFREDO R. GALASSI;ANTONIO CASCIO;MARCELLO CIACCIO;GIUSEPPINA NOVO;ANTONINO GIARRATANO;BRUNA LO SASSO;NICOLA SCICHILONE;ROSARIA VINCENZA GIGLIO;LUISA AGNELLO;GIULIANA GUGGINO;SERGIO SIRAGUSA;G VADALÀ;CRISTINA MADAUDO;VIRGINIA CARUSO;MARIACHIARA IPPOLITO;EGLE CORRADO;ANNA MARIA CIACCIO;CATERINA MARIA GAMBINO","12;11;10;9;9;9;8;8;7;7;7;7;7;6;6;6;6;5;5;5","CALOGERO CURATOLO;ANTONINO GIARRATANO;ANTONIO CASCIO;ALFREDO R. GALASSI;ANDREA CORTEGIANI;GIUSEPPINA NOVO;G VADALÀ;MARCELLO CIACCIO;NICOLA SCICHILONE;BRUNA LO SASSO;VIRGINIA CARUSO;LUISA AGNELLO;ROSARIA VINCENZA GIGLIO;CRISTINA MADAUDO;SERGIO SIRAGUSA;ANNA MARIA CIACCIO;CATERINA MARIA GAMBINO;STEFANIA PRINCIPE;F. REINA;ANGELO IMMORDINO","3.46;1.59;1.47;1.16;1.09;0.94;0.92;0.91;0.87;0.86;0.86;0.79;0.72;0.68;0.67;0.57;0.53;0.51;0.5;0.5","ANDREA CORTEGIANI;MARIACHIARA IPPOLITO;ANTONINO GIARRATANO;JOÃO ALVES;MARCELLO CIACCIO;BRUNA LO SASSO;CLAUDIA CRIMI;ALBERTO NOTO;ANNALISA CARLUCCI;RAFFAELE CAMPISI;SANTI NOLASCO;LUISA AGNELLO;DANIELE ROBERTO GIACOBBE;ENRICO CLINI;MATTEO BASSETTI;ROSARIA VINCENZA GIGLIO;ABDULLAH TARIK ASLAN;ALBERTO OREJAS GALLEGO;ALEXIS TABAH;ATA MAHMOODPOOR","198;140;103;92;83;77;70;69;69;69;69;68;67;67;67;66;62;62;62;62","ANTONINO GIARRATANO;MARIACHIARA IPPOLITO;ANDREA CORTEGIANI;MARCELLO CIACCIO;MARTA ALESSI;PASQUALE IOZZO;FRANCESCO DIELI;BRUNA LO SASSO;GIUSEPPINA NOVO;ANDREA DI GUARDO;ANNA MARIA CORSALE;MARTA DI SIMONE;SERENA MERAVIGLIA;ANDREA VIANELLO;GIULIANA GUGGINO;ROSARIA VINCENZA GIGLIO;SERGIO SIRAGUSA;ROSALIA CALDARELLA;DANIELA DI LISI;ADA MARIA FLORENA","103;83;82;74;46;45;43;38;38;37;34;34;34;30;30;27;27;26;24;23","CALOGERO CURATOLO;ANTONINO GIARRATANO;GIUSEPPINA NOVO;MARCELLO CIACCIO;GIULIANA GUGGINO;ANDREA CORTEGIANI;NICOLA SCICHILONE;ALFREDO R. GALASSI;CRISTINA MADAUDO;G VADALÀ;VIRGINIA CARUSO;BRUNA LO SASSO;EGLE CORRADO;GIANCARLO BUCCHERI;ROSARIA VINCENZA GIGLIO;SERGIO SIRAGUSA;DANIELA DI LISI;MARIACHIARA IPPOLITO;GABRIELLA TESTA;ROSALIA CALDARELLA","12;8;8;8;7;7;7;6;6;6;6;5;5;4;4;4;4;4;3;3","MEDICINE;BIOLOGY;COMPUTER SCIENCE;PHYSICS;CHEMISTRY;POLITICAL SCIENCE;PSYCHOLOGY;BUSINESS;ECONOMICS;MATHEMATICS;SOCIOLOGY;ENGINEERING;GEOGRAPHY;PHILOSOPHY;ART;ENVIRONMENTAL SCIENCE;GEOLOGY;MATERIALS SCIENCE","129;32;22;14;13;8;7;5;4;4;4;3;3;2;1;1;1;1","INTERNAL MEDICINE;SURGERY;PATHOLOGY;RADIOLOGY;ENVIRONMENTAL HEALTH;BIOCHEMISTRY;CARDIOLOGY;IMMUNOLOGY;INTENSIVE CARE MEDICINE;GASTROENTEROLOGY;PEDIATRICS;FAMILY MEDICINE;GENETICS;OPTICS;ARTIFICIAL INTELLIGENCE;VIROLOGY;ANESTHESIA;LAW;COMPUTER VISION;MEDICAL EMERGENCY;ONCOLOGY","89;28;27;21;20;19;19;18;15;14;12;10;10;10;9;9;8;8;7;7;7","DISEASE;POPULATION;CANCER;OBSERVATIONAL STUDY;HEART FAILURE;MAGNETIC RESONANCE IMAGING;ALTERNATIVE MEDICINE;COHORT;FILTER (SIGNAL PROCESSING);PROSPECTIVE COHORT STUDY;RETROSPECTIVE COHORT STUDY;ANTIBODY;GOLD STANDARD (TEST);IMMUNE SYSTEM;INTENSIVE CARE;MYOCARDIAL INFARCTION;OUTBREAK;ADVERSE EFFECT;BIOMARKER;CHEMOTHERAPY;CONFIDENCE INTERVAL;ENZYME;GENE;IMAGE (MATHEMATICS);INCIDENCE (GEOMETRY);SEQUENCE (BIOLOGY);STENT","31;16;12;12;10;9;7;7;7;7;7;6;6;6;6;6;6;5;5;5;5;5;5;5;5;5;5","INFECTIOUS DISEASE (MEDICAL SPECIALTY);EJECTION FRACTION;2019-20 CORONAVIRUS OUTBREAK;SAMPLING (SIGNAL PROCESSING);ALIASING;PROTOCOL (SCIENCE);BREAST CANCER;HAZARD RATIO;NOISE (VIDEO);PERCUTANEOUS CORONARY INTERVENTION;PSORIATIC ARTHRITIS;RESTENOSIS;TITER;ADALIMUMAB;ALKALINE PHOSPHATASE;ALZHEIMER'S DISEASE;ANTIBIOTIC RESISTANCE;AUTOIMMUNE DISEASE;CARDIOTOXICITY;CLINICAL ENDPOINT;COLORECTAL CANCER;CORONARY ANGIOGRAPHY;DEMENTIA;DIASTOLE;ESSENTIAL THROMBOCYTHEMIA;ETANERCEPT;EX VIVO;FAST SPIN ECHO;FEMALE PELVIS;FLIP ANGLE;GASTRITIS;IMAGE QUALITY;IMMUNITY;IMMUNOGLOBULIN G;INFERTILITY;INSULIN RESISTANCE;MYCOBACTERIUM TUBERCULOSIS;MYELOFIBROSIS;OVARIAN CANCER;QUARTILE;SEROLOGY;SINE WAVE;SPECIFIC ABSORPTION RATE;SPIN ECHO;T CELL;THROMBOELASTOMETRY;THYROID CARCINOMA;TOLERABILITY;TRANEXAMIC ACID;TUMOR MICROENVIRONMENT;TYPE 2 DIABETES","17;7;6;5;4;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","CORONAVIRUS DISEASE 2019 (COVID-19);SECUKINUMAB;GOLIMUMAB;MAMMOGRAPHY;RIGHT CORONARY ARTERY;STROKE VOLUME;TRANSIENT ELASTOGRAPHY;USTEKINUMAB;ACUTE AORTIC SYNDROME;ALPHA (FINANCE);ALPHA-SYNUCLEIN;ANAGRELIDE;ANTHRACYCLINE;ANTIBIOGRAM;ANTIBIOTIC STEWARDSHIP;ANTIBODY TITER;ANTIFIBRINOLYTIC;ANTIMICROBIAL STEWARDSHIP;ASPARTATE TRANSAMINASE;ATHERECTOMY;ATROPHIC GASTRITIS;BILIARY CIRRHOSIS;BTLA;CARDIAC RESYNCHRONIZATION THERAPY;CAREGIVER BURDEN;CAREGIVER STRESS;CERTOLIZUMAB PEGOL;CETUXIMAB;CHILD ABUSE;CLAUDICATION;COGNITIVE DECLINE;COLECTOMY;CONNECTIVE TISSUE DISEASE;CORONARY ARTERY ANEURYSM;CORONARY STENT;CRITICAL LIMB ISCHEMIA;CUTTING BALLOON;CYP3A4;DEBULKING;DESTINATION THERAPY;DIABETIC FOOT ULCER;DOMESTIC VIOLENCE;ENTHESITIS;FERROPORTIN;GENE SIGNATURE;GIANT CELL ARTERITIS;GLUCOSE HOMEOSTASIS;GLYCATED HAEMOGLOBIN;HEAD AND NECK SQUAMOUS-CELL CARCINOMA;HEALTH FACILITY;HEART FAILURE WITH PRESERVED EJECTION FRACTION;IDH1;IΚBΑ;KARYOTYPE;LATENT TUBERCULOSIS;LEGIONNAIRES' DISEASE;LUCIFERASE;MEMORY B CELL;MEPOLIZUMAB;MYCOBACTERIUM BOVIS;MYCOBACTERIUM TUBERCULOSIS COMPLEX;MYELOPROLIFERATIVE NEOPLASM;NEUROGRANIN;NEUROPEPTIDE Y RECEPTOR;NOISE-INDUCED HEARING LOSS;OBETICHOLIC ACID;PARATHYROIDECTOMY;RUXOLITINIB;SACUBITRIL;SACUBITRIL, VALSARTAN;SEVERE SEPSIS;SEXUAL CONTACT;SPECKLE TRACKING ECHOCARDIOGRAPHY;SPIRILLACEAE;TRANSFERRIN SATURATION;TRANSPULMONARY PRESSURE;TUMOR-INFILTRATING LYMPHOCYTES;VO2 MAX","17;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",";HUMANS;COVID-19;TREATMENT OUTCOME;MALE;FEMALE;RETROSPECTIVE STUDIES;ACUTE KIDNEY INJURY;ADULT;HEART FAILURE;AGED;CORONARY OCCLUSION;PROSPECTIVE STUDIES;INFLAMMATION;PERCUTANEOUS CORONARY INTERVENTION;SQUAMOUS CELL CARCINOMA OF HEAD AND NECK;AIR POLLUTION;COMMUNICABLE DISEASES;CORONARY ANGIOGRAPHY;ENDOCARDITIS","77;55;16;11;9;8;8;7;7;7;6;6;6;5;5;5;4;4;4;4","MAGNETIC RESONANCE IMAGING APPLICATIONS IN MEDICINE;MOLECULAR PATHOGENESIS OF MYELOPROLIFERATIVE DISORDERS;CLASSIFICATION AND TREATMENT OF SPONDYLOARTHRITIS;CORONAVIRUS DISEASE 2019 RESEARCH;ASTHMA;CARDIOTOXICITY OF CANCER TREATMENTS;CORONAVIRUS DISEASE 2019;MECHANICAL VENTILATION IN RESPIRATORY FAILURE AND ARDS;RECOMMENDATIONS FOR CARDIAC CHAMBER QUANTIFICATION BY ECHOCARDIOGRAPHY;ACUTE MYELOID LEUKEMIA;APPLICATIONS OF DEEP LEARNING IN MEDICAL IMAGING;BREAST MAGNETIC RESONANCE IMAGING IN ONCOLOGY;CARDIAC RESYNCHRONIZATION THERAPY IN HEART FAILURE;CLINICAL STUDIES ON CORONARY STENTS AND REVASCULARIZATION;COCHLEAR NEUROPATHY AND HEARING LOSS MECHANISMS;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;GLOBAL BURDEN OF ANTIMICROBIAL RESISTANCE;HELICOBACTER PYLORI INFECTION AND GASTRIC CANCER;IMPACT OF COVID-19 ON CANCER PATIENTS AND CARE","9;5;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2","PERFUSION IMAGING;MAGNETIC RESONANCE IMAGING;GOLD STANDARD (TEST);2019-20 CORONAVIRUS OUTBREAK;PANDEMIC;SEQUENCE (BIOLOGY);ALIASING;BREAST MRI;ETIOLOGY;LEFT VENTRICULAR FUNCTION;SIGNAL (PROGRAMMING LANGUAGE);TREATMENT;ASTHMA;CARDIAC IMAGING;ECHOCARDIOGRAPHY;B CELL ABNORMALITIES;BIOMARKERS FOR IMMUNOTHERAPY;CARDIOTOXICITY;CARDIOVASCULAR RISK ASSESSMENT;CLINICAL CHARACTERISTICS","8;7;6;5;5;5;4;4;4;4;4;4;3;3;3;2;2;2;2;2","MAGNETIC RESONANCE;HEART FAILURE;INTENSIVE CARE;MULTICENTRE STUDY;OBSERVATIONAL STUDY;PSORIATIC ARTHRITIS;RESONANCE IMAGING;BIOLOGIC TREATMENTS;CLINICAL PRACTICE;COVID- PANDEMIC;HIGH-FLOW NASAL;ITALY RESULTS;LONGITUDINAL STUDY;OBSERVATIONAL LONGITUDINAL;REAL-WORLD EVIDENCE;ACQUISITION MULTISHOT;ALZHEIMERS DISEASE;ANGLE MODULATION;ANTERIOR DESCENDING;ARTERY BYPASS;BILIARY CHOLANGITIS;BREAST CANCER;BRIDGING COLLATERALS;CANCER REGISTRIES;CARE UNITS;CEREBROSPINAL FLUID;CHRONICALLY OCCLUDED;COMPRESSED SENSE;CONFIRMED COVID-;CONTRASTOGRAPHIC STUDY","7;5;4;4;4;4;4;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","LEFT VENTRICULAR;STATISTICALLY SIGNIFICANT;MAGNETIC RESONANCE;COVID- PATIENTS;HEART FAILURE;RISK FACTORS;CARDIOVASCULAR RISK;INTENSIVE CARE;SIGNIFICANT DIFFERENCE;TEMPORAL RESOLUTION;AOR CI;EJECTION FRACTION;IDH MUTATIONS;PATIENTS AFFECTED;SIGNIFICANT REDUCTION;ANTI-S-RBD IGG;BREAST MRI;CARE UNITS;CORONARY ARTERY;CRITICALLY ILL;HYPERTENSIVE PATIENTS;MRI PROTOCOL;MULTIVANE SEQUENCE;OBSERVATIONAL STUDY;PATIENTS UNDERWENT;PRIMARY OUTCOME;RISK STRATIFICATION;SERUM CALCITONIN;SIGNIFICANT INCREASE;ADVERSE EVENTS","15;15;12;11;11;10;9;9;8;8;7;7;7;7;7;6;6;6;6;6;6;6;6;6;6;6;6;6;6;5",64,0.48,7.21,6,1.25,1,0,1,0,1,1,7.5,0,0,5,0,0,2,2,6,2.5,0,0,17,17,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,20,3.3,3435.4,10.2,9,0.45,157.6,0,0,5,0,6,0,1,8,0,15,5,0,0,0,0,0,0,20,0,0,20,0,0,0,0,0,0,0,0,0,"United States;Italy;Germany;Belgium;Denmark;Japan","5;4;3;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY;42 HEALTH SCIENCES;31 BIOLOGICAL SCIENCES;3204 IMMUNOLOGY;3210 NUTRITION AND DIETETICS;3211 ONCOLOGY AND CARCINOGENESIS;4206 PUBLIC HEALTH","20;14;3;3;2;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;DIGESTIVE DISEASES;RARE DISEASES;ATHEROSCLEROSIS;CANCER;CARDIOVASCULAR;AUTOIMMUNE DISEASE;CHRONIC LIVER DISEASE AND CIRRHOSIS;HEART DISEASE;HEART DISEASE - CORONARY HEART DISEASE;LIVER DISEASE;PATIENT SAFETY;AGING;HEMATOLOGY;NUTRITION;PREVENTION;ARTHRITIS;CHRONIC OBSTRUCTIVE PULMONARY DISEASE;CHRONIC PAIN","19;15;6;5;4;4;4;3;3;3;3;3;3;2;2;2;2;1;1;1","CARDIOVASCULAR;CANCER;INFLAMMATORY AND IMMUNE SYSTEM;METABOLIC AND ENDOCRINE;ORAL AND GASTROINTESTINAL;INFECTION;NEUROLOGICAL;RESPIRATORY","5;3;2;2;2;1;1;1","6.1 PHARMACEUTICALS;7.1 INDIVIDUAL CARE NEEDS;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;2.4 SURVEILLANCE AND DISTRIBUTION;6.2 CELLULAR AND GENE THERAPIES;7.3 MANAGEMENT AND DECISION MAKING","15;2;1;1;1;1","NON-HODGKIN'S LYMPHOMA;LEUKEMIA / LEUKAEMIA;LIVER CANCER;MELANOMA;SARCOMA","2;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","3",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,"FRONTIERS","1","35 COMMERCE, MANAGEMENT, TOURISM AND SERVICES;44 HUMAN SOCIETY;4410 SOCIOLOGY","1;1;1","PREVENTION","1",NA,NA,NA,NA,NA,NA,"PUBLIC HEALTH","1",NA,NA,NA,NA
"AOUSSN_GIACCONE",2023,202,16.980198019802,2.5049504950495,0.257425742574257,0.301980198019802,0.341584158415842,1.77543859649123,1.23809523809524,1.69444444444444,1.6046511627907,0.772277227722772,0,69,42,13,5,0.34,0.21,0.06,0.02,3.64,0.831277667015862,4.68523676880223,0.292079207920792,0.97029702970297,0.444,0.403,0.468,0.479,"ANTONIO CASCIO;ANDREA CORTEGIANI;LUCA PIPITÒ;GIUSEPPINA NOVO;ALESSANDRA IURLO;MARCELLO CIACCIO;ANTONIO RUSSO;FRANCESCO DIELI;ALFREDO R. GALASSI;MARIA ROSARIA VALERIO;ANTONINO GIARRATANO;ETTORE DINOTO;CRISTINA MADAUDO;ANTONIO SIMONE LAGANÀ;ANTONINO TUTTOLOMONDO;VITO CHIÀNTERA;CLAUDIA COLOMBA;ANNA MARIA CORSALE;SERENA MERAVIGLIA;WALTER MAZZUCCO","22;15;10;10;9;9;9;8;8;7;7;7;7;7;6;6;6;6;6;6","ANTONIO CASCIO;LUCA PIPITÒ;ANDREA CORTEGIANI;GIUSEPPINA NOVO;PAOLA DI CARLO;MARCELLO CIACCIO;FRANCESCO DIELI;ETTORE DINOTO;MARCELLO TRIZZINO;CLAUDIA COLOMBA;CRISTINA MADAUDO;FELICE PECORARO;ANTONINO GIARRATANO;VITO CHIÀNTERA;NICOLA SERRA;ANTONIO SIMONE LAGANÀ;MARIA ROSARIA VALERIO;ALFREDO R. GALASSI;VITTORIO GEBBIA;PAOLA CLAUSER","2.43;1.39;1.22;0.94;0.82;0.81;0.78;0.78;0.74;0.74;0.68;0.68;0.68;0.68;0.67;0.63;0.62;0.59;0.57;0.54","ANTONIO CASCIO;ANDREA CORTEGIANI;LUCA PIPITÒ;GIUSEPPINA NOVO;MARCELLO CIACCIO;ANTONIO RUSSO;FRANCESCO DIELI;ALFREDO R. GALASSI;MARIA ROSARIA VALERIO;ANTONINO GIARRATANO;ETTORE DINOTO;CRISTINA MADAUDO;ANTONIO SIMONE LAGANÀ;ANTONINO TUTTOLOMONDO;VITO CHIÀNTERA;ANNA MARIA CORSALE;SERENA MERAVIGLIA;WALTER MAZZUCCO;LORENA INCORVAIA;FELICE PECORARO","22;15;10;10;9;9;8;8;7;7;7;7;7;6;6;6;6;6;6;6","ANTONIO CASCIO;LUCA PIPITÒ;ANDREA CORTEGIANI;GIUSEPPINA NOVO;PAOLA DI CARLO;MARCELLO CIACCIO;FRANCESCO DIELI;ETTORE DINOTO;MARCELLO TRIZZINO;CRISTINA MADAUDO;FELICE PECORARO;ANTONINO GIARRATANO;VITO CHIÀNTERA;NICOLA SERRA;ANTONIO SIMONE LAGANÀ;MARIA ROSARIA VALERIO;ALFREDO R. GALASSI;ANTONIO RUSSO;ANNA GIAMMANCO;MARIASANTA NAPOLITANO","2.43;1.39;1.22;0.94;0.82;0.81;0.78;0.78;0.74;0.68;0.68;0.68;0.68;0.67;0.63;0.62;0.59;0.54;0.54;0.53","ANTONIO CASCIO;ANDREA CORTEGIANI;ALICE ANNALISA MEDAGLIA;ALESSANDRA MULARONI;MARCO FALCONE;CLAUDIA GIOÈ;ALBERTO ENRICO MARAOLO;ANDREA MARINO;ANNA MARIA CORSALE;ALESSIO FARCOMENI;ANNA CARRETTA;ANTONINA FRANCO;ANTONIO ALBANESE;BRUNO CACOPARDO;CALOGERO RICCARDO BUSCEMI;CARMELO IACOBELLO;CHRISTIAN SGROI;DONATELLA PALAZZO;FILIPPO PIERALLI;FRANCESCO MENICHETTI","104;74;69;63;62;59;55;55;54;53;53;53;53;53;53;53;53;53;53;53","ALICE ANNALISA MEDAGLIA;ANDREA CORTEGIANI;CLAUDIA GIOÈ;ANTONIO CASCIO;GIUSEPPINA NOVO;ANNA MARIA CORSALE;FRANCESCO DIELI;SERENA MERAVIGLIA;ALESSIA ANGELA MARIA ORLANDO;MARCO INSALACO;ANTONIO SIMONE LAGANÀ;GABRIELLA TESTA;ANDREA ETRUSCO;SERGIO SIRAGUSA;MARTA DI SIMONE;ANTONINO GIARRATANO;ANTONINO TUTTOLOMONDO;DANIELA DI LISI;MARCELLO CIACCIO;WALTER MAZZUCCO","69;65;59;51;45;42;41;38;37;37;36;35;31;31;26;23;23;23;22;22","ANTONIO CASCIO;ANDREA CORTEGIANI;GIUSEPPINA NOVO;LUCA PIPITÒ;MARIA ROSARIA VALERIO;ANTONINO GIARRATANO;ANTONIO SIMONE LAGANÀ;CRISTINA MADAUDO;ETTORE DINOTO;FRANCESCO DIELI;WALTER MAZZUCCO;ANTONINO TUTTOLOMONDO;DANIELA DI LISI;MARCELLO TRIZZINO;MARCO SANTORO;ALICE ANNALISA MEDAGLIA;ANDREA ETRUSCO;MARCELLO CIACCIO;ALFREDO R. GALASSI;BRUNA LO SASSO","21;14;10;9;7;6;6;6;6;6;6;5;5;5;5;5;5;5;4;4","MEDICINE;BIOLOGY;COMPUTER SCIENCE;CHEMISTRY;PHYSICS;ENGINEERING;SOCIOLOGY;MATHEMATICS;ECONOMICS;POLITICAL SCIENCE;PSYCHOLOGY;MATERIALS SCIENCE;PHILOSOPHY;BUSINESS;GEOLOGY;HISTORY","191;60;15;14;14;9;9;8;7;7;7;3;2;1;1;1","INTERNAL MEDICINE;SURGERY;GENETICS;IMMUNOLOGY;ONCOLOGY;PATHOLOGY;RADIOLOGY;GASTROENTEROLOGY;CARDIOLOGY;PEDIATRICS;ENVIRONMENTAL HEALTH;INTENSIVE CARE MEDICINE;BIOCHEMISTRY;MICROBIOLOGY;CANCER RESEARCH;ENDOCRINOLOGY;NURSING;GYNECOLOGY;FAMILY MEDICINE;ANESTHESIA;CELL BIOLOGY;PSYCHIATRY","152;62;37;31;31;29;25;24;22;20;19;17;16;14;12;12;12;11;10;9;9;9","CANCER;DISEASE;RETROSPECTIVE COHORT STUDY;GENE;COHORT;POPULATION;ADVERSE EFFECT;RANDOMIZED CONTROLLED TRIAL;CHEMOTHERAPY;ANTIBIOTICS;PREGNANCY;ANTIBODY;MYOCARDIAL INFARCTION;BACTERIA;HEART FAILURE;IMMUNE SYSTEM;OBSERVATIONAL STUDY;CONFIDENCE INTERVAL;DISCONTINUATION;INCIDENCE (GEOMETRY);MYELOID LEUKEMIA;PROSPECTIVE COHORT STUDY;SEPSIS","46;31;25;19;18;18;16;14;12;11;11;9;9;8;8;8;8;7;7;7;7;7;7","BREAST CANCER;INFECTIOUS DISEASE (MEDICAL SPECIALTY);CLINICAL ENDPOINT;EJECTION FRACTION;FETUS;OVARIAN CANCER;TOLERABILITY;IMATINIB;SEPTIC SHOCK;MUTATION;PSEUDOMONAS AERUGINOSA;GENOTYPE;HAZARD RATIO;HEART RATE;METASTATIC MELANOMA;ABDOMINAL AORTIC ANEURYSM;CARDIOTOXICITY;CD8;CERVICAL CANCER;COLORECTAL CANCER;CONVENTIONAL PCI;GESTATION;IMMUNOPHENOTYPING;IMMUNOTHERAPY;MAPK/ERK PATHWAY;MULTICENTER STUDY;PERCUTANEOUS CORONARY INTERVENTION;POLYMERASE;PORTAL HYPERTENSION;RANDOMIZATION;RITUXIMAB;UNIVARIATE ANALYSIS","20;14;8;7;7;7;7;6;6;5;5;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","CORONAVIRUS DISEASE 2019 (COVID-19);MAMMOGRAPHY;MASTECTOMY;NILOTINIB;BRCA MUTATION;DASATINIB;ENDOVASCULAR ANEURYSM REPAIR;GERMLINE MUTATION;METASTATIC BREAST CANCER;NEOADJUVANT THERAPY;POLY ADP RIBOSE POLYMERASE;TRAMETINIB;VEMURAFENIB;ACINETOBACTER BAUMANNII;ADIPOKINE;ANTIRETROVIRAL THERAPY;CARDIAC RESYNCHRONIZATION THERAPY;CEFTAZIDIME;CLAUDICATION;COLONOSCOPY;ESOPHAGEAL VARICES;GENE MUTATION;HEART RATE VARIABILITY;IMATINIB MESYLATE;KLEBSIELLA PNEUMONIAE;PITTSBURGH SLEEP QUALITY INDEX;PLACENTA;PRENATAL DIAGNOSIS;SPECKLE TRACKING ECHOCARDIOGRAPHY;TIMI;TRANSIENT ELASTOGRAPHY;TRIPLE-NEGATIVE BREAST CANCER","14;5;4;4;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2",";HUMANS;FEMALE;RETROSPECTIVE STUDIES;BREAST NEOPLASMS;MALE;ADULT;TREATMENT OUTCOME;MIDDLE AGED;AGED;ITALY;PROSPECTIVE STUDIES;ANTI-BACTERIAL AGENTS;COVID-19;HIV INFECTIONS;CORONARY OCCLUSION;OVARIAN NEOPLASMS;PERCUTANEOUS CORONARY INTERVENTION;RISK FACTORS;ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS","117;83;30;24;18;16;15;15;13;12;10;10;9;9;9;8;7;7;7;6","MOLECULAR RESEARCH ON BREAST CANCER;CARDIOTOXICITY OF CANCER TREATMENTS;CLINICAL STUDIES ON CORONARY STENTS AND REVASCULARIZATION;EFFICACY AND RESISTANCE IN CML TREATMENT;MOLECULAR PATHOGENESIS OF MYELOPROLIFERATIVE DISORDERS;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;MANAGEMENT AND PATHOPHYSIOLOGY OF ABDOMINAL AORTIC ANEURYSMS;CEREBELLAR CONTRIBUTIONS TO NEUROLOGICAL DISORDERS AND FUNCTIONS;GASTRIC CANCER RESEARCH AND TREATMENT;GENETIC RESEARCH ON BRCA MUTATIONS AND CANCER RISK;GLOBAL BURDEN OF ANTIMICROBIAL RESISTANCE;GLOBAL BURDEN OF LEISHMANIASIS INCIDENCE AND TREATMENT;GLOBAL CHALLENGE OF ANTIBIOTIC RESISTANCE IN BACTERIA;IMPACT OF COVID-19 ON MENTAL HEALTH;MAMMALIAN MAP KINASE SIGNALING PATHWAYS;MECHANICAL VENTILATION IN RESPIRATORY FAILURE AND ARDS;RADIOMICS IN MEDICAL IMAGING ANALYSIS;CARDIAC RESYNCHRONIZATION THERAPY IN HEART FAILURE;CORONAVIRUS DISEASE 2019 RESEARCH;DEEP LEARNING IN MEDICAL IMAGE ANALYSIS","6;5;5;5;5;4;4;3;3;3;3;3;3;3;3;3;3;2;2;2","PANDEMIC;CLINICAL ENDPOINT;DISCONTINUATION;TOLERABILITY;DIAGNOSIS;INTERQUARTILE RANGE;NEOADJUVANT THERAPY;TREATMENT;BREAST CANCER;BREAST MRI;CONCOMITANT;MELANOMA;PANDEMICS;PHLEBOTOMY;POSITIVE END-EXPIRATORY PRESSURE;SINGLE CENTER;VACCINATION INTENTION;BOSUTINIB;BRCA MUTATION;CANCER IMAGING","11;10;7;7;5;5;5;5;4;4;4;4;4;4;4;4;4;3;3;3","BREAST CANCER;ITALIAN ASSOCIATION;COVID- PANDEMIC;CANCER PATIENTS;COHORT STUDY;CHRONIC MYELOID;ITALIAN SOCIETY;MYELOID LEUKEMIA;OBSERVATIONAL STUDY;POLYETHYLENE GLYCOL;SARS-COV- INFECTION;CARDIAC DYSFUNCTION;CHRONIC TOTAL;CLINICAL OUTCOMES;CLINICAL TRIAL;ENDOSCOPIC SUBMUCOSAL;INTENSIVE CARE;LONGEVITY TRAIT;MULTICENTRE RANDOMIZED;OVARIAN CANCER;POLYCYTHEMIA VERA;PROSPECTIVE COHORT;RANDOMIZED CLINICAL;RETROSPECTIVE ANALYSIS;RETROSPECTIVE STUDY;SECONDARY ANALYSIS;SICILIAN SEMI-;STEM CELLS;SUBMUCOSAL DISSECTION;ADVANCED OVARIAN","13;10;7;5;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;2","BREAST CANCER;PATIENTS TREATED;COVID- PANDEMIC;CLINICAL PRACTICE;OBSERVATIONAL STUDY;CLINICAL OUTCOMES;MEDIAN FOLLOW-UP;RETROSPECTIVE STUDY;RISK FACTORS;STATISTICALLY SIGNIFICANT;DAY MORTALITY;MEDIAN AGE;DE NOVO;DIABETIC FOOT;DIAGNOSTIC ACCURACY;CANCER PATIENTS;HEART FAILURE;INTENSIVE CARE;INTERNAL SPHINCTEROTOMY;LATERAL INTERNAL;LIVER STIFFNESS;MEDIAN TIME;SPLEEN STIFFNESS;WIREBASED ADR;COHORT STUDY;MONTHS CI;MULTIVARIABLE ANALYSIS;PANCREATIC FF;ADVERSE EVENTS;CML PATIENTS","21;21;17;13;13;12;12;12;12;12;11;11;10;10;10;9;9;9;9;9;9;9;9;9;8;8;8;8;7;7",86,0.43,4.92,7,1,1.25,0,2.75,0,1,0,8,0,0,7.25,0,0,2,5,5.75,4,0,0,8,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,13,2.08,2096.92,5.08,2,0.15,25.54,0,0,2,0,1,0,0,10,0,7,6,0,0,0,0,0,0,13,0,0,12,0,0,1,0,0,0,0,0,0,"Italy;United States","5;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;3204 IMMUNOLOGY;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;3212 OPHTHALMOLOGY AND OPTOMETRY;52 PSYCHOLOGY","11;7;3;3;2;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;DIGESTIVE DISEASES;NUTRITION;AUTOIMMUNE DISEASE;CARDIOVASCULAR;RARE DISEASES;BIOENGINEERING;CANCER;CHRONIC LIVER DISEASE AND CIRRHOSIS;HEMATOLOGY;LIVER DISEASE;LUNG;PATIENT SAFETY;PREVENTION;ACUTE RESPIRATORY DISTRESS SYNDROME;ASSISTIVE TECHNOLOGY;ASTHMA;BEHAVIORAL AND SOCIAL SCIENCE;BIOTECHNOLOGY","12;9;5;4;3;3;3;2;2;2;2;2;2;2;2;1;1;1;1;1","CARDIOVASCULAR;ORAL AND GASTROINTESTINAL;INFLAMMATORY AND IMMUNE SYSTEM;RESPIRATORY;CANCER;EYE;MENTAL HEALTH;METABOLIC AND ENDOCRINE;STROKE","3;3;2;2;1;1;1;1;1","6.1 PHARMACEUTICALS;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;5.1 PHARMACEUTICALS;3.1 PRIMARY PREVENTION INTERVENTIONS TO MODIFY BEHAVIOURS OR PROMOTE WELLBEING;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;5.3 MEDICAL DEVICES;6.3 MEDICAL DEVICES;7.1 INDIVIDUAL CARE NEEDS","4;3;2;2;1;1;1;1;1","COLON AND RECTAL CANCER;LIVER CANCER;LUNG CANCER;MYELOMA","1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;2.1 EXOGENOUS FACTORS IN THE ORIGIN AND CAUSE OF CANCER;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","2;1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,"FRONTIERS","2","32 BIOMEDICAL AND CLINICAL SCIENCES;30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;3006 FOOD SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS","3;2;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;BREAST CANCER;CANCER;COMPLEMENTARY AND INTEGRATIVE HEALTH;DIGESTIVE DISEASES;LIVER DISEASE;NUTRITION;PREVENTION","2;2;1;1;1;1;1;1;1","CANCER;METABOLIC AND ENDOCRINE","1;1","6.1 PHARMACEUTICALS;3.3 NUTRITION AND CHEMOPREVENTION","2;1","CLINICAL","2","CLINICAL MEDICINE AND SCIENCE","2","BREAST CANCER","1",NA,NA
"AOUSSN_GIACCONE",2024,203,16.4433497536946,2.8423645320197,0.32512315270936,0.364532019704433,0.330049261083744,2.11355311355311,1.60975609756098,2,1.5952380952381,0.74384236453202,2,65,39,21,9,0.32,0.19,0.1,0.04,1.04,1.08758390757234,3.78536585365854,0.344827586206897,0.955665024630542,0.523,0.526,0.502,0.519,"ANTONIO SIMONE LAGANÀ;WALTER MAZZUCCO;ANTONIO CASCIO;ANDREA ETRUSCO;ALFREDO R. GALASSI;ANTONIO D’AMATO;FABIO TRAMUTO;LUCA PIPITÒ;G VADALÀ;FRANCESCO VITALE;VINCENZO SUCATO;ANDREA CORTEGIANI;EGLE CORRADO;CARMELO MASSIMO MAIDA;VITO CHIÀNTERA;SALVATORE EVOLA;MARCELLO CIACCIO;GIUSEPPINA NOVO;GIORGIO GRAZIANO;MARIO BARBAGALLO","31;18;17;17;13;11;10;9;9;9;9;9;8;8;8;8;8;8;7;7","ANTONIO SIMONE LAGANÀ;CHIARA AVALLONE;ANDREA ETRUSCO;ANTONIO CASCIO;ALFREDO R. GALASSI;VINCENZO SUCATO;GIUSEPPINA NOVO;ANTONELLA ORTELLO;EGLE CORRADO;LUCA PIPITÒ;ANTONIO D’AMATO;WALTER MAZZUCCO;MARCELLO CIACCIO;SALVATORE EVOLA;FRANCESCO COMPARATO;VITO CHIÀNTERA;MARIO BARBAGALLO;LUISA AGNELLO;FABIO TRAMUTO;FRANCESCO VITALE","3.59;2.25;2.07;1.73;1.51;1.38;1.21;1.18;1.14;1.08;1;0.92;0.86;0.85;0.83;0.79;0.69;0.69;0.68;0.65","ANTONIO SIMONE LAGANÀ;WALTER MAZZUCCO;ANTONIO CASCIO;ANDREA ETRUSCO;ALFREDO R. GALASSI;FABIO TRAMUTO;LUCA PIPITÒ;G VADALÀ;FRANCESCO VITALE;VINCENZO SUCATO;ANDREA CORTEGIANI;EGLE CORRADO;CARMELO MASSIMO MAIDA;SALVATORE EVOLA;MARCELLO CIACCIO;GIUSEPPINA NOVO;GIORGIO GRAZIANO;MARIO BARBAGALLO;CLAUDIO COSTANTINO;ANTONELLA ORTELLO","31;18;17;17;13;10;9;9;9;9;9;8;8;8;8;8;7;7;7;7","ANTONIO SIMONE LAGANÀ;CHIARA AVALLONE;ANDREA ETRUSCO;ANTONIO CASCIO;ALFREDO R. GALASSI;VINCENZO SUCATO;GIUSEPPINA NOVO;ANTONELLA ORTELLO;EGLE CORRADO;LUCA PIPITÒ;WALTER MAZZUCCO;MARCELLO CIACCIO;SALVATORE EVOLA;FRANCESCO COMPARATO;MARIO BARBAGALLO;FABIO TRAMUTO;FRANCESCO VITALE;GIUSEPPINA CAMPISI;ALESSIA ANGELA MARIA ORLANDO;CRISTINA MADAUDO","3.59;2.25;2.07;1.73;1.51;1.38;1.21;1.18;1.14;1.08;0.92;0.86;0.85;0.83;0.69;0.68;0.65;0.63;0.62;0.62","ANTONIO SIMONE LAGANÀ;ANDREA ETRUSCO;ANTONIO D’AMATO;TULLIO GOLIA D’AUGÈ;ALFREDO R. GALASSI;GIORGIO BOGANI;LUDOVICO MUZII;OTTAVIA D’ORIA;VIOLANTE DI DONATO;G VADALÀ;ANTONIO CASCIO;A. JAMES GIANNINI;I. CUCCU;RENATO VENEZIA;ANTONELLA ORTELLO;VINCENZO SUCATO;ANDREA GIANNINI;GIUSEPPINA NOVO;AMAL AYED;BAYDAA AL-SANNAN","67;56;40;29;26;25;25;25;25;23;20;19;19;17;16;16;13;13;12;12","ANTONIO SIMONE LAGANÀ;ANDREA ETRUSCO;G VADALÀ;ANTONIO CASCIO;ALFREDO R. GALASSI;RENATO VENEZIA;ANTONELLA ORTELLO;VINCENZO SUCATO;GIUSEPPINA NOVO;FRANCESCO COMPARATO;WALTER MAZZUCCO;ALESSIA ANGELA MARIA ORLANDO;FRANCESCO DIELI;GIUSTO DAVIDE BADAMI;LAURA MANISCALCO;MARCO PIO LA MANNA;NADIA CACCAMO;ALICE ANNALISA MEDAGLIA;LUDOVICO LA GRUTTA;VITTORIO AGRIFOGLIO","66;56;23;19;18;17;16;16;13;12;10;7;7;7;7;7;7;6;6;6","ANTONIO SIMONE LAGANÀ;WALTER MAZZUCCO;ANDREA ETRUSCO;ANTONIO CASCIO;GIUSEPPINA NOVO;FABIO TRAMUTO;G VADALÀ;ALFREDO R. GALASSI;EGLE CORRADO;FRANCESCO VITALE;SALVATORE EVOLA;VINCENZO SUCATO;ANDREA CORTEGIANI;GIORGIO GRAZIANO;CARMELO MASSIMO MAIDA;DANIELA DI LISI;CLAUDIO COSTANTINO;LUCA PIPITÒ;ANTONELLA ORTELLO;ALESSANDRO D’AGOSTINO","30;17;17;16;11;9;9;8;8;8;8;8;7;7;7;6;6;6;5;4","MEDICINE;BIOLOGY;COMPUTER SCIENCE;PHYSICS;ECONOMICS;POLITICAL SCIENCE;CHEMISTRY;MATHEMATICS;SOCIOLOGY;PHILOSOPHY;ENGINEERING;PSYCHOLOGY;MATERIALS SCIENCE;ART;BUSINESS;GEOGRAPHY;ENVIRONMENTAL SCIENCE;GEOLOGY","200;67;27;13;9;9;8;8;8;7;5;5;4;3;3;3;2;1","INTERNAL MEDICINE;SURGERY;PATHOLOGY;CARDIOLOGY;GENETICS;ENVIRONMENTAL HEALTH;INTENSIVE CARE MEDICINE;RADIOLOGY;GYNECOLOGY;OBSTETRICS;ONCOLOGY;IMMUNOLOGY;ENDOCRINOLOGY;PEDIATRICS;VIROLOGY;PSYCHIATRY;EMERGENCY MEDICINE;NURSING;PHYSICAL THERAPY;ARTIFICIAL INTELLIGENCE;GASTROENTEROLOGY;LAW;MICROBIOLOGY","138;41;35;34;34;29;29;26;23;20;19;18;16;13;13;12;10;10;10;9;9;9;9","CANCER;DISEASE;POPULATION;PREGNANCY;RETROSPECTIVE COHORT STUDY;GENE;MYOCARDIAL INFARCTION;RANDOMIZED CONTROLLED TRIAL;ANTIBIOTICS;DIABETES MELLITUS;LOGISTIC REGRESSION;MAGNETIC RESONANCE IMAGING;PROSPECTIVE COHORT STUDY;CHEMOTHERAPY;CROSS-SECTIONAL STUDY;EPIDEMIOLOGY;OUTBREAK;STENOSIS;BACTERIA;COHORT;HEALTH CARE","37;37;23;19;16;12;12;11;9;9;9;9;9;8;8;7;7;7;6;6;6","BREAST CANCER;INFECTIOUS DISEASE (MEDICAL SPECIALTY);INFERTILITY;REVASCULARIZATION;2019-20 CORONAVIRUS OUTBREAK;ACUTE CORONARY SYNDROME;ANTIBIOTIC RESISTANCE;CERVICAL CANCER;CLINICAL ENDPOINT;COLORECTAL CANCER;CONVENTIONAL PCI;GENOTYPE;IN VITRO FERTILISATION;INSULIN RESISTANCE;MISCARRIAGE;OVARIAN CANCER;PROSTATE CANCER;ABORTION;CANCER REGISTRY;CARDIOTOXICITY;CORONARY ARTERIES;CULPRIT;EJECTION FRACTION;FATTY LIVER;FERTILITY;MYCOBACTERIUM TUBERCULOSIS;PERCUTANEOUS CORONARY INTERVENTION;RESTENOSIS;STAPHYLOCOCCUS AUREUS;TYPE 2 DIABETES;VIRAL LOAD","17;14;10;6;5;4;4;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3","CORONAVIRUS DISEASE 2019 (COVID-19);MAMMOGRAPHY;POLYCYSTIC OVARY;VANCOMYCIN;ACINETOBACTER BAUMANNII;AROMATASE;ASSISTED REPRODUCTIVE TECHNOLOGY;COGNITIVE DECLINE;GENOTYPING;HUMAN PAPILLOMA VIRUS;KLEBSIELLA PNEUMONIAE;MEROPENEM;MULTIFOCAL MOTOR NEUROPATHY;OVARIAN RESERVE;SENTINEL LYMPH NODE;SPECKLE TRACKING ECHOCARDIOGRAPHY;ANDROGEN RECEPTOR;ANTHRACYCLINE;ANTIMICROBIAL STEWARDSHIP;ANTIRETROVIRAL THERAPY;APOLIPOPROTEIN A1;AXILLA;AXILLARY LYMPH NODES;BASOPHIL;BILIARY ATRESIA;BRCA MUTATION;BROTH MICRODILUTION;CARDIOTOCOGRAPHY;CAROTID STENTING;CLADE;CLAUDICATION;COLONOSCOPY;CONTRAST-INDUCED NEPHROPATHY;CORONARY ARTERY ANEURYSM;CRITICAL LIMB ISCHEMIA;CUTTING BALLOON;DAPAGLIFLOZIN;DRUG-ELUTING STENT;ENDOVASCULAR ANEURYSM REPAIR;ENTEROCOCCUS FAECALIS;EPITHELIAL OVARIAN CANCER;EPSTEIN–BARR VIRUS INFECTION;EVANS SYNDROME;EXENATIDE;FALL PREVENTION;FERTILITY PRESERVATION;FIRST TRIMESTER;FMR1;FOLLICLE-STIMULATING HORMONE;FUSOBACTERIUM;GLUTAMATE CARBOXYPEPTIDASE II;HEMODIALYSIS ACCESS;HOMEOSTATIC MODEL ASSESSMENT;HPV INFECTION;INCRETIN;INHA;INNATE LYMPHOID CELL;INTERLEUKIN 21;INTERMITTENT CLAUDICATION;INTRACYTOPLASMIC SPERM INJECTION;INVASIVE DUCTAL CARCINOMA;KNEE PAIN;LATENT TUBERCULOSIS;LDL RECEPTOR;LEMIERRE'S SYNDROME;LIRAGLUTIDE;LMNA;MACE;MANAGEMENT OF PROSTATE CANCER;MEDROXYPROGESTERONE;MISOPROSTOL;NEOADJUVANT THERAPY;NEUROGRANIN;NIVOLUMAB;ORLISTAT;PARATHYROIDECTOMY;PHOSPHODIESTERASE 3;PLACENTA;PROCTOCOLECTOMY;PURE TONE AUDIOMETRY;SEED DORMANCY;SINGLE-NUCLEOTIDE POLYMORPHISM;STEATOHEPATITIS;T-CELL RECEPTOR;UROTHELIAL CARCINOMA;VEDOLIZUMAB","13;4;3;3;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",";HUMANS;FEMALE;MALE;ADULT;MIDDLE AGED;AGED;ITALY;AGED, 80 AND OVER;RISK FACTORS;RETROSPECTIVE STUDIES;CROSS-SECTIONAL STUDIES;PROSPECTIVE STUDIES;TREATMENT OUTCOME;PREGNANCY;PREVALENCE;COVID-19;BREAST NEOPLASMS;CHILD;REGISTRIES","128;74;51;36;29;28;24;23;13;13;11;9;9;9;8;8;7;6;6;6","DIAGNOSIS AND MANAGEMENT OF ENDOMETRIOSIS;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;EPIDEMIOLOGY AND MANAGEMENT OF SEPSIS AND SEPTIC SHOCK;ASTHMA;CLINICAL STUDIES ON CORONARY STENTS AND REVASCULARIZATION;DIAGNOSIS AND MANAGEMENT OF POLYCYSTIC OVARY SYNDROME;HUMAN PAPILLOMAVIRUS AND CERVICAL CANCER EPIDEMIOLOGY;MANAGEMENT OF VALVULAR HEART DISEASE;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;CARDIOTOXICITY OF CANCER TREATMENTS;CHOLESTEROL-LOWERING TREATMENT;CORONAVIRUS DISEASE 2019;GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS;GLOBAL CANCER INCIDENCE AND MORTALITY PATTERNS;GLOBAL CHALLENGE OF ANTIBIOTIC RESISTANCE IN BACTERIA;GUILLAIN-BARRÉ SYNDROME AND RELATED NEUROPATHIES;TUBERCULOSIS;BREAST MAGNETIC RESONANCE IMAGING IN ONCOLOGY;CEREBROSPINAL FLUID DISORDERS AND HEMATOMAS;CLOSTRIDIUM DIFFICILE INFECTION AND TREATMENT","6;5;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;2;2;2","CROSS-SECTIONAL STUDY;CARDIAC IMAGING;2019-20 CORONAVIRUS OUTBREAK;BREAST CANCER;BREAST MRI;CARDIOVASCULAR RISK ASSESSMENT;DIAGNOSIS;PANDEMIC;CLINICAL ENDPOINT;DELPHI METHOD;MYOCARDIAL INFARCTION;MYOCARDIAL REVASCULARIZATION;NEURODEGENERATION;PERFUSION IMAGING;TREATMENT;ANGIOLOGY;ASTHMA;CARDIAC SURGERY RISK MODELS;CARDIOTOXICITY;CARDIOVASCULAR EVALUATION","8;7;6;6;6;6;5;5;4;4;4;4;4;4;4;3;3;3;3;3","BREAST CANCER;RETROSPECTIVE STUDY;COHORT STUDY;MAGNETIC RESONANCE;CROSS-SECTIONAL STUDY;INTENSIVE CARE;MYOCARDIAL INFARCTION;PROSPECTIVE STUDY;ACUTE CORONARY;CARE UNIT;CLINICAL PRACTICE;DELPHI CONSENSUS;ELDERLY PATIENTS;ITALIAN SOCIETY;PAIN MANAGEMENT;RANDOMIZED CONTROLLED;REPRODUCTIVE OUTCOMES;SICILY ITALY;ACUTE MYELOID;ALZHEIMERS DISEASE;AORTIC STENOSIS;AORTIC VALVE;ARACHNOID CYST;ARTERIES MINOCA;ARTERY ANEURYSM;BLOOD PRESSURE;CANCER PATIENTS;CARDIAC MAGNETIC;CARDIOVASCULAR DISEASE;CENTER EXPERIENCE","7;6;5;5;4;4;4;4;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2","MYOCARDIAL INFARCTION;BREAST CANCER;CORONARY ARTERY;CURE PREVALENCE;SEPTIC SHOCK;CLINICAL PRACTICE;LEFT VENTRICULAR;ADJOR CI;BLOOD PRESSURE;INTENSIVE CARE;INTER-READER AGREEMENT;NK CELLS;PUBLIC HEALTH;AID USERS;AORTIC STENOSIS;COHORT STUDY;HEARING AID;RETROSPECTIVE STUDY;RISK FACTORS;RISK SCORES;ADULT PATIENTS;BENIGN LESIONS;BRACHIAL ARTERY;CANCER DIAGNOSIS;CANCER REGISTRIES;COMPLETE PREVALENCE;COVID- PATIENTS;INCREASED RISK;LESION CONSPICUITY;LIPOPROTEIN CHOLESTEROL","13;11;11;11;11;10;10;8;8;8;8;8;8;7;7;7;7;7;7;7;6;6;6;6;6;6;6;6;6;6",1,0,1,1,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,1,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,4,2.5,123.5,1.56,0,0,15.25,0,0,0,0,1,0,0,3,0,4,0,0,0,0,0,0,0,4,0,0,4,0,0,0,0,0,0,0,0,0,"Italy;Switzerland","3;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;3004 CROP AND PASTURE PRODUCTION;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3211 ONCOLOGY AND CARCINOGENESIS","4;3;1;1;1;1","CLINICAL RESEARCH;AUTOIMMUNE DISEASE;CHRONIC PAIN;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;DIGESTIVE DISEASES;NUTRITION;PAIN RESEARCH;ARTHRITIS;CANCER;HEMATOLOGY;INFECTIOUS DISEASES;INFLAMMATORY BOWEL DISEASE;LYMPHOMA;MIND AND BODY;PREVENTION;RARE DISEASES","4;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1","INFLAMMATORY AND IMMUNE SYSTEM;CANCER;ORAL AND GASTROINTESTINAL","2;1;1","6.1 PHARMACEUTICALS;6.5 RADIOTHERAPY AND OTHER NON-INVASIVE THERAPIES","3;1","NON-HODGKIN'S LYMPHOMA","1","5.2 LOCALIZED THERAPIES - CLINICAL APPLICATIONS;5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
